| 1 | placebo | 87,219 |
| 2 | glipizide | 210 |
| 3 | treatment-as-usual | 170 |
| 4 | iglar | 117 |
| 5 | headgear | 95 |
| 6 | ketofol | 56 |
| 7 | care-as-usual | 48 |
| 8 | placebo/control | 48 |
| 9 | beractant | 41 |
| 10 | 4plc | 40 |
| 11 | estazolam | 35 |
| 12 | sham-acupuncture | 35 |
| 13 | tac/mmf | 30 |
| 14 | surgery-alone | 29 |
| 15 | abacavir-lamivudine | 28 |
| 16 | efv/ftc/tdf | 27 |
| 17 | elcatonin | 27 |
| 18 | epipen | 26 |
| 19 | fcdt | 24 |
| 20 | biperiden | 22 |
| 21 | verorab | 22 |
| 22 | 6/60 | 21 |
| 23 | menps | 21 |
| 24 | gla-100 | 19 |
| 25 | imiglucerase | 19 |
| 26 | trichlormethiazide | 19 |
| 27 | xalatan | 19 |
| 28 | hbsag-eng | 18 |
| 29 | lopinavir-ritonavir | 18 |
| 30 | mosaicplasty | 18 |
| 31 | chop-r | 17 |
| 32 | sb-p/c | 17 |
| 33 | spongostan | 17 |
| 34 | matt | 15 |
| 35 | menacwy-d | 15 |
| 36 | midazolam-fentanyl | 15 |
| 37 | non-cm | 15 |
| 38 | phytohaemagglutinin | 15 |
| 39 | s-cpr | 15 |
| 40 | segd | 15 |
| 41 | std-cpr | 15 |
| 42 | as02 | 14 |
| 43 | aten | 14 |
| 44 | maobi | 14 |
| 45 | placebo-tens | 14 |
| 46 | poly/bac | 14 |
| 47 | pre-mix | 14 |
| 48 | norepinephrine-dobutamine | 13 |
| 49 | pill-placebo | 13 |
| 50 | sb-pc | 13 |
| 51 | tacrolimus/sirolimus | 13 |
| 52 | teprenone | 13 |
| 53 | b+h | 12 |
| 54 | co-amilozide | 12 |
| 55 | dmbi | 12 |
| 56 | midazolam/fentanyl | 12 |
| 57 | no-brace | 12 |
| 58 | non-icm | 12 |
| 59 | placebo+mtx | 12 |
| 60 | sham-tdcs | 12 |
| 61 | tupkp | 12 |
| 62 | enoxaparin/vka | 11 |
| 63 | erypo®/eprex® | 11 |
| 64 | immuno-chemotherapy | 11 |
| 65 | lapatinib-capecitabine | 11 |
| 66 | mifl | 11 |
| 67 | pp-ees | 11 |
| 68 | r-dhap | 11 |
| 69 | trimethoprimsulfamethoxazole | 11 |
| 70 | vivostat | 11 |
| 71 | cf-wbi | 10 |
| 72 | cvt-mdi | 10 |
| 73 | ec-p | 10 |
| 74 | gemcitabine/paclitaxel | 10 |
| 75 | li-nppv | 10 |
| 76 | nacr | 10 |
| 77 | nbca-ms | 10 |
| 78 | non-adenocarcinoma | 10 |
| 79 | pbo-sc | 10 |
| 80 | placebo-cisplatin | 10 |
| 81 | placebo-teriparatide | 10 |
| 82 | placebo-treatment | 10 |
| 83 | sisb | 10 |
| 84 | ta-ir | 10 |
| 85 | tcz-iv | 10 |
| 86 | tipranavir-ritonavir | 10 |
| 87 | trusopt | 10 |
| 88 | aecus | 9 |
| 89 | angioguard | 9 |
| 90 | cephamandole | 9 |
| 91 | cribs | 9 |
| 92 | ctla | 9 |
| 93 | dmte | 9 |
| 94 | et+mt | 9 |
| 95 | et-b | 9 |
| 96 | flortec | 9 |
| 97 | fu+lv | 9 |
| 98 | lrsb | 9 |
| 99 | merck-20c | 9 |
| 100 | metformin/placebo | 9 |
| 101 | mmf/cni | 9 |
| 102 | no-ap | 9 |
| 103 | no-steroid | 9 |
| 104 | o+g+t | 9 |
| 105 | oxc-ir | 9 |
| 106 | oxycodone/acetaminophen | 9 |
| 107 | pxl01 | 9 |
| 108 | t-fec | 9 |
| 109 | thalidomide-dexamethasone | 9 |
| 110 | ty-51469 | 9 |
| 111 | wm-treated | 9 |
| 112 | wp-crt | 9 |
| 113 | 100nm | 8 |
| 114 | 30gy | 8 |
| 115 | atazanavir-ritonavir | 8 |
| 116 | azt/3tc | 8 |
| 117 | comti | 8 |
| 118 | cq-pq | 8 |
| 119 | cy-flu-atg | 8 |
| 120 | cyc/aza | 8 |
| 121 | densiron | 8 |
| 122 | depain-x | 8 |
| 123 | efavirenz/tenofovir/emtricitabine | 8 |
| 124 | egbs | 8 |
| 125 | emd/dfdba | 8 |
| 126 | euflavine | 8 |
| 127 | flu/itra | 8 |
| 128 | gfn | 8 |
| 129 | hbo-4 | 8 |
| 130 | hemcon | 8 |
| 131 | meoc+p | 8 |
| 132 | multi-rc | 8 |
| 133 | na-hy | 8 |
| 134 | non-ta | 8 |
| 135 | nudsa | 8 |
| 136 | parecoxib/valdecoxib | 8 |
| 137 | passive-rtms | 8 |
| 138 | pedialyte | 8 |
| 139 | pipobroman | 8 |
| 140 | pseudo-ea | 8 |
| 141 | q-1,000 | 8 |
| 142 | r-chop21 | 8 |
| 143 | redef | 8 |
| 144 | rif-mmx | 8 |
| 145 | sham-rtms | 8 |
| 146 | siui | 8 |
| 147 | tp/at | 8 |
| 148 | trastuzumab-capecitabine | 8 |
| 149 | vr-cap | 8 |
| 150 | abc/3tc+atv | 7 |
| 151 | aggressor | 7 |
| 152 | as2o5 | 7 |
| 153 | b-beam | 7 |
| 154 | bevacizumab-pemetrexed | 7 |
| 155 | bevacizumab-xelox | 7 |
| 156 | bilevel-st | 7 |
| 157 | bolus-infusion | 7 |
| 158 | c/abpm | 7 |
| 159 | cfc-mdi | 7 |
| 160 | changmei | 7 |
| 161 | co-codamol | 7 |
| 162 | cocr-zes | 7 |
| 163 | cprmeter | 7 |
| 164 | desciclovir | 7 |
| 165 | diuretics/beta-blockers | 7 |
| 166 | dm/t | 7 |
| 167 | dosulepin | 7 |
| 168 | efv+ftc/tdf | 7 |
| 169 | ethoglucid | 7 |
| 170 | fb-rt | 7 |
| 171 | fccam | 7 |
| 172 | gh/cs | 7 |
| 173 | hemosol-b0 | 7 |
| 174 | hextend® | 7 |
| 175 | hiberix™ | 7 |
| 176 | infanrix-hexa | 7 |
| 177 | k-712 | 7 |
| 178 | lmwh/vka | 7 |
| 179 | methotrexate-doxorubicin | 7 |
| 180 | methotrexate/tacrolimus | 7 |
| 181 | na-1 | 7 |
| 182 | no-asa | 7 |
| 183 | npsv | 7 |
| 184 | oaps | 7 |
| 185 | oxy40 | 7 |
| 186 | pac+cb+bev | 7 |
| 187 | pd-apcc | 7 |
| 188 | pemetrexed+erlotinib | 7 |
| 189 | post-incision | 7 |
| 190 | pph33-03 | 7 |
| 191 | preef | 7 |
| 192 | prosigne | 7 |
| 193 | salazopyrin | 7 |
| 194 | sg-ssg | 7 |
| 195 | sham-ultrasound | 7 |
| 196 | tr-fec | 7 |
| 197 | weo | 7 |
| 198 | xeliri-bev | 7 |
| 199 | zdv/nvp | 7 |
| 200 | 128° | 6 |
| 201 | 200-u | 6 |
| 202 | 270° | 6 |
| 203 | 5fu-ccrt | 6 |
| 204 | a+m | 6 |
| 205 | adlacz | 6 |
| 206 | amx-cl | 6 |
| 207 | as02b | 6 |
| 208 | bfhx | 6 |
| 209 | biasp1-2-3 | 6 |
| 210 | bifonazole-urea | 6 |
| 211 | body-optimized | 6 |
| 212 | carbcountabc | 6 |
| 213 | carboplatin-docetaxel | 6 |
| 214 | cemt-pi-l | 6 |
| 215 | cftdna | 6 |
| 216 | chloraprep | 6 |
| 217 | control/sham | 6 |
| 218 | cyclophosphamide-vincristine-doxorubicin-dexamethasone | 6 |
| 219 | dapsone/pyrimethamine | 6 |
| 220 | ddiet | 6 |
| 221 | deferrioxamine | 6 |
| 222 | desacyl-ghrelin | 6 |
| 223 | dgia | 6 |
| 224 | dicaine | 6 |
| 225 | diffuse-cad | 6 |
| 226 | dnr/ara | 6 |
| 227 | ed-sbp | 6 |
| 228 | engerix-b™ | 6 |
| 229 | er/rfa | 6 |
| 230 | fec-dh | 6 |
| 231 | fenestration/coagulation | 6 |
| 232 | g+b | 6 |
| 233 | hb-200 | 6 |
| 234 | healon5 | 6 |
| 235 | ho-ors | 6 |
| 236 | hrp102 | 6 |
| 237 | hydrothermablation | 6 |
| 238 | i150 | 6 |
| 239 | iggma | 6 |
| 240 | insuplant | 6 |
| 241 | lap+cap | 6 |
| 242 | locator® | 6 |
| 243 | lpv/r+tdf/ftc | 6 |
| 244 | m-cavi | 6 |
| 245 | methscopolamine | 6 |
| 246 | methycobal | 6 |
| 247 | mi-act | 6 |
| 248 | mild/early | 6 |
| 249 | mitoxantrone-prednisone | 6 |
| 250 | ngrt | 6 |
| 251 | non-cp | 6 |
| 252 | non-epidural | 6 |
| 253 | noplug | 6 |
| 254 | nosiheptide | 6 |
| 255 | ooxy | 6 |
| 256 | paccbev | 6 |
| 257 | pancreatojejunostomy | 6 |
| 258 | pbo+li/dvp | 6 |
| 259 | ph-sbp | 6 |
| 260 | pip/taz-amc | 6 |
| 261 | pivampicillin/pivmecillinam | 6 |
| 262 | placebo-mtx | 6 |
| 263 | playstation2 | 6 |
| 264 | pvi+ll | 6 |
| 265 | r-af | 6 |
| 266 | rct-s | 6 |
| 267 | s-1+cisplatin | 6 |
| 268 | saquinavir/ritonavir | 6 |
| 269 | sb415286 | 6 |
| 270 | sbeg | 6 |
| 271 | sham-emt | 6 |
| 272 | sp-aq | 6 |
| 273 | spco2 | 6 |
| 274 | srl+csa | 6 |
| 275 | sti571 | 6 |
| 276 | thioproline | 6 |
| 277 | tlls- | 6 |
| 278 | triclofos | 6 |
| 279 | uvh | 6 |
| 280 | vace | 6 |
| 281 | vial-and-syringe | 6 |
| 282 | 3-branched | 5 |
| 283 | 4l-peg | 5 |
| 284 | 5/70 | 5 |
| 285 | acels | 5 |
| 286 | ada160/80 | 5 |
| 287 | adalimumab-continuation | 5 |
| 288 | adapalene/bpo | 5 |
| 289 | alc-cho | 5 |
| 290 | aml+hctz | 5 |
| 291 | amlodipine/hydrochlorothiazide | 5 |
| 292 | arip | 5 |
| 293 | aspirine | 5 |
| 294 | b-cpap | 5 |
| 295 | basal+ | 5 |
| 296 | bb536-h | 5 |
| 297 | bellovac | 5 |
| 298 | bevacizumab-folfiri | 5 |
| 299 | bisoprolol-first | 5 |
| 300 | bst-100 | 5 |
| 301 | bst-50 | 5 |
| 302 | bupivacaine/fentanyl | 5 |
| 303 | c-pdt | 5 |
| 304 | captoril | 5 |
| 305 | cbt+cm | 5 |
| 306 | conf | 5 |
| 307 | d-fish-bm | 5 |
| 308 | d-fish-pb | 5 |
| 309 | deoxycoformycin | 5 |
| 310 | dha+aa | 5 |
| 311 | diazemuls | 5 |
| 312 | dinoprostone-only | 5 |
| 313 | dipyrone/spasmolytics | 5 |
| 314 | dzp-iv | 5 |
| 315 | endoserter | 5 |
| 316 | fp-bi | 5 |
| 317 | fresubin | 5 |
| 318 | galactography | 5 |
| 319 | hcp-laiv | 5 |
| 320 | hm-off | 5 |
| 321 | hvpd | 5 |
| 322 | hxp | 5 |
| 323 | ifn/bevacizumab | 5 |
| 324 | iiv3-sd | 5 |
| 325 | il-1beta/tnf-alpha | 5 |
| 326 | iv-pb | 5 |
| 327 | ivig+rituximab | 5 |
| 328 | kjai | 5 |
| 329 | lc-ioes | 5 |
| 330 | lc-lcbde | 5 |
| 331 | lch-ii | 5 |
| 332 | levosulpiride | 5 |
| 333 | lgj | 5 |
| 334 | m-er | 5 |
| 335 | mei-cap | 5 |
| 336 | micro-implant | 5 |
| 337 | mmn-2 | 5 |
| 338 | mp/ifn | 5 |
| 339 | mycophenolate/dexamethasone | 5 |
| 340 | na77 | 5 |
| 341 | na₂seo₃ | 5 |
| 342 | neurostan | 5 |
| 343 | nilestriol | 5 |
| 344 | no-bpd | 5 |
| 345 | no-fes | 5 |
| 346 | obese-3 | 5 |
| 347 | pb-pes | 5 |
| 348 | pbo+exe | 5 |
| 349 | pbo/mtx | 5 |
| 350 | pegfp-c1 | 5 |
| 351 | pes/ses | 5 |
| 352 | phaco-trabeculectomy | 5 |
| 353 | pi/nnrti | 5 |
| 354 | placebo-sham | 5 |
| 355 | placebo/vehicle | 5 |
| 356 | post-nac | 5 |
| 357 | rba/pba | 5 |
| 358 | restudying | 5 |
| 359 | restylane® | 5 |
| 360 | rtv/sqv/d4t | 5 |
| 361 | sabeluzole | 5 |
| 362 | salm/fp | 5 |
| 363 | sevoflurane | 5 |
| 364 | sham-stimulation | 5 |
| 365 | simeprevir/pr | 5 |
| 366 | spoon-feeding | 5 |
| 367 | ssri- | 5 |
| 368 | sulphinpyrazone | 5 |
| 369 | t5-fu | 5 |
| 370 | tau-only | 5 |
| 371 | time-control | 5 |
| 372 | tio+for | 5 |
| 373 | tissucol | 5 |
| 374 | tprop | 5 |
| 375 | training-as-usual | 5 |
| 376 | tsga | 5 |
| 377 | uobc | 5 |
| 378 | v160+hctz12.5 | 5 |
| 379 | vinc | 5 |
| 380 | vindesine/cisplatin | 5 |
| 381 | zdv+ddi | 5 |
| 382 | zinc-ors | 5 |
| 383 | ω3fa | 5 |
| 384 | 16-hr | 4 |
| 385 | 20/5mg | 4 |
| 386 | 26/73 | 4 |
| 387 | 300mg/kg/day | 4 |
| 388 | 5fu/mtx | 4 |
| 389 | a-gi | 4 |
| 390 | acceptability/tolerability | 4 |
| 391 | adhd-ct | 4 |
| 392 | amodiaquine+artesunate | 4 |
| 393 | angiotensin-receptor-blockers | 4 |
| 394 | antibiot* | 4 |
| 395 | asdas-low | 4 |
| 396 | atv/rtv+ftc/tdf | 4 |
| 397 | azq | 4 |
| 398 | azt/sdnvp | 4 |
| 399 | bcd+lcn | 4 |
| 400 | berocca™ | 4 |
| 401 | bev-cap | 4 |
| 402 | bms/des | 4 |
| 403 | bonviva | 4 |
| 404 | c33 | 4 |
| 405 | caif | 4 |
| 406 | catechin/theanine | 4 |
| 407 | cav3.1 | 4 |
| 408 | cbdca/ptx | 4 |
| 409 | cisplatin-paclitaxel | 4 |
| 410 | con-lc | 4 |
| 411 | conceptrol | 4 |
| 412 | cpv-2c | 4 |
| 413 | ctbe | 4 |
| 414 | cyclosporine/sirolimus | 4 |
| 415 | czon+mino | 4 |
| 416 | dectin-2 | 4 |
| 417 | deoxycorticosterone/salt | 4 |
| 418 | diclofenac-gel | 4 |
| 419 | diclofenac/ha | 4 |
| 420 | dicyclanil | 4 |
| 421 | dryvax | 4 |
| 422 | dsbcs | 4 |
| 423 | dtp-ipv | 4 |
| 424 | duramorph | 4 |
| 425 | easyfour | 4 |
| 426 | enalapril-first | 4 |
| 427 | erythritol/maltitol | 4 |
| 428 | everolimus-continuation | 4 |
| 429 | evolocumab+soc | 4 |
| 430 | flu-25 | 4 |
| 431 | folfox/bev | 4 |
| 432 | folfox4/ptk/zk | 4 |
| 433 | galnac-gd1a | 4 |
| 434 | gentamicin/clindamycin | 4 |
| 435 | haemtocrit | 4 |
| 436 | higher-carbohydrate | 4 |
| 437 | hplchol | 4 |
| 438 | ia-sa | 4 |
| 439 | ideg+iasp | 4 |
| 440 | ivcy | 4 |
| 441 | jamshidi | 4 |
| 442 | jev-gcc | 4 |
| 443 | l-avd | 4 |
| 444 | lassbio-1471 | 4 |
| 445 | losartan/hct | 4 |
| 446 | malignity | 4 |
| 447 | meperedine | 4 |
| 448 | methylphenidate-only | 4 |
| 449 | microtrabeculectomy | 4 |
| 450 | mipt | 4 |
| 451 | mtx+twhf | 4 |
| 452 | naturopath | 4 |
| 453 | neostigmine/glycopyrrolate | 4 |
| 454 | nihh | 4 |
| 455 | nobex | 4 |
| 456 | non-iabp | 4 |
| 457 | non-initiators | 4 |
| 458 | non-meningitis | 4 |
| 459 | non-suturing | 4 |
| 460 | non-wlff | 4 |
| 461 | nonsuccess | 4 |
| 462 | norx | 4 |
| 463 | ns+e | 4 |
| 464 | obac | 4 |
| 465 | obag | 4 |
| 466 | oral-only | 4 |
| 467 | oraquick | 4 |
| 468 | pancreatico-splenectomy | 4 |
| 469 | pemetrexed/bevacizumab | 4 |
| 470 | pharm-cat | 4 |
| 471 | pias3 | 4 |
| 472 | placebo-imt | 4 |
| 473 | placebo-prednisone | 4 |
| 474 | placebo/gemcitabine | 4 |
| 475 | post-tdcs | 4 |
| 476 | proactiv | 4 |
| 477 | r2.5/e10 | 4 |
| 478 | rituximab-chlorambucil | 4 |
| 479 | rtsi | 4 |
| 480 | s-asa | 4 |
| 481 | s-imrt | 4 |
| 482 | s-scls | 4 |
| 483 | sbnocp | 4 |
| 484 | sd-dn | 4 |
| 485 | sham-bsa | 4 |
| 486 | sl-uvcs | 4 |
| 487 | slvsd | 4 |
| 488 | sofosbuvir-ribavirin | 4 |
| 489 | sorbalgon | 4 |
| 490 | st-pd | 4 |
| 491 | standard-detection | 4 |
| 492 | stentplacement | 4 |
| 493 | stomatovis | 4 |
| 494 | structum® | 4 |
| 495 | tamsulosin/placebo | 4 |
| 496 | tau/wl | 4 |
| 497 | tdf/emtricitabine | 4 |
| 498 | tiv-2 | 4 |
| 499 | tmp-smx-gentamicin | 4 |
| 500 | tmz-21 | 4 |
| 501 | torcetrapib/atorvastatin | 4 |
| 502 | tubotomy | 4 |
| 503 | tzp-amc | 4 |
| 504 | vcpap | 4 |
| 505 | vibration/pd | 4 |
| 506 | walk* | 4 |
| 507 | xelox/bev | 4 |
| 508 | yeast-se | 4 |
| 509 | zdv/3tc/nvp | 4 |
| 510 | zorubicin | 4 |
| 511 | -tn | 3 |
| 512 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 3 |
| 513 | 1-branched | 3 |
| 514 | 1.3±0.5 | 3 |
| 515 | 1.774 | 3 |
| 516 | 1/181 | 3 |
| 517 | 10/34 | 3 |
| 518 | 12.5° | 3 |
| 519 | 13n-ammonia | 3 |
| 520 | 15-gy | 3 |
| 521 | 20,000/microl | 3 |
| 522 | 29.6°c | 3 |
| 523 | 3.620 | 3 |
| 524 | 5/hpf | 3 |
| 525 | 6:1-om3 | 3 |
| 526 | =10-mm | 3 |
| 527 | =100mg/dl | 3 |
| 528 | abacavir/zidovudine/lamivudine | 3 |
| 529 | abstracts-only | 3 |
| 530 | act-hib+viscogel | 3 |
| 531 | adas-cog12 | 3 |
| 532 | adq | 3 |
| 533 | ag2co3 | 3 |
| 534 | am+cba | 3 |
| 535 | aml/hctz | 3 |
| 536 | amytriptyline | 3 |
| 537 | angioconray | 3 |
| 538 | ariva | 3 |
| 539 | aspirin-monotherapy | 3 |
| 540 | athsp90 | 3 |
| 541 | atv+allo | 3 |
| 542 | auc-low | 3 |
| 543 | azt+lcm | 3 |
| 544 | baby-massage | 3 |
| 545 | bap+β-carotene | 3 |
| 546 | bav851 | 3 |
| 547 | besafibrate | 3 |
| 548 | beschitin-f® | 3 |
| 549 | binifibrate | 3 |
| 550 | buffer/cpm | 3 |
| 551 | c-hf | 3 |
| 552 | cap45 | 3 |
| 553 | capox50 | 3 |
| 554 | cc-pt | 3 |
| 555 | cdiets | 3 |
| 556 | ceftezole | 3 |
| 557 | clinic-managed | 3 |
| 558 | clnp-bpo2.5/tz | 3 |
| 559 | compli* | 3 |
| 560 | counsel* | 3 |
| 561 | cpr-only | 3 |
| 562 | crt-pacemaker | 3 |
| 563 | cst+os | 3 |
| 564 | dac-placebo | 3 |
| 565 | dermamatrix | 3 |
| 566 | dermofasciectomy | 3 |
| 567 | detoxification-only | 3 |
| 568 | diabetes/igt | 3 |
| 569 | diatoric | 3 |
| 570 | didanosine/stavudine | 3 |
| 571 | diet+exercise | 3 |
| 572 | dihydrotachysterol | 3 |
| 573 | dingzhongxian | 3 |
| 574 | doca-vehicle | 3 |
| 575 | drospirenone+ethinylestradiol | 3 |
| 576 | dysthymi* | 3 |
| 577 | e2- | 3 |
| 578 | encephabol | 3 |
| 579 | enoxaparin/placebo | 3 |
| 580 | filmstrip | 3 |
| 581 | fluorouracil/doxorubicin/cyclophosphamide | 3 |
| 582 | full-intervention | 3 |
| 583 | gantaile | 3 |
| 584 | gh/pl | 3 |
| 585 | glimepiride+metformin | 3 |
| 586 | h-meals | 3 |
| 587 | heparin/warfarin | 3 |
| 588 | hmpsa | 3 |
| 589 | hrt+bezafibrate | 3 |
| 590 | hurricaine® | 3 |
| 591 | ia-placebo | 3 |
| 592 | ics/salmeterol | 3 |
| 593 | il-2/ifn | 3 |
| 594 | immunace | 3 |
| 595 | ketoprofen-oxymorphone | 3 |
| 596 | lac2e | 3 |
| 597 | lc+ep | 3 |
| 598 | ldr-icbt | 3 |
| 599 | lg-sil | 3 |
| 600 | li120 | 3 |
| 601 | lng- | 3 |
| 602 | low+ | 3 |
| 603 | lower-rate | 3 |
| 604 | map-alone | 3 |
| 605 | matched-placebo | 3 |
| 606 | mbt-iop | 3 |
| 607 | mequitazine | 3 |
| 608 | mfg-standard | 3 |
| 609 | mfolfox6/bevacizumab | 3 |
| 610 | midodrine-octreotide | 3 |
| 611 | mini-octr | 3 |
| 612 | mini-parapatellar | 3 |
| 613 | molixan | 3 |
| 614 | moodswings-plus | 3 |
| 615 | mvr-pp | 3 |
| 616 | never/rarely | 3 |
| 617 | no-diabetes | 3 |
| 618 | no-mm | 3 |
| 619 | non-asa | 3 |
| 620 | non-household | 3 |
| 621 | non-mixed | 3 |
| 622 | non-pst | 3 |
| 623 | non-suction | 3 |
| 624 | non-tcfa | 3 |
| 625 | non-titrated | 3 |
| 626 | non-vestib | 3 |
| 627 | noncandidates | 3 |
| 628 | nonhydrated | 3 |
| 629 | nonnucleosides | 3 |
| 630 | nonspontaneous | 3 |
| 631 | not-treated | 3 |
| 632 | ofd-group | 3 |
| 633 | olanzapine+placebo | 3 |
| 634 | paclitaxel/gemcitabine | 3 |
| 635 | pbo-tnk-tnk | 3 |
| 636 | pbs-immunized | 3 |
| 637 | pe1.3 | 3 |
| 638 | peg-infα-2b | 3 |
| 639 | pertofran | 3 |
| 640 | pinda | 3 |
| 641 | placebo+adt | 3 |
| 642 | placebo+risperidone | 3 |
| 643 | placebo-cpap | 3 |
| 644 | placebo/adalimumab | 3 |
| 645 | placebo/amlodipine | 3 |
| 646 | placebo/pr | 3 |
| 647 | pp+map | 3 |
| 648 | primatrix | 3 |
| 649 | pro/prebiotics | 3 |
| 650 | prp/bdx | 3 |
| 651 | psgag | 3 |
| 652 | pyruvate-lactate | 3 |
| 653 | q1000 | 3 |
| 654 | rasc | 3 |
| 655 | re-offend | 3 |
| 656 | reflect-3 | 3 |
| 657 | rem4 | 3 |
| 658 | s-1/psk | 3 |
| 659 | saber-placebo | 3 |
| 660 | sevoflurane/opioid | 3 |
| 661 | sfa- | 3 |
| 662 | sham-imt | 3 |
| 663 | sham-irradiation | 3 |
| 664 | shr-h | 3 |
| 665 | si/ho | 3 |
| 666 | simvastatin/placebo | 3 |
| 667 | soft-brace | 3 |
| 668 | soy-oil | 3 |
| 669 | standard-aa | 3 |
| 670 | t-buli | 3 |
| 671 | t3cdm | 3 |
| 672 | t4a | 3 |
| 673 | tanezumab+dsr | 3 |
| 674 | tangmaikang | 3 |
| 675 | tau-positive | 3 |
| 676 | tcas/oads | 3 |
| 677 | technetium-stress | 3 |
| 678 | tenofovir/lamivudine | 3 |
| 679 | timolol/dorzolamide | 3 |
| 680 | tritanrix™-hbv/hib | 3 |
| 681 | tvr/pr | 3 |
| 682 | vac- | 3 |
| 683 | vcu200 | 3 |
| 684 | vinorelbine/ifosfamide | 3 |
| 685 | visine | 3 |
| 686 | vocals | 3 |
| 687 | αb-crystallins | 3 |
| 688 | 'saline | 2 |
| 689 | +0.94 | 2 |
| 690 | +247 | 2 |
| 691 | -0.08±0.26 | 2 |
| 692 | -16.72 | 2 |
| 693 | -2·73 | 2 |
| 694 | -lbp/+brace | 2 |
| 695 | 0.06-0.51 | 2 |
| 696 | 0.5-mg/kg | 2 |
| 697 | 0.50±0.11 | 2 |
| 698 | 0/210 | 2 |
| 699 | 1-octadecanol | 2 |
| 700 | 1.00+/-0.67 | 2 |
| 701 | 1.251 | 2 |
| 702 | 1.5±1.4 | 2 |
| 703 | 1.68-10 | 2 |
| 704 | 1.888 | 2 |
| 705 | 10,000/microl | 2 |
| 706 | 10/358 | 2 |
| 707 | 100ml/kg/day | 2 |
| 708 | 11-c2 | 2 |
| 709 | 11.3+/-4.1 | 2 |
| 710 | 13/124 | 2 |
| 711 | 140℃ | 2 |
| 712 | 146/1118 | 2 |
| 713 | 15,000/microl | 2 |
| 714 | 15/110 | 2 |
| 715 | 17/176 | 2 |
| 716 | 19.7+/-8.4 | 2 |
| 717 | 19/250 | 2 |
| 718 | 1mamp | 2 |
| 719 | 2.507 | 2 |
| 720 | 2/49 | 2 |
| 721 | 206/257 | 2 |
| 722 | 21/85 | 2 |
| 723 | 22/103 | 2 |
| 724 | 23/120 | 2 |
| 725 | 23·38 | 2 |
| 726 | 24.0° | 2 |
| 727 | 274.6 | 2 |
| 728 | 28.97+/-4.96 | 2 |
| 729 | 3,000/microliters | 2 |
| 730 | 3.4±0.9 | 2 |
| 731 | 3.8±1.9 | 2 |
| 732 | 3/295 | 2 |
| 733 | 3/380 | 2 |
| 734 | 31.3° | 2 |
| 735 | 31/1118 | 2 |
| 736 | 31/295 | 2 |
| 737 | 31/77 | 2 |
| 738 | 35/30°c | 2 |
| 739 | 37.37 | 2 |
| 740 | 37/295 | 2 |
| 741 | 38.5c | 2 |
| 742 | 39.04 | 2 |
| 743 | 3·15 | 2 |
| 744 | 3μg.kg | 2 |
| 745 | 4-hydroperoxycyclophosphamide | 2 |
| 746 | 4.00±0 | 2 |
| 747 | 409/2176 | 2 |
| 748 | 40×10 | 2 |
| 749 | 41/103 | 2 |
| 750 | 41/92 | 2 |
| 751 | 47/296 | 2 |
| 752 | 47/297 | 2 |
| 753 | 49/380 | 2 |
| 754 | 49° | 2 |
| 755 | 5-fluorouracil/cisplatin | 2 |
| 756 | 5-fu/heparin | 2 |
| 757 | 5-nitro-8-hydroxyquinoline | 2 |
| 758 | 52weeks | 2 |
| 759 | 54.6° | 2 |
| 760 | 6-activity | 2 |
| 761 | 60×10 | 2 |
| 762 | 61/130 | 2 |
| 763 | 64.3±6.4 | 2 |
| 764 | 67/358 | 2 |
| 765 | 6g/kg/day | 2 |
| 766 | 6mp/aza | 2 |
| 767 | 7,739 | 2 |
| 768 | 7.25min | 2 |
| 769 | 7/235 | 2 |
| 770 | 78/372 | 2 |
| 771 | 86/86 | 2 |
| 772 | 8696 | 2 |
| 773 | 98/765 | 2 |
| 774 | =-2.0 | 2 |
| 775 | =7,000 | 2 |
| 776 | aav2-cox8-mcherry | 2 |
| 777 | active-caspase-3 | 2 |
| 778 | active-medication | 2 |
| 779 | ad-hpap | 2 |
| 780 | ademetionin | 2 |
| 781 | ages-mf30 | 2 |
| 782 | agitation-aggression | 2 |
| 783 | ags4 | 2 |
| 784 | alphacypermethrin | 2 |
| 785 | amicacin | 2 |
| 786 | anticlotting | 2 |
| 787 | arrthymia | 2 |
| 788 | arvt+jobelyn | 2 |
| 789 | asdn | 2 |
| 790 | asystolia | 2 |
| 791 | atenolol/hydrochlorothiazide | 2 |
| 792 | athenolol | 2 |
| 793 | atp2a2 | 2 |
| 794 | at→cmx | 2 |
| 795 | azt+ddc | 2 |
| 796 | bacop | 2 |
| 797 | bak-tafluprost | 2 |
| 798 | baralgin | 2 |
| 799 | bav308 | 2 |
| 800 | beschitin-f | 2 |
| 801 | beta-blockers/diuretics | 2 |
| 802 | bevacizumab/paclitaxel/carboplatin | 2 |
| 803 | bezafibrate-fed | 2 |
| 804 | bionators | 2 |
| 805 | biopsy/surgery | 2 |
| 806 | bite-blocks | 2 |
| 807 | budesonide+formoterol | 2 |
| 808 | bunsimgi-eum | 2 |
| 809 | c5a- | 2 |
| 810 | c6-7 | 2 |
| 811 | ca-125+/tvu+ | 2 |
| 812 | cannualaide® | 2 |
| 813 | cb+cbm | 2 |
| 814 | cddgs | 2 |
| 815 | cecum/colon | 2 |
| 816 | cee-mpa | 2 |
| 817 | ceftriaxone/tobramycin | 2 |
| 818 | celtect | 2 |
| 819 | cervex-brush® | 2 |
| 820 | chp2 | 2 |
| 821 | cidr+hcg | 2 |
| 822 | circoflex-vaccinated | 2 |
| 823 | cisplatin/firocoxib | 2 |
| 824 | clonidine/methyldopa | 2 |
| 825 | cm-treated | 2 |
| 826 | cni-withdrawal | 2 |
| 827 | colace | 2 |
| 828 | cometabolism | 2 |
| 829 | continuous=0.90 | 2 |
| 830 | control-therapy | 2 |
| 831 | cortico-subcortically | 2 |
| 832 | cotrimexazole | 2 |
| 833 | cpg-treatments | 2 |
| 834 | csd+caffeine | 2 |
| 835 | cucl2·2h2o | 2 |
| 836 | cyp2j6-like | 2 |
| 837 | cystadenofibroma | 2 |
| 838 | d0-re | 2 |
| 839 | d1246y | 2 |
| 840 | daytime-wetting | 2 |
| 841 | dddr-40 | 2 |
| 842 | defibrillation-first | 2 |
| 843 | depressed/suicidal | 2 |
| 844 | disability/dependency | 2 |
| 845 | docetaxel-placebo | 2 |
| 846 | egfr+ | 2 |
| 847 | end-goals | 2 |
| 848 | enoxaparin-idrabiotaparinux | 2 |
| 849 | epi-adt | 2 |
| 850 | escitalopram+ipt | 2 |
| 851 | etoposide-carboplatin | 2 |
| 852 | etravirine-darunavir-ritonavir | 2 |
| 853 | event-recorder | 2 |
| 854 | extreme/unable | 2 |
| 855 | ezetimibe/atorvastatin | 2 |
| 856 | f-tests | 2 |
| 857 | fentanyl/droperidol | 2 |
| 858 | flex-d. | 2 |
| 859 | flupentixol/melitracen | 2 |
| 860 | forteo® | 2 |
| 861 | fracture/dislocation | 2 |
| 862 | free-jaw | 2 |
| 863 | freeze-killing | 2 |
| 864 | ge-dsc | 2 |
| 865 | gem/other | 2 |
| 866 | ghr+phosphate-sandoz | 2 |
| 867 | gillnets | 2 |
| 868 | glargine/aspart | 2 |
| 869 | gog-182 | 2 |
| 870 | group-threat | 2 |
| 871 | gtp-gamma-s | 2 |
| 872 | havrix-healive | 2 |
| 873 | hcn2-hcn4 | 2 |
| 874 | hemopneumothorax | 2 |
| 875 | hie2 | 2 |
| 876 | homoproparglyglycine | 2 |
| 877 | hotpack | 2 |
| 878 | hydrochlorothiazide/benazepril | 2 |
| 879 | hypafix-elefix | 2 |
| 880 | hypothalamo-pituitary-adrenal-axis | 2 |
| 881 | ice-popsicles | 2 |
| 882 | ics+labas | 2 |
| 883 | icsi-only | 2 |
| 884 | immunosuppressing | 2 |
| 885 | infliximab/azathioprine | 2 |
| 886 | infliximab/mtx | 2 |
| 887 | integrated-low | 2 |
| 888 | inunction | 2 |
| 889 | irinotecan/fu/fa | 2 |
| 890 | isosthenuria | 2 |
| 891 | it+mgn-3 | 2 |
| 892 | iui-coh | 2 |
| 893 | ivacaftor-to-ivacaftor | 2 |
| 894 | juca | 2 |
| 895 | keels | 2 |
| 896 | keishinieppiittokaryojutsubu | 2 |
| 897 | kw-4354 | 2 |
| 898 | l-d+ | 2 |
| 899 | l-dopa/carbidopa/entacapone | 2 |
| 900 | lai-risperidone | 2 |
| 901 | lam/tdf | 2 |
| 902 | lavandulyl | 2 |
| 903 | ldv/sof+rbv | 2 |
| 904 | letrezole | 2 |
| 905 | letrozole/placebo | 2 |
| 906 | leukotoxin-negative | 2 |
| 907 | li/li | 2 |
| 908 | linear/micronodular | 2 |
| 909 | lisinopril-telmisartan | 2 |
| 910 | lkess | 2 |
| 911 | lmw-heparinoid | 2 |
| 912 | locularity | 2 |
| 913 | lopinavirritonavir | 2 |
| 914 | low-flavanone | 2 |
| 915 | low-pa/high-oa | 2 |
| 916 | ls+et | 2 |
| 917 | lumbosciatica | 2 |
| 918 | lvad+ccp | 2 |
| 919 | maa-alb | 2 |
| 920 | manual-control | 2 |
| 921 | matti | 2 |
| 922 | meibopatch | 2 |
| 923 | mesnex | 2 |
| 924 | met+pio45 | 2 |
| 925 | metformin-xr | 2 |
| 926 | methrorraghia | 2 |
| 927 | mi-high | 2 |
| 928 | mkp-2 | 2 |
| 929 | mobicox | 2 |
| 930 | mont+ics | 2 |
| 931 | mosapramine | 2 |
| 932 | mtx-cdp-adm | 2 |
| 933 | mtz-placebo | 2 |
| 934 | n-acetyl-carnitine | 2 |
| 935 | naphthylacyl | 2 |
| 936 | nd-vaccinated | 2 |
| 937 | neostomia | 2 |
| 938 | ngxml-1xh-1 | 2 |
| 939 | no-acei/arb | 2 |
| 940 | no-am | 2 |
| 941 | no-cpap | 2 |
| 942 | no-ets | 2 |
| 943 | no-hme | 2 |
| 944 | no-str | 2 |
| 945 | non-apex | 2 |
| 946 | non-apn | 2 |
| 947 | non-btl | 2 |
| 948 | non-carbapenems | 2 |
| 949 | non-concomitantly | 2 |
| 950 | non-consistent | 2 |
| 951 | non-dc | 2 |
| 952 | non-division | 2 |
| 953 | non-ecf | 2 |
| 954 | non-endorsers | 2 |
| 955 | non-intensively | 2 |
| 956 | non-kyds | 2 |
| 957 | non-mvd | 2 |
| 958 | non-packed | 2 |
| 959 | non-packing | 2 |
| 960 | non-rhg-csf | 2 |
| 961 | non-ripc | 2 |
| 962 | non-smbg | 2 |
| 963 | non-stenting | 2 |
| 964 | non-twhf | 2 |
| 965 | nonanemia | 2 |
| 966 | nondihydropyridines | 2 |
| 967 | nonfluoroscopy | 2 |
| 968 | nootropil | 2 |
| 969 | norbni | 2 |
| 970 | not-coached | 2 |
| 971 | ols-si | 2 |
| 972 | onca | 2 |
| 973 | opticol® | 2 |
| 974 | oscillation+rotation | 2 |
| 975 | p-placebo | 2 |
| 976 | pacebo | 2 |
| 977 | paclitaxel+cisplatin | 2 |
| 978 | paricalcitol- | 2 |
| 979 | peg-ifnα2b/rbv | 2 |
| 980 | peginterferon-alpha-2b | 2 |
| 981 | pelvitrainer | 2 |
| 982 | pemetrexed/carboplatin/bevacizumab | 2 |
| 983 | per. | 2 |
| 984 | philadelphia-chromosome | 2 |
| 985 | photoepilation | 2 |
| 986 | phyllocontin | 2 |
| 987 | piko/software | 2 |
| 988 | pl-mis | 2 |
| 989 | pla3 | 2 |
| 990 | placebo+dsr | 2 |
| 991 | placebo+ms | 2 |
| 992 | placebo+snri | 2 |
| 993 | placebo-doxycycline | 2 |
| 994 | placebo-fulvestrant | 2 |
| 995 | placebo-uvc | 2 |
| 996 | placebo/ezetimibe | 2 |
| 997 | placebo/ibuprofen | 2 |
| 998 | placebo/moxifloxacin | 2 |
| 999 | placebo/statin | 2 |
| 1000 | play-as-usual | 2 |
| 1001 | plc-pmr | 2 |
| 1002 | polymer-only | 2 |
| 1003 | polymethoxychalcones | 2 |
| 1004 | polyphenyl | 2 |
| 1005 | porfiromycin | 2 |
| 1006 | postacclimatization | 2 |
| 1007 | pre-delinquents | 2 |
| 1008 | pre-stratification | 2 |
| 1009 | prolaps | 2 |
| 1010 | prolastin® | 2 |
| 1011 | propofol+alfentanil | 2 |
| 1012 | prostate-vesiculo-epididymitis | 2 |
| 1013 | pss-c | 2 |
| 1014 | pvax1-ori-g-ltb | 2 |
| 1015 | re4 | 2 |
| 1016 | repaglinide-only | 2 |
| 1017 | rifampin-treated | 2 |
| 1018 | risperidone-lai | 2 |
| 1019 | rosiglitazone/placebo | 2 |
| 1020 | s-273 | 2 |
| 1021 | s-l- | 2 |
| 1022 | s-tna | 2 |
| 1023 | sab5 | 2 |
| 1024 | saf-t-coil | 2 |
| 1025 | sagb® | 2 |
| 1026 | saline/gentamicin | 2 |
| 1027 | sbp+rm | 2 |
| 1028 | self-perspectives | 2 |
| 1029 | serotonergics | 2 |
| 1030 | sg+gg | 2 |
| 1031 | sg-t0 | 2 |
| 1032 | sham-exposure | 2 |
| 1033 | smdxr | 2 |
| 1034 | sp+as+pq | 2 |
| 1035 | stilbestrol | 2 |
| 1036 | sub-systems | 2 |
| 1037 | sugar-water | 2 |
| 1038 | sulbenicillin | 2 |
| 1039 | sulfaclomid | 2 |
| 1040 | sulfasalazine+hydroxychloroquine | 2 |
| 1041 | super-eba | 2 |
| 1042 | superior+occi | 2 |
| 1043 | survanta® | 2 |
| 1044 | suture-anchors | 2 |
| 1045 | t-cef | 2 |
| 1046 | taurolin | 2 |
| 1047 | tcp+ca+orc | 2 |
| 1048 | temporal+occi | 2 |
| 1049 | thalidomide/dexamethasone | 2 |
| 1050 | theophylline- | 2 |
| 1051 | tianquan | 2 |
| 1052 | tid40w | 2 |
| 1053 | topical/intracameral | 2 |
| 1054 | trabeculectomy-alt-trabeculectomy | 2 |
| 1055 | triple-immunotherapy | 2 |
| 1056 | ucort | 2 |
| 1057 | ukallxii/e2993 | 2 |
| 1058 | unshared | 2 |
| 1059 | upper-income | 2 |
| 1060 | usual-care-treated | 2 |
| 1061 | usual-practice | 2 |
| 1062 | usualcare | 2 |
| 1063 | uva2 | 2 |
| 1064 | valsartan-hctz | 2 |
| 1065 | vapo-coolant | 2 |
| 1066 | vinorelbin/cisplatin | 2 |
| 1067 | weight-management-plus-exercise | 2 |
| 1068 | xeromammograms | 2 |
| 1069 | xeromammography | 2 |
| 1070 | youthful/active | 2 |
| 1071 | yvoire® | 2 |
| 1072 | zdv/3tc- | 2 |
| 1073 | zdv/3tc/nfv | 2 |
| 1074 | zn-ppix | 2 |
| 1075 | £4,619 | 2 |
| 1076 | λ-signs | 2 |
| 1077 | 'pca | 1 |
| 1078 | 'uncaring | 1 |
| 1079 | *01:02 | 1 |
| 1080 | *i-ib-mal-d-geeek-nanobody | 1 |
| 1081 | +0.02±0.29 | 1 |
| 1082 | +10.2±12.8 | 1 |
| 1083 | +106.3 | 1 |
| 1084 | +3610 | 1 |
| 1085 | +6424 | 1 |
| 1086 | +9.3±13.9 | 1 |
| 1087 | -.054 | 1 |
| 1088 | -0.02+/-0.07 | 1 |
| 1089 | -0.03±0.31 | 1 |
| 1090 | -0.04±0.21 | 1 |
| 1091 | -0.04±0.38ms | 1 |
| 1092 | -0.12±0.69 | 1 |
| 1093 | -0.17±0.30 | 1 |
| 1094 | -0.23±0.19 | 1 |
| 1095 | -0.41±0.21 | 1 |
| 1096 | -0.41±0.43 | 1 |
| 1097 | -0.42+/-0.13 | 1 |
| 1098 | -0.51/second | 1 |
| 1099 | -0.6+/-0 | 1 |
| 1100 | -0.61±0.90 | 1 |
| 1101 | -0.84±0.09 | 1 |
| 1102 | -0.89±0.13 | 1 |
| 1103 | -0.99±0.09 | 1 |
| 1104 | -1.589 | 1 |
| 1105 | -1.7±0.5 | 1 |
| 1106 | -11.4±1.3 | 1 |
| 1107 | -134.7 | 1 |
| 1108 | -13·42 | 1 |
| 1109 | -169.3 | 1 |
| 1110 | -20.3+/-12.7 | 1 |
| 1111 | -3.6±6.8mm | 1 |
| 1112 | -306.4 | 1 |
| 1113 | -32°c | 1 |
| 1114 | -4.8±3.1° | 1 |
| 1115 | -4.9+/-5.7 | 1 |
| 1116 | -6/min | 1 |
| 1117 | -7/8 | 1 |
| 1118 | -8.20±1.28 | 1 |
| 1119 | -8.26±1.24 | 1 |
| 1120 | -87.2 | 1 |
| 1121 | -930.2 | 1 |
| 1122 | -alkylamino-1,2,3,4-tetrahydropyridines | 1 |
| 1123 | -dna-positive | 1 |
| 1124 | -elbow | 1 |
| 1125 | -hemorrhage | 1 |
| 1126 | -i.p | 1 |
| 1127 | -sc | 1 |
| 1128 | -tachycardia | 1 |
| 1129 | -vildaglitpin | 1 |
| 1130 | .68±.92 | 1 |
| 1131 | 0,393 | 1 |
| 1132 | 0.00291+/-0.00041 | 1 |
| 1133 | 0.00322+/-0.00050 | 1 |
| 1134 | 0.004+/-0.001 | 1 |
| 1135 | 0.01*10 | 1 |
| 1136 | 0.01±0.2 | 1 |
| 1137 | 0.02+/-0.14 | 1 |
| 1138 | 0.039+/-0.008 | 1 |
| 1139 | 0.03±0.16 | 1 |
| 1140 | 0.03±0.31 | 1 |
| 1141 | 0.04±2.19×10 | 1 |
| 1142 | 0.071±0.12 | 1 |
| 1143 | 0.0772 | 1 |
| 1144 | 0.10±1.08 | 1 |
| 1145 | 0.13±0.40 | 1 |
| 1146 | 0.17-0.32 | 1 |
| 1147 | 0.19+/-0.09 | 1 |
| 1148 | 0.23+/-0.22 | 1 |
| 1149 | 0.24/patient/year | 1 |
| 1150 | 0.28±0.18 | 1 |
| 1151 | 0.31+/-0.04 | 1 |
| 1152 | 0.31±0.12°c | 1 |
| 1153 | 0.32±0.05 | 1 |
| 1154 | 0.354+/-0.041 | 1 |
| 1155 | 0.35kg | 1 |
| 1156 | 0.35±0.14°c | 1 |
| 1157 | 0.36+/-0.03 | 1 |
| 1158 | 0.3±17.2 | 1 |
| 1159 | 0.41±0.2 | 1 |
| 1160 | 0.45±0.11 | 1 |
| 1161 | 0.46±0.11 | 1 |
| 1162 | 0.48+/-0.10 | 1 |
| 1163 | 0.49±0.10 | 1 |
| 1164 | 0.49±0.12 | 1 |
| 1165 | 0.52+/-0.08n | 1 |
| 1166 | 0.52+/-0.45 | 1 |
| 1167 | 0.52log | 1 |
| 1168 | 0.57±0.09 | 1 |
| 1169 | 0.59±0.16 | 1 |
| 1170 | 0.6+/-0.3 | 1 |
| 1171 | 0.6+/-0.5 | 1 |
| 1172 | 0.6cm | 1 |
| 1173 | 0.71±0.27 | 1 |
| 1174 | 0.73+/-0.07 | 1 |
| 1175 | 0.75±1.2 | 1 |
| 1176 | 0.76±1.16 | 1 |
| 1177 | 0.79±0.26 | 1 |
| 1178 | 0.82+/-0.05 | 1 |
| 1179 | 0.83±0.24 | 1 |
| 1180 | 0.89-3.63 | 1 |
| 1181 | 0.9+/-0.5s | 1 |
| 1182 | 0/119 | 1 |
| 1183 | 0/123 | 1 |
| 1184 | 0/211 | 1 |
| 1185 | 0/259 | 1 |
| 1186 | 0/86 | 1 |
| 1187 | 0·256 | 1 |
| 1188 | 0·346 | 1 |
| 1189 | 1,0,1/t | 1 |
| 1190 | 1,10-phenan-throline | 1 |
| 1191 | 1,2-dihydroanthracene | 1 |
| 1192 | 1,2-dioleoyl-3-trimethylammonium-propane | 1 |
| 1193 | 1,2-enediols | 1 |
| 1194 | 1,3-di-oleoyloxy-2- | 1 |
| 1195 | 1,4-benzenedithiol | 1 |
| 1196 | 1,4-bisnucleophiles | 1 |
| 1197 | 1,9-nonanediol | 1 |
| 1198 | 1-butylimidazole | 1 |
| 1199 | 1-lysophosphatidylethanolamine | 1 |
| 1200 | 1-methylsilene | 1 |
| 1201 | 1.01+/-0.18 | 1 |
| 1202 | 1.05+/-0.1 | 1 |
| 1203 | 1.05×10 | 1 |
| 1204 | 1.0±3.2 | 1 |
| 1205 | 1.15/year | 1 |
| 1206 | 1.17±0.37 | 1 |
| 1207 | 1.1±3.6 | 1 |
| 1208 | 1.20-1.28 | 1 |
| 1209 | 1.21mg/l | 1 |
| 1210 | 1.24+/-0.15 | 1 |
| 1211 | 1.27±0.9 | 1 |
| 1212 | 1.28±0.64 | 1 |
| 1213 | 1.30±0.13 | 1 |
| 1214 | 1.33±0.82 | 1 |
| 1215 | 1.35mmol/l | 1 |
| 1216 | 1.37-/+0.64 | 1 |
| 1217 | 1.37±6.4mm | 1 |
| 1218 | 1.3±1.7 | 1 |
| 1219 | 1.41° | 1 |
| 1220 | 1.42±0.53 | 1 |
| 1221 | 1.46+/-0.12 | 1 |
| 1222 | 1.50±0.95 | 1 |
| 1223 | 1.55±0.17 | 1 |
| 1224 | 1.57mmol/l | 1 |
| 1225 | 1.58±0.03 | 1 |
| 1226 | 1.67+/-0.08 | 1 |
| 1227 | 1.7+/-0.6 | 1 |
| 1228 | 1.721 | 1 |
| 1229 | 1.72±0.18m | 1 |
| 1230 | 1.749 | 1 |
| 1231 | 1.74°/s | 1 |
| 1232 | 1.74±0.22 | 1 |
| 1233 | 1.77+/-0.13 | 1 |
| 1234 | 1.780 | 1 |
| 1235 | 1.78±0.02 | 1 |
| 1236 | 1.8/1,000 | 1 |
| 1237 | 1.8min+/-0.9 | 1 |
| 1238 | 1.9/patient | 1 |
| 1239 | 1.958 | 1 |
| 1240 | 1.99-1.16 | 1 |
| 1241 | 1.996.500€ | 1 |
| 1242 | 1/142 | 1 |
| 1243 | 1/259 | 1 |
| 1244 | 1/349 | 1 |
| 1245 | 1/4707 | 1 |
| 1246 | 1/579 | 1 |
| 1247 | 1/74 | 1 |
| 1248 | 1/76 | 1 |
| 1249 | 1/86 | 1 |
| 1250 | 1/mm2 | 1 |
| 1251 | 10.0±4.5 | 1 |
| 1252 | 10.2±2.9μg/ml | 1 |
| 1253 | 10.34°/s | 1 |
| 1254 | 10.5±2.8° | 1 |
| 1255 | 10.6min | 1 |
| 1256 | 10.7/h | 1 |
| 1257 | 10.7±2.8µmol/l | 1 |
| 1258 | 10.7±2.9µmol/l | 1 |
| 1259 | 10.8+/-0.8 | 1 |
| 1260 | 10.9months | 1 |
| 1261 | 10/80-mg | 1 |
| 1262 | 10/95 | 1 |
| 1263 | 101.7±31.5 | 1 |
| 1264 | 103/270 | 1 |
| 1265 | 104.1+/-43.4 | 1 |
| 1266 | 105/154 | 1 |
| 1267 | 105/362 | 1 |
| 1268 | 106.38 | 1 |
| 1269 | 1065.9 | 1 |
| 1270 | 107/687 | 1 |
| 1271 | 108+/-36 | 1 |
| 1272 | 108/130 | 1 |
| 1273 | 11.0+/-5.8 | 1 |
| 1274 | 11.0±1.2 | 1 |
| 1275 | 11.175 | 1 |
| 1276 | 11.4±19.6 | 1 |
| 1277 | 11.51±15.04 | 1 |
| 1278 | 11/136 | 1 |
| 1279 | 11/193 | 1 |
| 1280 | 110.4±25.0 | 1 |
| 1281 | 111±71pg/ml | 1 |
| 1282 | 112±33 | 1 |
| 1283 | 113/2,465 | 1 |
| 1284 | 113/422 | 1 |
| 1285 | 114±13mmhg | 1 |
| 1286 | 115.7±59.9 | 1 |
| 1287 | 1151/1848 | 1 |
| 1288 | 116.39 | 1 |
| 1289 | 117.05±12.74le | 1 |
| 1290 | 117.5±36.5cmh | 1 |
| 1291 | 117.93±13.13 | 1 |
| 1292 | 117/1653 | 1 |
| 1293 | 118.6g/m | 1 |
| 1294 | 118/151 | 1 |
| 1295 | 119/147 | 1 |
| 1296 | 119/496 | 1 |
| 1297 | 1193±263nmolesca | 1 |
| 1298 | 11:12 | 1 |
| 1299 | 11α- | 1 |
| 1300 | 12+/-3.8 | 1 |
| 1301 | 12,138 | 1 |
| 1302 | 12.026 | 1 |
| 1303 | 12.0±5.1 | 1 |
| 1304 | 12.3±2.8µmol/l | 1 |
| 1305 | 12.680 | 1 |
| 1306 | 12.7months | 1 |
| 1307 | 12.8±1.5 | 1 |
| 1308 | 12.9±5.4 | 1 |
| 1309 | 12/100,100 | 1 |
| 1310 | 12/134 | 1 |
| 1311 | 12/352 | 1 |
| 1312 | 12/47 | 1 |
| 1313 | 120+/-20 | 1 |
| 1314 | 120/175 | 1 |
| 1315 | 120/576 | 1 |
| 1316 | 123/443 | 1 |
| 1317 | 125/150 | 1 |
| 1318 | 125:1 | 1 |
| 1319 | 126/75 | 1 |
| 1320 | 127/208 | 1 |
| 1321 | 127/380 | 1 |
| 1322 | 128h | 1 |
| 1323 | 128mmhg | 1 |
| 1324 | 12gray | 1 |
| 1325 | 13'-cis-lutein | 1 |
| 1326 | 13'-cis-β-carotene | 1 |
| 1327 | 13.0+/-6.2 | 1 |
| 1328 | 13.0±0.57 | 1 |
| 1329 | 13.28+/-9.7micromol/l/13.15 | 1 |
| 1330 | 13.2±3.8 | 1 |
| 1331 | 13.4±0.46 | 1 |
| 1332 | 13.5±2.3kg | 1 |
| 1333 | 13.6months | 1 |
| 1334 | 13.70h | 1 |
| 1335 | 13/349 | 1 |
| 1336 | 132/180 | 1 |
| 1337 | 132/292 | 1 |
| 1338 | 1327/3075 | 1 |
| 1339 | 1348.6 | 1 |
| 1340 | 135.1±7.8mmhg | 1 |
| 1341 | 136.05 | 1 |
| 1342 | 136.9±16.9 | 1 |
| 1343 | 13·33 | 1 |
| 1344 | 14.3+/-8.5 | 1 |
| 1345 | 14.409 | 1 |
| 1346 | 14.4±1.8pg/ml | 1 |
| 1347 | 14.9±1.7° | 1 |
| 1348 | 14/107 | 1 |
| 1349 | 14/173 | 1 |
| 1350 | 14/179 | 1 |
| 1351 | 14/210 | 1 |
| 1352 | 145.4±22.9g | 1 |
| 1353 | 145/212 | 1 |
| 1354 | 146/353 | 1 |
| 1355 | 148±14.24 | 1 |
| 1356 | 149+/-21 | 1 |
| 1357 | 149+/-47 | 1 |
| 1358 | 14951 | 1 |
| 1359 | 14c-thymidine | 1 |
| 1360 | 14rpm | 1 |
| 1361 | 15.2±5.1 | 1 |
| 1362 | 15.9±6.3×10 | 1 |
| 1363 | 15/152 | 1 |
| 1364 | 15/205 | 1 |
| 1365 | 150.7mg | 1 |
| 1366 | 152.95 | 1 |
| 1367 | 153±46min | 1 |
| 1368 | 154/398 | 1 |
| 1369 | 1544.4miu/ml | 1 |
| 1370 | 1559,4 | 1 |
| 1371 | 157.0±18.1/mm | 1 |
| 1372 | 16.2±10.0 | 1 |
| 1373 | 16.356 | 1 |
| 1374 | 16.6pg/ml | 1 |
| 1375 | 16.7-38.1 | 1 |
| 1376 | 16.7±5.4 | 1 |
| 1377 | 16.8±3.8 | 1 |
| 1378 | 16/105 | 1 |
| 1379 | 16/150 | 1 |
| 1380 | 16/682 | 1 |
| 1381 | 16/82 | 1 |
| 1382 | 160/215 | 1 |
| 1383 | 160/5144 | 1 |
| 1384 | 1625.7 | 1 |
| 1385 | 163.3° | 1 |
| 1386 | 164/259 | 1 |
| 1387 | 166.0+/-169.5 | 1 |
| 1388 | 166/309 | 1 |
| 1389 | 16±5mm | 1 |
| 1390 | 17+/-10x10 | 1 |
| 1391 | 17.0±7.8 | 1 |
| 1392 | 17.1fold | 1 |
| 1393 | 17.5±10.4 | 1 |
| 1394 | 17.5±5.2 | 1 |
| 1395 | 17.8±7.5 | 1 |
| 1396 | 17.9‰ | 1 |
| 1397 | 17/179 | 1 |
| 1398 | 17/347 | 1 |
| 1399 | 173/240 | 1 |
| 1400 | 1737/2721 | 1 |
| 1401 | 174/244 | 1 |
| 1402 | 175/1873 | 1 |
| 1403 | 176/211 | 1 |
| 1404 | 17beta-e2 | 1 |
| 1405 | 17ß-estradiol | 1 |
| 1406 | 18.1+/-7.8 | 1 |
| 1407 | 18.4±7.7 | 1 |
| 1408 | 18/211 | 1 |
| 1409 | 18/352 | 1 |
| 1410 | 18/634 | 1 |
| 1411 | 18/867 | 1 |
| 1412 | 181.6° | 1 |
| 1413 | 18103 | 1 |
| 1414 | 182±110 | 1 |
| 1415 | 185/242 | 1 |
| 1416 | 185/7668 | 1 |
| 1417 | 186/649 | 1 |
| 1418 | 188.4mg | 1 |
| 1419 | 18:2δ4,9 | 1 |
| 1420 | 19.0±12.6 | 1 |
| 1421 | 19.21+/-2.8 | 1 |
| 1422 | 19.4°±11.4° | 1 |
| 1423 | 19.7min | 1 |
| 1424 | 19/54 | 1 |
| 1425 | 191.4pg/ml | 1 |
| 1426 | 1933/24,983 | 1 |
| 1427 | 194.8pg/ml | 1 |
| 1428 | 1943/100,000 | 1 |
| 1429 | 1943/25,348 | 1 |
| 1430 | 1957-2000 | 1 |
| 1431 | 19beta | 1 |
| 1432 | 19q13.43 | 1 |
| 1433 | 19±0.8ml | 1 |
| 1434 | 1:1.1 | 1 |
| 1435 | 1:12.5 | 1 |
| 1436 | 1dpc | 1 |
| 1437 | 1·22/week | 1 |
| 1438 | 2,1,3-benzoselenadiazole | 1 |
| 1439 | 2,3,4,4',5-pentachlorobiphenyl | 1 |
| 1440 | 2,3,4,5-tetrahydro-2,8-dimethyl-5- | 1 |
| 1441 | 2,5-di- | 1 |
| 1442 | 2,665.57 | 1 |
| 1443 | 2-chloro-4-pyridinyl | 1 |
| 1444 | 2-furylcarbene | 1 |
| 1445 | 2-furyldiazomethane | 1 |
| 1446 | 2-methf | 1 |
| 1447 | 2-methyl-2-pentenal | 1 |
| 1448 | 2.05±1.19 | 1 |
| 1449 | 2.0847 | 1 |
| 1450 | 2.0±0.2 | 1 |
| 1451 | 2.0±0.9 | 1 |
| 1452 | 2.0±2.3 | 1 |
| 1453 | 2.12+/-0.40 | 1 |
| 1454 | 2.12-5.84 | 1 |
| 1455 | 2.171 | 1 |
| 1456 | 2.19±0.06 | 1 |
| 1457 | 2.1±1.5 | 1 |
| 1458 | 2.2/1,000 | 1 |
| 1459 | 2.23±0.73 | 1 |
| 1460 | 2.27+/-0.8 | 1 |
| 1461 | 2.286 | 1 |
| 1462 | 2.3.2.2 | 1 |
| 1463 | 2.342 | 1 |
| 1464 | 2.379 | 1 |
| 1465 | 2.4+0.8 | 1 |
| 1466 | 2.4-6.8 | 1 |
| 1467 | 2.46/wk | 1 |
| 1468 | 2.48±3.89 | 1 |
| 1469 | 2.5. | 1 |
| 1470 | 2.504 | 1 |
| 1471 | 2.52-5.27 | 1 |
| 1472 | 2.5±2 | 1 |
| 1473 | 2.66±0.50 | 1 |
| 1474 | 2.743 | 1 |
| 1475 | 2.797 | 1 |
| 1476 | 2.7±0.5mm | 1 |
| 1477 | 2.8+/-3.2 | 1 |
| 1478 | 2.89/5 | 1 |
| 1479 | 2.9-2.6 | 1 |
| 1480 | 2.955 | 1 |
| 1481 | 2/112 | 1 |
| 1482 | 2/75 | 1 |
| 1483 | 20.0min | 1 |
| 1484 | 20.59+/-2.1 | 1 |
| 1485 | 20/1694 | 1 |
| 1486 | 20/170 | 1 |
| 1487 | 20/197 | 1 |
| 1488 | 20/47 | 1 |
| 1489 | 200/110 | 1 |
| 1490 | 2007/25,020 | 1 |
| 1491 | 201.7 | 1 |
| 1492 | 203.52×10 | 1 |
| 1493 | 204/729 | 1 |
| 1494 | 205.0 | 1 |
| 1495 | 206±67min | 1 |
| 1496 | 207/496 | 1 |
| 1497 | 208/255 | 1 |
| 1498 | 20±7.5days | 1 |
| 1499 | 21.6±30.4 | 1 |
| 1500 | 21/204 | 1 |
| 1501 | 21/226 | 1 |
| 1502 | 211.41+/-71.28 | 1 |
| 1503 | 211/743 | 1 |
| 1504 | 217/1624 | 1 |
| 1505 | 21:00h | 1 |
| 1506 | 22.2±8.2 | 1 |
| 1507 | 22/41 | 1 |
| 1508 | 22/61 | 1 |
| 1509 | 22/62 | 1 |
| 1510 | 2296.3 | 1 |
| 1511 | 23+/-4.2x10 | 1 |
| 1512 | 23.87±11.96 | 1 |
| 1513 | 23/1082 | 1 |
| 1514 | 23/13/10/4 | 1 |
| 1515 | 23/332 | 1 |
| 1516 | 23/61 | 1 |
| 1517 | 235·2 | 1 |
| 1518 | 24+/-5bpm | 1 |
| 1519 | 24.1±4.7 | 1 |
| 1520 | 24.2+/-4bpm | 1 |
| 1521 | 24.9+/-4.3 | 1 |
| 1522 | 24/125 | 1 |
| 1523 | 24/358 | 1 |
| 1524 | 242±141s | 1 |
| 1525 | 249/597 | 1 |
| 1526 | 24±1cm | 1 |
| 1527 | 25/72 | 1 |
| 1528 | 250µg | 1 |
| 1529 | 252.5 | 1 |
| 1530 | 255°c | 1 |
| 1531 | 256/308 | 1 |
| 1532 | 259/7660 | 1 |
| 1533 | 26.3+/-5.1 | 1 |
| 1534 | 26.9+/-3.7 | 1 |
| 1535 | 26/106 | 1 |
| 1536 | 264/599 | 1 |
| 1537 | 266.19 | 1 |
| 1538 | 268.5±8.6pg/ml | 1 |
| 1539 | 269.8μmol/l | 1 |
| 1540 | 26mg/m | 1 |
| 1541 | 27.2±5.0 | 1 |
| 1542 | 27.8+/-4 | 1 |
| 1543 | 27.8kg/m | 1 |
| 1544 | 27.8±9.4msv | 1 |
| 1545 | 27/841 | 1 |
| 1546 | 272/355 | 1 |
| 1547 | 274.2±23.9mm | 1 |
| 1548 | 275/307 | 1 |
| 1549 | 28.0+/-7.8 | 1 |
| 1550 | 28.1min | 1 |
| 1551 | 28.7+/-5.7 | 1 |
| 1552 | 28/144 | 1 |
| 1553 | 28/52 | 1 |
| 1554 | 28/62 | 1 |
| 1555 | 28/86 | 1 |
| 1556 | 282/1194 | 1 |
| 1557 | 284±77 | 1 |
| 1558 | 28:1 | 1 |
| 1559 | 29.3° | 1 |
| 1560 | 29/109 | 1 |
| 1561 | 29/161 | 1 |
| 1562 | 29/61 | 1 |
| 1563 | 293/2777 | 1 |
| 1564 | 296/352 | 1 |
| 1565 | 2nrti/etr/efv-placebo | 1 |
| 1566 | 2nrtis+pi | 1 |
| 1567 | 2×week | 1 |
| 1568 | 3'-acetyl | 1 |
| 1569 | 3-ab+suc | 1 |
| 1570 | 3-acyl-4-aryldihydroquinolin-2 | 1 |
| 1571 | 3.0±2.9 | 1 |
| 1572 | 3.100 | 1 |
| 1573 | 3.13±3.1 | 1 |
| 1574 | 3.1g/day | 1 |
| 1575 | 3.21±1.70×10 | 1 |
| 1576 | 3.22±0.16 | 1 |
| 1577 | 3.3+/-0.3 | 1 |
| 1578 | 3.37°c | 1 |
| 1579 | 3.388 | 1 |
| 1580 | 3.3±3.9 | 1 |
| 1581 | 3.4+/-0.3 | 1 |
| 1582 | 3.4mo | 1 |
| 1583 | 3.501 | 1 |
| 1584 | 3.54±0.14 | 1 |
| 1585 | 3.58±1.47×10 | 1 |
| 1586 | 3.59-12.96 | 1 |
| 1587 | 3.638 | 1 |
| 1588 | 3.674 | 1 |
| 1589 | 3.727 | 1 |
| 1590 | 3.8gy | 1 |
| 1591 | 3.90±1.46 | 1 |
| 1592 | 3.92-20.99 | 1 |
| 1593 | 3/137 | 1 |
| 1594 | 3/15,369 | 1 |
| 1595 | 30.13 | 1 |
| 1596 | 30.311 | 1 |
| 1597 | 30.56+/-2.1 | 1 |
| 1598 | 30/29 | 1 |
| 1599 | 3000/mm3 | 1 |
| 1600 | 305/377 | 1 |
| 1601 | 31.1±2.4 | 1 |
| 1602 | 31.22+/-1.7 | 1 |
| 1603 | 31/151 | 1 |
| 1604 | 31/169 | 1 |
| 1605 | 310-320°c | 1 |
| 1606 | 311/3169 | 1 |
| 1607 | 32.2±16.5 | 1 |
| 1608 | 32.6±4.7kg/m | 1 |
| 1609 | 32.75+/-3.0 | 1 |
| 1610 | 32.9°c | 1 |
| 1611 | 32/mm | 1 |
| 1612 | 323.4±40.6pg/ml | 1 |
| 1613 | 325/356 | 1 |
| 1614 | 329.1 | 1 |
| 1615 | 3292±943 | 1 |
| 1616 | 33.3±20.3 | 1 |
| 1617 | 33.9+/-6.5 | 1 |
| 1618 | 33/83 | 1 |
| 1619 | 330/1424 | 1 |
| 1620 | 34,585 | 1 |
| 1621 | 34.5±2.8 | 1 |
| 1622 | 34/179 | 1 |
| 1623 | 35.19+/-4.5 | 1 |
| 1624 | 35.4°c | 1 |
| 1625 | 350/1522 | 1 |
| 1626 | 354/1239 | 1 |
| 1627 | 356/3146 | 1 |
| 1628 | 36,404 | 1 |
| 1629 | 36.7+/-16.3mgh/l | 1 |
| 1630 | 36/205 | 1 |
| 1631 | 362/526 | 1 |
| 1632 | 37-39°c | 1 |
| 1633 | 37.4+/-9.2 | 1 |
| 1634 | 37.7±0.4°c | 1 |
| 1635 | 37.8+/-10.5 | 1 |
| 1636 | 37/218 | 1 |
| 1637 | 37/362 | 1 |
| 1638 | 37/585 | 1 |
| 1639 | 375mg/m | 1 |
| 1640 | 377.1 | 1 |
| 1641 | 379/1710 | 1 |
| 1642 | 38,267 | 1 |
| 1643 | 38/124 | 1 |
| 1644 | 38/144 | 1 |
| 1645 | 3804+/-494jsprint | 1 |
| 1646 | 382.45 | 1 |
| 1647 | 382/415 | 1 |
| 1648 | 386/429 | 1 |
| 1649 | 39.4+/-12.18 | 1 |
| 1650 | 39.65 | 1 |
| 1651 | 39/102 | 1 |
| 1652 | 39/343 | 1 |
| 1653 | 39:11 | 1 |
| 1654 | 3h/day | 1 |
| 1655 | 3·80 | 1 |
| 1656 | 4+/-4cm | 1 |
| 1657 | 4,340/38,110 | 1 |
| 1658 | 4-bromophenacyl | 1 |
| 1659 | 4-chloro-3-hydroxyanthranilate | 1 |
| 1660 | 4-morpholino | 1 |
| 1661 | 4-nitrotoluene | 1 |
| 1662 | 4-toluidine | 1 |
| 1663 | 4.07±0.52 | 1 |
| 1664 | 4.169 | 1 |
| 1665 | 4.179 | 1 |
| 1666 | 4.25+/-0.17 | 1 |
| 1667 | 4.25±0.07 | 1 |
| 1668 | 4.261 | 1 |
| 1669 | 4.27±1.75×10 | 1 |
| 1670 | 4.336 | 1 |
| 1671 | 4.33±6.56 | 1 |
| 1672 | 4.34+/-0.25 | 1 |
| 1673 | 4.375 | 1 |
| 1674 | 4.4+/-0.36 | 1 |
| 1675 | 4.430 | 1 |
| 1676 | 4.464 | 1 |
| 1677 | 4.4h | 1 |
| 1678 | 4.500 | 1 |
| 1679 | 4.524 | 1 |
| 1680 | 4.6+/-1.1ms/hz | 1 |
| 1681 | 4.630 | 1 |
| 1682 | 4.694 | 1 |
| 1683 | 4.6±1.9 | 1 |
| 1684 | 4.70+/-0.76 | 1 |
| 1685 | 4.732 | 1 |
| 1686 | 4.744 | 1 |
| 1687 | 4.7±2.7h | 1 |
| 1688 | 4.8±1.4 | 1 |
| 1689 | 4.9+/-1.67 | 1 |
| 1690 | 4/181 | 1 |
| 1691 | 4/185 | 1 |
| 1692 | 4/882 | 1 |
| 1693 | 4/99 | 1 |
| 1694 | 40.06°c | 1 |
| 1695 | 40/552 | 1 |
| 1696 | 40/82 | 1 |
| 1697 | 40/minute | 1 |
| 1698 | 400.8±579.8 | 1 |
| 1699 | 400/1039 | 1 |
| 1700 | 4079±333s | 1 |
| 1701 | 41.33±7.44 | 1 |
| 1702 | 41/118 | 1 |
| 1703 | 41/123 | 1 |
| 1704 | 41/83 | 1 |
| 1705 | 411.1 | 1 |
| 1706 | 416/497 | 1 |
| 1707 | 42.1+/-16.9/mul | 1 |
| 1708 | 42.9±11.2 | 1 |
| 1709 | 42/151 | 1 |
| 1710 | 420.2 | 1 |
| 1711 | 422/18,161 | 1 |
| 1712 | 427/463 | 1 |
| 1713 | 42:36 | 1 |
| 1714 | 43/1648 | 1 |
| 1715 | 43/214 | 1 |
| 1716 | 439/3302 | 1 |
| 1717 | 43±23 | 1 |
| 1718 | 44/104 | 1 |
| 1719 | 44/319 | 1 |
| 1720 | 447/628 | 1 |
| 1721 | 44±9 | 1 |
| 1722 | 45.4cm | 1 |
| 1723 | 45.5±5.5 | 1 |
| 1724 | 45/279 | 1 |
| 1725 | 455.8 | 1 |
| 1726 | 458/576 | 1 |
| 1727 | 459/2399 | 1 |
| 1728 | 45±16 | 1 |
| 1729 | 46.6±9.8 | 1 |
| 1730 | 46/692 | 1 |
| 1731 | 46/87 | 1 |
| 1732 | 465mg | 1 |
| 1733 | 47.1±10.6 | 1 |
| 1734 | 47.46±7.31 | 1 |
| 1735 | 47.80±8.45 | 1 |
| 1736 | 47/1119 | 1 |
| 1737 | 47/181 | 1 |
| 1738 | 47/350 | 1 |
| 1739 | 47040 | 1 |
| 1740 | 48.605 | 1 |
| 1741 | 48.6±10.1g | 1 |
| 1742 | 48/70 | 1 |
| 1743 | 49.1° | 1 |
| 1744 | 49/181 | 1 |
| 1745 | 4egi-1 | 1 |
| 1746 | 4mgday | 1 |
| 1747 | 5'-hydroxyomeprazole | 1 |
| 1748 | 5-fluorouracil/leucovorin/irinotecan | 1 |
| 1749 | 5.03+/-1.97 | 1 |
| 1750 | 5.05-6.11 | 1 |
| 1751 | 5.06+/-0 | 1 |
| 1752 | 5.0±1.7h | 1 |
| 1753 | 5.0±15.6 | 1 |
| 1754 | 5.139 | 1 |
| 1755 | 5.27°c | 1 |
| 1756 | 5.4+/-0.3 | 1 |
| 1757 | 5.440 | 1 |
| 1758 | 5.75±1.39 | 1 |
| 1759 | 5.7ml/min/1.73m | 1 |
| 1760 | 5.87-fold | 1 |
| 1761 | 5.9±2.7 | 1 |
| 1762 | 5/111 | 1 |
| 1763 | 5/129 | 1 |
| 1764 | 5/208 | 1 |
| 1765 | 5/233 | 1 |
| 1766 | 5/239 | 1 |
| 1767 | 5/245 | 1 |
| 1768 | 5/455 | 1 |
| 1769 | 5/98 | 1 |
| 1770 | 50/25-mg/d | 1 |
| 1771 | 501/mm2 | 1 |
| 1772 | 505/356,654 | 1 |
| 1773 | 508±149dayg/ml | 1 |
| 1774 | 51.2±18.9s | 1 |
| 1775 | 51.44±18.98 | 1 |
| 1776 | 51/338 | 1 |
| 1777 | 517μa/cm | 1 |
| 1778 | 518,000 | 1 |
| 1779 | 52/194 | 1 |
| 1780 | 52/59 | 1 |
| 1781 | 52/80 | 1 |
| 1782 | 525·0 | 1 |
| 1783 | 529/1245 | 1 |
| 1784 | 529±61 | 1 |
| 1785 | 53.1±4.7 | 1 |
| 1786 | 53/157 | 1 |
| 1787 | 53/62 | 1 |
| 1788 | 54/83 | 1 |
| 1789 | 54:1 | 1 |
| 1790 | 556.x | 1 |
| 1791 | 56.7±10.1 | 1 |
| 1792 | 56/153 | 1 |
| 1793 | 57+/-8.2g | 1 |
| 1794 | 57.7+/-0.8l/d | 1 |
| 1795 | 57.7±3.2 | 1 |
| 1796 | 57.9cm | 1 |
| 1797 | 57/848 | 1 |
| 1798 | 57±4.7 | 1 |
| 1799 | 582.3 | 1 |
| 1800 | 58±3 | 1 |
| 1801 | 59/214 | 1 |
| 1802 | 5fu-mitomycin | 1 |
| 1803 | 5gl | 1 |
| 1804 | 5±2.3mm | 1 |
| 1805 | 5·02 | 1 |
| 1806 | 5·55 | 1 |
| 1807 | 6,077/47,814 | 1 |
| 1808 | 6.062 | 1 |
| 1809 | 6.0gy | 1 |
| 1810 | 6.18+/-0.25 | 1 |
| 1811 | 6.24-70.27 | 1 |
| 1812 | 6.25+/-0.18 | 1 |
| 1813 | 6.34-fold | 1 |
| 1814 | 6.361 | 1 |
| 1815 | 6.3±2.5 | 1 |
| 1816 | 6.4+/-0.9 | 1 |
| 1817 | 6.47±0.31 | 1 |
| 1818 | 6.5+/-0.3 | 1 |
| 1819 | 6.56m/s | 1 |
| 1820 | 6.5±2.4 | 1 |
| 1821 | 6.8±2 | 1 |
| 1822 | 6.9±0.9×10 | 1 |
| 1823 | 6/2264 | 1 |
| 1824 | 60.32+/-3.5 | 1 |
| 1825 | 60/362 | 1 |
| 1826 | 60/477 | 1 |
| 1827 | 60u/kg | 1 |
| 1828 | 60±11mmhg | 1 |
| 1829 | 61.0±14.2 | 1 |
| 1830 | 61.3+/-8.6 | 1 |
| 1831 | 61.4+/-16.9 | 1 |
| 1832 | 61/169 | 1 |
| 1833 | 61/37 | 1 |
| 1834 | 613.0 | 1 |
| 1835 | 614/26,800 | 1 |
| 1836 | 617.88 | 1 |
| 1837 | 62.2°c | 1 |
| 1838 | 62.8-84 | 1 |
| 1839 | 62/867 | 1 |
| 1840 | 63/286 | 1 |
| 1841 | 634/22,206 | 1 |
| 1842 | 64+/-18 | 1 |
| 1843 | 64+/-19 | 1 |
| 1844 | 64.6° | 1 |
| 1845 | 64.7±14.0 | 1 |
| 1846 | 64/181 | 1 |
| 1847 | 64±4 | 1 |
| 1848 | 65,100 | 1 |
| 1849 | 65.8±27.0 | 1 |
| 1850 | 65/166 | 1 |
| 1851 | 654.00 | 1 |
| 1852 | 668/842 | 1 |
| 1853 | 67.5±3.3 | 1 |
| 1854 | 67.7±13.8 | 1 |
| 1855 | 677/78960 | 1 |
| 1856 | 67·5 | 1 |
| 1857 | 68,5 | 1 |
| 1858 | 68.0+/-11 | 1 |
| 1859 | 68.18+/-2.8 | 1 |
| 1860 | 68/99 | 1 |
| 1861 | 69.0±10.8 | 1 |
| 1862 | 69.5-17 | 1 |
| 1863 | 69/117 | 1 |
| 1864 | 6·92 | 1 |
| 1865 | 6·94 | 1 |
| 1866 | 7.0°±4.6° | 1 |
| 1867 | 7.0±3.6 | 1 |
| 1868 | 7.2+/-3.2 | 1 |
| 1869 | 7.3±2.3 | 1 |
| 1870 | 7.464 | 1 |
| 1871 | 7.4min | 1 |
| 1872 | 7.4±2.6msv | 1 |
| 1873 | 7.51+/-.10 | 1 |
| 1874 | 7.7+/-4.8 | 1 |
| 1875 | 7.7±2.5 | 1 |
| 1876 | 7.84±1.44 | 1 |
| 1877 | 7.84±2.44 | 1 |
| 1878 | 7/166 | 1 |
| 1879 | 7/393 | 1 |
| 1880 | 7/95 | 1 |
| 1881 | 70.5±22g/m | 1 |
| 1882 | 70.8±33.7 | 1 |
| 1883 | 700mg/kg | 1 |
| 1884 | 703±179 | 1 |
| 1885 | 705.61 | 1 |
| 1886 | 71/204 | 1 |
| 1887 | 72/756 | 1 |
| 1888 | 724.2 | 1 |
| 1889 | 730.84 | 1 |
| 1890 | 732/1100 | 1 |
| 1891 | 74/3343 | 1 |
| 1892 | 747+130n | 1 |
| 1893 | 74·0 | 1 |
| 1894 | 75·1 | 1 |
| 1895 | 76.6±10.7 | 1 |
| 1896 | 76/338 | 1 |
| 1897 | 761/134529 | 1 |
| 1898 | 767/3346 | 1 |
| 1899 | 76°±3° | 1 |
| 1900 | 77.0cm | 1 |
| 1901 | 77.2/99.5/63.5 | 1 |
| 1902 | 77.4min | 1 |
| 1903 | 77/99 | 1 |
| 1904 | 78.20 | 1 |
| 1905 | 78/826 | 1 |
| 1906 | 79/108 | 1 |
| 1907 | 79/756 | 1 |
| 1908 | 7mg/ | 1 |
| 1909 | 8.068 | 1 |
| 1910 | 8.1months | 1 |
| 1911 | 8.2±0.3s | 1 |
| 1912 | 8.7±3.9hours | 1 |
| 1913 | 8.95±2.08 | 1 |
| 1914 | 8/149 | 1 |
| 1915 | 8/157 | 1 |
| 1916 | 8/63 | 1 |
| 1917 | 8/81 | 1 |
| 1918 | 8/85 | 1 |
| 1919 | 8/d | 1 |
| 1920 | 80-age | 1 |
| 1921 | 80-microg/kg | 1 |
| 1922 | 80.0beats/min | 1 |
| 1923 | 81.5h | 1 |
| 1924 | 82±12 | 1 |
| 1925 | 83.9±23.3 | 1 |
| 1926 | 83/140 | 1 |
| 1927 | 83/216 | 1 |
| 1928 | 84.42 | 1 |
| 1929 | 84.5° | 1 |
| 1930 | 843ml | 1 |
| 1931 | 847/1546 | 1 |
| 1932 | 86/153 | 1 |
| 1933 | 86/617 | 1 |
| 1934 | 86/857 | 1 |
| 1935 | 87/226 | 1 |
| 1936 | 89/706 | 1 |
| 1937 | 8·46 | 1 |
| 1938 | 9'-cis-lutein | 1 |
| 1939 | 9'-cis-β-carotene | 1 |
| 1940 | 9.1+/-13.1 | 1 |
| 1941 | 9.11+/-1.24 | 1 |
| 1942 | 9.1±4.7×10 | 1 |
| 1943 | 9.2+/-1.5 | 1 |
| 1944 | 9.26±3 | 1 |
| 1945 | 9.3±2.6° | 1 |
| 1946 | 9.9±2.61 | 1 |
| 1947 | 9/148 | 1 |
| 1948 | 9/154 | 1 |
| 1949 | 9/161 | 1 |
| 1950 | 9/175 | 1 |
| 1951 | 9/208 | 1 |
| 1952 | 9/279 | 1 |
| 1953 | 9/2953 | 1 |
| 1954 | 9/62 | 1 |
| 1955 | 90.5° | 1 |
| 1956 | 90/137 | 1 |
| 1957 | 907/100,000 | 1 |
| 1958 | 90μmolphotonsm | 1 |
| 1959 | 91.63 | 1 |
| 1960 | 91/397 | 1 |
| 1961 | 92.5±15.9 | 1 |
| 1962 | 92.9±21.4cmh | 1 |
| 1963 | 92/20,746 | 1 |
| 1964 | 92/397 | 1 |
| 1965 | 93.72 | 1 |
| 1966 | 95.0+/-4.9 | 1 |
| 1967 | 95/306 | 1 |
| 1968 | 95/96 | 1 |
| 1969 | 96.04±8.94 | 1 |
| 1970 | 96.0±3.6 | 1 |
| 1971 | 98.2±20.7g | 1 |
| 1972 | 98/156 | 1 |
| 1973 | 98/172 | 1 |
| 1974 | 98/186 | 1 |
| 1975 | 985±463ml | 1 |
| 1976 | 987/mm | 1 |
| 1977 | 989.80 | 1 |
| 1978 | 9:11 | 1 |
| 1979 | 9:16 | 1 |
| 1980 | 9l/d | 1 |
| 1981 | 9·90 | 1 |
| 1982 | 9×7 | 1 |
| 1983 | 9α,11β-pgf | 1 |
| 1984 | =0.879 | 1 |
| 1985 | =1.626 | 1 |
| 1986 | =1.70mmol | 1 |
| 1987 | =1.893 | 1 |
| 1988 | =100-cell/mm | 1 |
| 1989 | =160mg/dl | 1 |
| 1990 | =2.10 | 1 |
| 1991 | =2.640 | 1 |
| 1992 | =2.75x10 | 1 |
| 1993 | =20.23 | 1 |
| 1994 | =200/ml | 1 |
| 1995 | =30kg/m | 1 |
| 1996 | =3h | 1 |
| 1997 | =5.18mmol | 1 |
| 1998 | =55mmhg | 1 |
| 1999 | =8.224 | 1 |
| 2000 | =90mmhg | 1 |
| 2001 | =cin-2 | 1 |
| 2002 | =p75 | 1 |
| 2003 | a-code | 1 |
| 2004 | a/hk/415742/09 | 1 |
| 2005 | a/uruguay/h3n2 | 1 |
| 2006 | a2064g | 1 |
| 2007 | a358a | 1 |
| 2008 | a_rimidex | 1 |
| 2009 | aab2 | 1 |
| 2010 | abacavir/lamivudine/efavirenz | 1 |
| 2011 | absti* | 1 |
| 2012 | abt-199 | 1 |
| 2013 | acaa | 1 |
| 2014 | acarophobia | 1 |
| 2015 | acei/β-blocker | 1 |
| 2016 | aceis/aras | 1 |
| 2017 | acepromazine-methadone | 1 |
| 2018 | aci.fhh-rf1b | 1 |
| 2019 | aclacinomycin-a | 1 |
| 2020 | acrypoint | 1 |
| 2021 | active-commute | 1 |
| 2022 | adalimumab-withdrawal | 1 |
| 2023 | adaptive-avd | 1 |
| 2024 | adenoitonsillectomy | 1 |
| 2025 | adp-actin | 1 |
| 2026 | adults.well-designed | 1 |
| 2027 | aerobic+resistance | 1 |
| 2028 | ag/agcl/kcl | 1 |
| 2029 | aggregated-ldl | 1 |
| 2030 | aggression/hostility | 1 |
| 2031 | agn43b | 1 |
| 2032 | aicds | 1 |
| 2033 | air-cf2 | 1 |
| 2034 | akiva | 1 |
| 2035 | alanyl-leucine | 1 |
| 2036 | alcohol-fixed | 1 |
| 2037 | alemtuzumab/tacrolimus | 1 |
| 2038 | alinamin-f | 1 |
| 2039 | alk-tkis | 1 |
| 2040 | alkalization-therapy-alone | 1 |
| 2041 | allergenes | 1 |
| 2042 | alpha-aminopropiophenone | 1 |
| 2043 | alpha2,6-linkage | 1 |
| 2044 | alphacd2 | 1 |
| 2045 | amisulprideagain | 1 |
| 2046 | ampicillin-tobramycin | 1 |
| 2047 | anechogenic | 1 |
| 2048 | anergy/apoptosis | 1 |
| 2049 | aneurine | 1 |
| 2050 | anger/depression | 1 |
| 2051 | angiodema | 1 |
| 2052 | angiorrhaphy | 1 |
| 2053 | angularity | 1 |
| 2054 | antagonists+clonidine+1c | 1 |
| 2055 | anthracycline+atra | 1 |
| 2056 | anti-science | 1 |
| 2057 | antiabortifacients | 1 |
| 2058 | antimellin | 1 |
| 2059 | antioxidant-fortified | 1 |
| 2060 | antipathogens | 1 |
| 2061 | antiplatelet-therapy | 1 |
| 2062 | antiplatelets/anticoagulants | 1 |
| 2063 | anxiety/nervousness | 1 |
| 2064 | aplanatic | 1 |
| 2065 | apo-rbp | 1 |
| 2066 | apoe*2 | 1 |
| 2067 | aqdsh | 1 |
| 2068 | aqiva | 1 |
| 2069 | arbitrage | 1 |
| 2070 | arbs+ccbs | 1 |
| 2071 | aristololactam-i | 1 |
| 2072 | arsenite-specific | 1 |
| 2073 | arthodesis | 1 |
| 2074 | asn656/asn656 | 1 |
| 2075 | aspirin+phytosterols | 1 |
| 2076 | atfd2 | 1 |
| 2077 | atheist | 1 |
| 2078 | ato+atra+chemotherapy | 1 |
| 2079 | atopy/inflammation | 1 |
| 2080 | atropine-plus-pralidoxime | 1 |
| 2081 | atsumo3 | 1 |
| 2082 | aurothioglucose | 1 |
| 2083 | auto-hmscs | 1 |
| 2084 | auto-polymerised | 1 |
| 2085 | axospinous | 1 |
| 2086 | azithromycin-atovaquone | 1 |
| 2087 | b-a-a | 1 |
| 2088 | b2-antagonist | 1 |
| 2089 | back-school | 1 |
| 2090 | bacteremia/urosepsis | 1 |
| 2091 | badc | 1 |
| 2092 | band-aids | 1 |
| 2093 | bcg-ifn-α | 1 |
| 2094 | bee×1.1 | 1 |
| 2095 | bellyaches | 1 |
| 2096 | bencao-gangmu | 1 |
| 2097 | bevacizumab-capecitabine | 1 |
| 2098 | bi/trisegmentectomy | 1 |
| 2099 | biagents | 1 |
| 2100 | bismuth-metronidazole-tetracycline-ranitidine | 1 |
| 2101 | biteplane | 1 |
| 2102 | blank-sap | 1 |
| 2103 | bmi≥35kg/m | 1 |
| 2104 | bortezomib-td | 1 |
| 2105 | boswagade | 1 |
| 2106 | boy/girlfriends | 1 |
| 2107 | breast/endometrial | 1 |
| 2108 | breed-associated | 1 |
| 2109 | bronchiolits | 1 |
| 2110 | bt-cottonseed | 1 |
| 2111 | btx-b5 | 1 |
| 2112 | buildability | 1 |
| 2113 | butm | 1 |
| 2114 | butorphanol-medetomidine | 1 |
| 2115 | c-hypotensive | 1 |
| 2116 | c2bn2 | 1 |
| 2117 | c34 | 1 |
| 2118 | c3c4 | 1 |
| 2119 | cag+pci | 1 |
| 2120 | cam3noa1 | 1 |
| 2121 | capecitabine-lapatinib | 1 |
| 2122 | caragher | 1 |
| 2123 | carboplatin-irinotecan | 1 |
| 2124 | carboplatin/paclitaxel/sorafenib | 1 |
| 2125 | cardiopalmus | 1 |
| 2126 | carfentanil-xylazine | 1 |
| 2127 | caspase-3+calpastatin | 1 |
| 2128 | caspases-6 | 1 |
| 2129 | caudo-ventro-lateral | 1 |
| 2130 | cbevacizumab | 1 |
| 2131 | cc5-mrsa-i/ii/iv | 1 |
| 2132 | cd79α | 1 |
| 2133 | cefacetrile | 1 |
| 2134 | cefazolin/metronidazole | 1 |
| 2135 | cefepime-tazobactam | 1 |
| 2136 | cerebritis | 1 |
| 2137 | chadv63 | 1 |
| 2138 | change-trials | 1 |
| 2139 | chemotherapy/autologoussct | 1 |
| 2140 | chictr-trc-00000032 | 1 |
| 2141 | chitosan-hexamer | 1 |
| 2142 | chloroquine-primaquine | 1 |
| 2143 | ciclosporin/azathioprine/prednisone | 1 |
| 2144 | cinnovex® | 1 |
| 2145 | cis-dichlorodiamineplatinum | 1 |
| 2146 | cisplatin/leucovorin/5-fu | 1 |
| 2147 | cisplatin/paclitaxel/ifosfamide | 1 |
| 2148 | citr | 1 |
| 2149 | ckd/hs | 1 |
| 2150 | cl316243 | 1 |
| 2151 | clarithyromicin | 1 |
| 2152 | claritromycin | 1 |
| 2153 | climiphene | 1 |
| 2154 | clomifene-resistance | 1 |
| 2155 | clotrimazole-ointments | 1 |
| 2156 | cluster-set | 1 |
| 2157 | cnidocyte | 1 |
| 2158 | cnot10 | 1 |
| 2159 | cns=9.75 | 1 |
| 2160 | co-habitating | 1 |
| 2161 | co-indications | 1 |
| 2162 | co-toxicity | 1 |
| 2163 | coach-prescribed | 1 |
| 2164 | cobra-pla | 1 |
| 2165 | cocaine/dexmedetomidine | 1 |
| 2166 | coeruloplasmin | 1 |
| 2167 | cold-break | 1 |
| 2168 | cold/dry | 1 |
| 2169 | colocolostomy | 1 |
| 2170 | comorbities | 1 |
| 2171 | concise® | 1 |
| 2172 | confocal/two-photon | 1 |
| 2173 | conglomerations | 1 |
| 2174 | connexin32 | 1 |
| 2175 | control/dhf | 1 |
| 2176 | controlthere | 1 |
| 2177 | conventional-schedule | 1 |
| 2178 | copper-iud | 1 |
| 2179 | corral | 1 |
| 2180 | corticodependence | 1 |
| 2181 | counseling-as-usual | 1 |
| 2182 | cr-after | 1 |
| 2183 | craniocaudal-view | 1 |
| 2184 | creaking | 1 |
| 2185 | creationism | 1 |
| 2186 | crossed-path | 1 |
| 2187 | crs7270101 | 1 |
| 2188 | crtcp | 1 |
| 2189 | cryoshock | 1 |
| 2190 | cs-t1 | 1 |
| 2191 | csa-aza-mp | 1 |
| 2192 | ctl-std | 1 |
| 2193 | ctr+hr | 1 |
| 2194 | ctx-m-9-group | 1 |
| 2195 | cullin-type | 1 |
| 2196 | cutting/stepping | 1 |
| 2197 | cyclocreatine | 1 |
| 2198 | cyclophosphamide/csa | 1 |
| 2199 | cyclophosphomide-methotrexate-5 | 1 |
| 2200 | cyclorphan | 1 |
| 2201 | cyclosporine/azathioprine | 1 |
| 2202 | cyp175a1 | 1 |
| 2203 | d.i.v. | 1 |
| 2204 | d=≥65 | 1 |
| 2205 | daclizumab/tacrolimus/mycophenolate | 1 |
| 2206 | dalotuzumab/ridaforolimus | 1 |
| 2207 | daph | 1 |
| 2208 | dapsone-pyrimethamine | 1 |
| 2209 | darunavir-rtv | 1 |
| 2210 | daunorubicin/clofarabine | 1 |
| 2211 | dc+cm | 1 |
| 2212 | dcg-iv | 1 |
| 2213 | dcu/gangrene | 1 |
| 2214 | ddp-pdc | 1 |
| 2215 | decamers | 1 |
| 2216 | demeaning | 1 |
| 2217 | denuded-endothelium | 1 |
| 2218 | deontologic | 1 |
| 2219 | derivable | 1 |
| 2220 | dermabondtm | 1 |
| 2221 | dermatovenerologists | 1 |
| 2222 | desensiti* | 1 |
| 2223 | desmosterolosis | 1 |
| 2224 | detrusorhyperreflexia | 1 |
| 2225 | dexmedetomidine-ketamine-midazolam | 1 |
| 2226 | dexmedetomidine-sevoflurane | 1 |
| 2227 | dgct-d1 | 1 |
| 2228 | dgct-d2 | 1 |
| 2229 | dhf/control | 1 |
| 2230 | didanosine/lamivudine/tenofovir | 1 |
| 2231 | diet+g | 1 |
| 2232 | diet+metformin | 1 |
| 2233 | dimethyloxalylglycine | 1 |
| 2234 | disajustment | 1 |
| 2235 | dishcloth-gourd-shaped | 1 |
| 2236 | diskinesia | 1 |
| 2237 | disophenol | 1 |
| 2238 | disrobing | 1 |
| 2239 | divalproex* | 1 |
| 2240 | dl-diltiazem | 1 |
| 2241 | dm+chd | 1 |
| 2242 | dndd | 1 |
| 2243 | dobrava | 1 |
| 2244 | doctor-counselor | 1 |
| 2245 | donor-seropositive | 1 |
| 2246 | down-conditioned | 1 |
| 2247 | downtitrate | 1 |
| 2248 | doxorubicin-pemetrexed | 1 |
| 2249 | doxorubicin/cisplatin/paclitaxel | 1 |
| 2250 | doxorubicin/pemetrexed | 1 |
| 2251 | dragonfish | 1 |
| 2252 | dre/trus | 1 |
| 2253 | drug-vehicle | 1 |
| 2254 | dtmu | 1 |
| 2255 | dtmu/trx | 1 |
| 2256 | dvd-irv | 1 |
| 2257 | dyestuffs | 1 |
| 2258 | dynamised | 1 |
| 2259 | dysorgasmia | 1 |
| 2260 | dysperistalsis | 1 |
| 2261 | dysplastic/neoplastic | 1 |
| 2262 | d₄₂ | 1 |
| 2263 | earex | 1 |
| 2264 | ecdfs | 1 |
| 2265 | education-alone | 1 |
| 2266 | ee+hs | 1 |
| 2267 | ef-rt.crt | 1 |
| 2268 | eg-arms | 1 |
| 2269 | egfp-cre | 1 |
| 2270 | eglu | 1 |
| 2271 | electrocauter | 1 |
| 2272 | embosurgery | 1 |
| 2273 | emerg* | 1 |
| 2274 | endoduplication | 1 |
| 2275 | eplin | 1 |
| 2276 | epotilones | 1 |
| 2277 | equuli | 1 |
| 2278 | ergotamine/caffeine | 1 |
| 2279 | erlotinib-arm | 1 |
| 2280 | erp+placebo | 1 |
| 2281 | error-strewn | 1 |
| 2282 | erv14p | 1 |
| 2283 | escitalopram-paroxetine | 1 |
| 2284 | espc | 1 |
| 2285 | especially-developed | 1 |
| 2286 | ethinylestradiol/norgestimate | 1 |
| 2287 | etr/darunavir | 1 |
| 2288 | euro1729+/-1209 | 1 |
| 2289 | euro2904+/-1510 | 1 |
| 2290 | european-made | 1 |
| 2291 | even-days | 1 |
| 2292 | eversion-endarterectomy | 1 |
| 2293 | every-three-week | 1 |
| 2294 | ex-boyfriends | 1 |
| 2295 | exendin-4- | 1 |
| 2296 | exitus | 1 |
| 2297 | exon9 | 1 |
| 2298 | experimental/before | 1 |
| 2299 | external/controlled | 1 |
| 2300 | extraturbinally | 1 |
| 2301 | f1-generations | 1 |
| 2302 | fasting/interprandial | 1 |
| 2303 | fc+/fc | 1 |
| 2304 | femoral/sciatic | 1 |
| 2305 | fenofibrate/bezafibrate | 1 |
| 2306 | ffns-treatment | 1 |
| 2307 | fibrothecomas | 1 |
| 2308 | filter-leukoreduced | 1 |
| 2309 | flagellin-deficient | 1 |
| 2310 | flesh-colored | 1 |
| 2311 | fluordeoxyuridine- | 1 |
| 2312 | fluoride-rinse | 1 |
| 2313 | fluoroquinolone-resistance | 1 |
| 2314 | fluvastatin-alone | 1 |
| 2315 | folfiri-alone | 1 |
| 2316 | foreignization | 1 |
| 2317 | fortune-teller | 1 |
| 2318 | foscan | 1 |
| 2319 | free-forms | 1 |
| 2320 | free-regimens | 1 |
| 2321 | fructose/min | 1 |
| 2322 | fsh-ctp | 1 |
| 2323 | g12r | 1 |
| 2324 | g12s | 1 |
| 2325 | galantamine/placebo | 1 |
| 2326 | gemcitabine-ifosfamide-vinorelbine | 1 |
| 2327 | geranylgeranyl-pyrophosphate | 1 |
| 2328 | gill-over-the-ground | 1 |
| 2329 | glargine/detemir-aspart | 1 |
| 2330 | glf | 1 |
| 2331 | glua1-4 | 1 |
| 2332 | glycation/glycoxidation | 1 |
| 2333 | gp39 | 1 |
| 2334 | grandiosity/excitement | 1 |
| 2335 | grandmother-in-law | 1 |
| 2336 | h-0 | 1 |
| 2337 | h596 | 1 |
| 2338 | hal2mg+pim20mg | 1 |
| 2339 | halakhah | 1 |
| 2340 | halland | 1 |
| 2341 | havrix-havrix | 1 |
| 2342 | hctz/bena | 1 |
| 2343 | head-brace | 1 |
| 2344 | heartfailure | 1 |
| 2345 | herb-like | 1 |
| 2346 | heretic | 1 |
| 2347 | hetero-dimers | 1 |
| 2348 | hetero-nuclei | 1 |
| 2349 | heterospecifics | 1 |
| 2350 | hfrt/afrt | 1 |
| 2351 | hfsa-only | 1 |
| 2352 | hi-asca | 1 |
| 2353 | high-cadence | 1 |
| 2354 | high-cfdna | 1 |
| 2355 | histamine-receptor-2 | 1 |
| 2356 | hlar-spn | 1 |
| 2357 | hna-1b/-1c | 1 |
| 2358 | hotpack+exercise | 1 |
| 2359 | hpv-persistent | 1 |
| 2360 | hs/tnf | 1 |
| 2361 | hsf3-gus | 1 |
| 2362 | hsf4-gus | 1 |
| 2363 | hsfd/streptozotocin | 1 |
| 2364 | htia | 1 |
| 2365 | hydride-generation | 1 |
| 2366 | hydrocholorothiazide | 1 |
| 2367 | hydrocolpometra | 1 |
| 2368 | hydrocolpometras | 1 |
| 2369 | hydrogenated-vegetable-fat | 1 |
| 2370 | hydroxyapatite-cement | 1 |
| 2371 | hydroxyethyl-starch | 1 |
| 2372 | hyper-kinesis | 1 |
| 2373 | hyperpotass* | 1 |
| 2374 | hyperthyroiditis | 1 |
| 2375 | hypo-pharynx | 1 |
| 2376 | hypoalbuninaemia | 1 |
| 2377 | hypomenorrhoe | 1 |
| 2378 | hyposphagma | 1 |
| 2379 | i+iv | 1 |
| 2380 | i-butene | 1 |
| 2381 | ibdq-social | 1 |
| 2382 | ic50=1.6μm | 1 |
| 2383 | ifn-α/placebo | 1 |
| 2384 | ii-l | 1 |
| 2385 | ii-low | 1 |
| 2386 | illness-detecting | 1 |
| 2387 | imagevis3d | 1 |
| 2388 | imatinib+interferon | 1 |
| 2389 | imatinib+peg-ifn-α2b | 1 |
| 2390 | imidamides | 1 |
| 2391 | immuno-pathological | 1 |
| 2392 | inaccurate/lagging | 1 |
| 2393 | inconsistent/nonusers | 1 |
| 2394 | indeterminate-probability | 1 |
| 2395 | indirect-induction | 1 |
| 2396 | information-gathering | 1 |
| 2397 | infra-systolic | 1 |
| 2398 | infratentorially | 1 |
| 2399 | inguinal-subcutaneous | 1 |
| 2400 | injected-cured | 1 |
| 2401 | inratio | 1 |
| 2402 | interleukine-2 | 1 |
| 2403 | intragroups | 1 |
| 2404 | intramuscularly-administered | 1 |
| 2405 | intranasally.overall | 1 |
| 2406 | ipt+escitalopram | 1 |
| 2407 | irinotecan+5fu/lv | 1 |
| 2408 | irinotecan+fu/lv | 1 |
| 2409 | irinotecan/capecitabine | 1 |
| 2410 | irrelevant/noisy | 1 |
| 2411 | isoretinoin | 1 |
| 2412 | itnis | 1 |
| 2413 | itopride.nevertheless | 1 |
| 2414 | jaukay | 1 |
| 2415 | jelled-type | 1 |
| 2416 | k2m′′cl4 | 1 |
| 2417 | kangulamira | 1 |
| 2418 | kardonit | 1 |
| 2419 | kbh₄ | 1 |
| 2420 | ki/edta | 1 |
| 2421 | knee-disarticulation | 1 |
| 2422 | kpms | 1 |
| 2423 | krt17 | 1 |
| 2424 | kynurenine-3-monooxygenase | 1 |
| 2425 | kyposcoliosis | 1 |
| 2426 | l-685,458 | 1 |
| 2427 | l-carnitine-supplemented | 1 |
| 2428 | l-dopa/benserazide | 1 |
| 2429 | l-meals | 1 |
| 2430 | la/la+g/a | 1 |
| 2431 | lactose/mcc | 1 |
| 2432 | land-basedthere | 1 |
| 2433 | laporotomy | 1 |
| 2434 | laser-etch | 1 |
| 2435 | last-observations-carried-forward | 1 |
| 2436 | later.2 | 1 |
| 2437 | later.3 | 1 |
| 2438 | latina/hispanic | 1 |
| 2439 | lay-off | 1 |
| 2440 | ldac+ato | 1 |
| 2441 | ldl-radius | 1 |
| 2442 | lechatelierite | 1 |
| 2443 | lentisk | 1 |
| 2444 | less/ml | 1 |
| 2445 | leto-gbs | 1 |
| 2446 | levobopivacaine | 1 |
| 2447 | lidocaine-ketamine-dexmedetomidine | 1 |
| 2448 | life-as-usual | 1 |
| 2449 | ligand-to-ligand | 1 |
| 2450 | live-caught | 1 |
| 2451 | lm/mm55 | 1 |
| 2452 | lma.however | 1 |
| 2453 | lmwh+gcs | 1 |
| 2454 | ln=y | 1 |
| 2455 | lo-output | 1 |
| 2456 | loperamide-treated | 1 |
| 2457 | lopinavir/ritonavir+efavirenz | 1 |
| 2458 | lopinavir–ritonavir | 1 |
| 2459 | loracarbef-resistant | 1 |
| 2460 | low-cavity | 1 |
| 2461 | low-cho/high-monounsaturated-fat | 1 |
| 2462 | low-fat/sedentary | 1 |
| 2463 | low-protein/lgi | 1 |
| 2464 | low-suppressed | 1 |
| 2465 | low-weight-loss | 1 |
| 2466 | lqt-3 | 1 |
| 2467 | ltd₄ | 1 |
| 2468 | lympho-lipedema | 1 |
| 2469 | lysine-aspirin | 1 |
| 2470 | lz37 | 1 |
| 2471 | m-substituents | 1 |
| 2472 | macro-ethics | 1 |
| 2473 | mact+ta | 1 |
| 2474 | maleficio | 1 |
| 2475 | maltorsion | 1 |
| 2476 | manic/mania | 1 |
| 2477 | manufacturer-designed | 1 |
| 2478 | maoris | 1 |
| 2479 | marsupialisation | 1 |
| 2480 | maxilla/mandible | 1 |
| 2481 | mean=-0.7 | 1 |
| 2482 | mean=0.79 | 1 |
| 2483 | med16 | 1 |
| 2484 | medline+handsearching | 1 |
| 2485 | melphalan/dexamethasone/thalidomide | 1 |
| 2486 | mentalism | 1 |
| 2487 | mephenytoin | 1 |
| 2488 | meso-h4dmsa | 1 |
| 2489 | meta-characteristics | 1 |
| 2490 | methotrexate+placebo-adalimumab | 1 |
| 2491 | methotrexate/carboplatin/vinblastine | 1 |
| 2492 | methyljasmonate | 1 |
| 2493 | methylphenidate-placebo | 1 |
| 2494 | metorpolol | 1 |
| 2495 | mexilitene | 1 |
| 2496 | mi+ns | 1 |
| 2497 | microinvasions | 1 |
| 2498 | micromaterials | 1 |
| 2499 | micromitophagy | 1 |
| 2500 | midazolam-morphine | 1 |
| 2501 | midpuberty | 1 |
| 2502 | minicones | 1 |
| 2503 | mission/shelter | 1 |
| 2504 | mitomycin/ifosfamide/cisplatin | 1 |
| 2505 | mitomycin/vinblastine | 1 |
| 2506 | mmf- | 1 |
| 2507 | mmf/myf | 1 |
| 2508 | mmrii® | 1 |
| 2509 | mo-salts | 1 |
| 2510 | mock-radiation | 1 |
| 2511 | modafinil+escitalopram | 1 |
| 2512 | moderate-resistance-high-endurance | 1 |
| 2513 | monacolins-washout-placebo | 1 |
| 2514 | mono-methoxy | 1 |
| 2515 | monoproducts | 1 |
| 2516 | mr=0 | 1 |
| 2517 | mtx+placebo | 1 |
| 2518 | mtx+placebo-cya | 1 |
| 2519 | mtx/tacrolimus | 1 |
| 2520 | mtz+amoxicillin | 1 |
| 2521 | multi-gravidae | 1 |
| 2522 | multimin90 | 1 |
| 2523 | musculoskeletal-related | 1 |
| 2524 | music-headphones | 1 |
| 2525 | mva-f6-sfmr | 1 |
| 2526 | n-acetyl-asp-glu-val-asp-cho | 1 |
| 2527 | n-acetyl-β-end | 1 |
| 2528 | n-cyclohexylcarboxamidine | 1 |
| 2529 | n-ifn-beta | 1 |
| 2530 | n-methyl-dehydroalanine | 1 |
| 2531 | n70 | 1 |
| 2532 | n=1553 | 1 |
| 2533 | na2m | 1 |
| 2534 | naloxonazine | 1 |
| 2535 | naltriben | 1 |
| 2536 | nap+ifn-α | 1 |
| 2537 | nbce1 | 1 |
| 2538 | nbhsp | 1 |
| 2539 | near-planar | 1 |
| 2540 | nebivolol/hydrochlorothiazide | 1 |
| 2541 | nefopam-paracetamol | 1 |
| 2542 | negative-angry | 1 |
| 2543 | neo-adjuvantly | 1 |
| 2544 | neochlamydia | 1 |
| 2545 | nerve-myocyte | 1 |
| 2546 | neurobloc/myobloc | 1 |
| 2547 | newly-launched | 1 |
| 2548 | nfjxy | 1 |
| 2549 | nidcap/experimental | 1 |
| 2550 | no-bracing | 1 |
| 2551 | no-burping | 1 |
| 2552 | no-cancer | 1 |
| 2553 | no-menthol | 1 |
| 2554 | nodulosis | 1 |
| 2555 | nogo-repeat | 1 |
| 2556 | non-activity | 1 |
| 2557 | non-age-matched | 1 |
| 2558 | non-atopy | 1 |
| 2559 | non-bds | 1 |
| 2560 | non-block | 1 |
| 2561 | non-celebrities | 1 |
| 2562 | non-cohabitant | 1 |
| 2563 | non-concomitant | 1 |
| 2564 | non-dialysis-related | 1 |
| 2565 | non-documented | 1 |
| 2566 | non-ee | 1 |
| 2567 | non-emr | 1 |
| 2568 | non-icm.1 | 1 |
| 2569 | non-inflammation | 1 |
| 2570 | non-interventions | 1 |
| 2571 | non-irinotecan | 1 |
| 2572 | non-lasting | 1 |
| 2573 | non-leukoreduction | 1 |
| 2574 | non-losses | 1 |
| 2575 | non-mtd | 1 |
| 2576 | non-pathcr | 1 |
| 2577 | non-platinum- | 1 |
| 2578 | non-producer | 1 |
| 2579 | non-ruptured | 1 |
| 2580 | non-rvd | 1 |
| 2581 | non-spanish-speaking | 1 |
| 2582 | non-st-elevation-acs | 1 |
| 2583 | non-vest | 1 |
| 2584 | nonaminobisphosphonate | 1 |
| 2585 | nonaspirating | 1 |
| 2586 | nonaspiration | 1 |
| 2587 | nonbracing | 1 |
| 2588 | nonbreastfeeding | 1 |
| 2589 | nonceliotomy | 1 |
| 2590 | nonclopidogrel | 1 |
| 2591 | nondisclosers | 1 |
| 2592 | nondisinfection | 1 |
| 2593 | nonemulsified | 1 |
| 2594 | nonenzyme-treated | 1 |
| 2595 | nonhaptics-trained | 1 |
| 2596 | noninducers | 1 |
| 2597 | nonirrigation | 1 |
| 2598 | nonlinemen | 1 |
| 2599 | nonradicals | 1 |
| 2600 | nonreduction | 1 |
| 2601 | nonresurfacoing | 1 |
| 2602 | nonstarters | 1 |
| 2603 | nonsuccessful | 1 |
| 2604 | nonswaddling | 1 |
| 2605 | nonusefulness | 1 |
| 2606 | nonylphenylethers | 1 |
| 2607 | norepineprhine | 1 |
| 2608 | normal-testosterone | 1 |
| 2609 | normofiltration | 1 |
| 2610 | not-follow | 1 |
| 2611 | not-sudden | 1 |
| 2612 | novofine | 1 |
| 2613 | np-28rnp | 1 |
| 2614 | ns-nsaid | 1 |
| 2615 | nurse-qodd | 1 |
| 2616 | nϵ- | 1 |
| 2617 | o-blood | 1 |
| 2618 | oats-fed | 1 |
| 2619 | obtrusion | 1 |
| 2620 | occlusion-2 | 1 |
| 2621 | octanol-aqueous | 1 |
| 2622 | octreotide-everolimus | 1 |
| 2623 | olanzapine+topiramate | 1 |
| 2624 | olfactory+gustatory | 1 |
| 2625 | olive-oil-enriched | 1 |
| 2626 | olmesertan | 1 |
| 2627 | on-warfarin | 1 |
| 2628 | once-a-wk | 1 |
| 2629 | oncoprotein-18 | 1 |
| 2630 | opcab-surgery | 1 |
| 2631 | osteopaenic | 1 |
| 2632 | other-than-placebo | 1 |
| 2633 | otorragy | 1 |
| 2634 | over-reciprocating | 1 |
| 2635 | ovoids | 1 |
| 2636 | oxa-carbapenemases | 1 |
| 2637 | oxliplatin | 1 |
| 2638 | oxyplatin | 1 |
| 2639 | ozena | 1 |
| 2640 | p-28rnp | 1 |
| 2641 | p-dihydroxyborylphenylalanine | 1 |
| 2642 | p-nitrophenyl-α-d-galactoside | 1 |
| 2643 | p94 | 1 |
| 2644 | pacemaker-defibrillator | 1 |
| 2645 | paracematol | 1 |
| 2646 | parametrectomy | 1 |
| 2647 | paranodes | 1 |
| 2648 | paraparetic | 1 |
| 2649 | paraxially | 1 |
| 2650 | paroxetine+quetiapine | 1 |
| 2651 | pash-1 | 1 |
| 2652 | pathological-and | 1 |
| 2653 | pbp2xhis₆ | 1 |
| 2654 | pcv13+p80 | 1 |
| 2655 | pds® | 1 |
| 2656 | pdt/ivb/ivt | 1 |
| 2657 | peg-ifnα-2a/rbv/fluvastatin | 1 |
| 2658 | pepsi® | 1 |
| 2659 | peridinioids | 1 |
| 2660 | peritrochanter | 1 |
| 2661 | peritumorally | 1 |
| 2662 | pertuzumab-docetaxel | 1 |
| 2663 | pet28b-tvcp3c | 1 |
| 2664 | pfp×c18 | 1 |
| 2665 | phe-cys-tyr-trp-orn-thr-pen-thr-nh2 | 1 |
| 2666 | phenocoumaron | 1 |
| 2667 | phosphate-buffer | 1 |
| 2668 | phosphoantigens | 1 |
| 2669 | photoallergenic | 1 |
| 2670 | photophores | 1 |
| 2671 | pinnules | 1 |
| 2672 | pla+dtic | 1 |
| 2673 | pla-cebo | 1 |
| 2674 | placebo+lifestyle | 1 |
| 2675 | placebo+obt | 1 |
| 2676 | placebo-dronabinol | 1 |
| 2677 | placebo-methylphenidate | 1 |
| 2678 | placebo-plus-bwl | 1 |
| 2679 | placebo-primed | 1 |
| 2680 | placebo-stimulation | 1 |
| 2681 | placebo-walnuts | 1 |
| 2682 | placebo/cbt | 1 |
| 2683 | placebo/dtic | 1 |
| 2684 | placebo/prednisone | 1 |
| 2685 | placebo/sertraline | 1 |
| 2686 | placebo/steroids | 1 |
| 2687 | placebo/washout/nac | 1 |
| 2688 | plastificants | 1 |
| 2689 | platinum-responsiveness | 1 |
| 2690 | platinum/vinorelbine | 1 |
| 2691 | play-audiometry | 1 |
| 2692 | pm/em | 1 |
| 2693 | pnd21-42 | 1 |
| 2694 | pnd42 | 1 |
| 2695 | po+pr | 1 |
| 2696 | poly-chemotherapies | 1 |
| 2697 | poly-phyletic | 1 |
| 2698 | poly-victimization | 1 |
| 2699 | polyleucine | 1 |
| 2700 | polyoxytetramethylenediols | 1 |
| 2701 | polytetrafluoroethelene | 1 |
| 2702 | polytypism | 1 |
| 2703 | polyvinylpyrolidone | 1 |
| 2704 | poorly-reported | 1 |
| 2705 | post-last-dose | 1 |
| 2706 | post-ps | 1 |
| 2707 | post-studies | 1 |
| 2708 | post-synaptically | 1 |
| 2709 | postprocedures | 1 |
| 2710 | postpyloris | 1 |
| 2711 | power-modes | 1 |
| 2712 | pq1wc | 1 |
| 2713 | pr+/her2+ | 1 |
| 2714 | pr+/her2- | 1 |
| 2715 | pre-cirrhosis | 1 |
| 2716 | pre-conceptually | 1 |
| 2717 | prednimustine | 1 |
| 2718 | prednisolone/mps | 1 |
| 2719 | preleukemia | 1 |
| 2720 | premphase | 1 |
| 2721 | prentice-wilcoxon | 1 |
| 2722 | pressurelike | 1 |
| 2723 | prevention/mediation | 1 |
| 2724 | prilocaine-phenylephrine | 1 |
| 2725 | principal/secondary | 1 |
| 2726 | probable/possible-ptb | 1 |
| 2727 | progression-control | 1 |
| 2728 | progression-controls | 1 |
| 2729 | pronase/bicarbonate/simethicone | 1 |
| 2730 | propofol/fentanyl/placebo-saline | 1 |
| 2731 | prostaglandinanalogue | 1 |
| 2732 | protease-activated-receptor-2 | 1 |
| 2733 | pseudallescheria | 1 |
| 2734 | pseudo-randomisation | 1 |
| 2735 | pseudo-relapse | 1 |
| 2736 | pseudoepiphysis | 1 |
| 2737 | pseudohematuria | 1 |
| 2738 | pseudooxynicotine | 1 |
| 2739 | pseudophosphatases | 1 |
| 2740 | psos | 1 |
| 2741 | pstae-yoghurt | 1 |
| 2742 | psychological-mindset | 1 |
| 2743 | pt2b/pt3 | 1 |
| 2744 | ptany | 1 |
| 2745 | pueperium | 1 |
| 2746 | pylorus-removal | 1 |
| 2747 | pyrimathamine+clindamycin | 1 |
| 2748 | p≤0.0025 | 1 |
| 2749 | q148r | 1 |
| 2750 | qr/rr192 | 1 |
| 2751 | quantitative-measured | 1 |
| 2752 | quinine-tetracycline | 1 |
| 2753 | r-cells | 1 |
| 2754 | r-γ | 1 |
| 2755 | r56865 | 1 |
| 2756 | radiation.mcnu.interferon-beta | 1 |
| 2757 | radio-isotopes | 1 |
| 2758 | radmhe2 | 1 |
| 2759 | raktadushti | 1 |
| 2760 | randomised-response | 1 |
| 2761 | rapid-weight-reduction | 1 |
| 2762 | rarc/plnd | 1 |
| 2763 | rawness | 1 |
| 2764 | rbca | 1 |
| 2765 | rcht-treated | 1 |
| 2766 | re-draping | 1 |
| 2767 | readmissions/patient | 1 |
| 2768 | red-clover | 1 |
| 2769 | reexplorations | 1 |
| 2770 | referred-care | 1 |
| 2771 | relapse/reactivation | 1 |
| 2772 | ren2-eta/etb | 1 |
| 2773 | renting | 1 |
| 2774 | renutrition | 1 |
| 2775 | reovirus-1 | 1 |
| 2776 | retinectomy | 1 |
| 2777 | revivification | 1 |
| 2778 | rhcl3·3h2o | 1 |
| 2779 | ribbling | 1 |
| 2780 | right-noncoronary | 1 |
| 2781 | rimonabant/ | 1 |
| 2782 | rituximab-cyclophosphamide | 1 |
| 2783 | riukiu-yomogi | 1 |
| 2784 | rmsp1-19 | 1 |
| 2785 | rns10.3 | 1 |
| 2786 | ro-3306 | 1 |
| 2787 | romifidine-ketamine | 1 |
| 2788 | rostellum | 1 |
| 2789 | rosuvastatin/exercise | 1 |
| 2790 | rp-8-br-camps | 1 |
| 2791 | rt-hyperthermia | 1 |
| 2792 | rtv/sqv/stavudine | 1 |
| 2793 | s/s+a/a | 1 |
| 2794 | s1179 | 1 |
| 2795 | sabethes | 1 |
| 2796 | saline-atropine | 1 |
| 2797 | saline-placebo | 1 |
| 2798 | saline±r-tpa | 1 |
| 2799 | salpingits | 1 |
| 2800 | salpingo | 1 |
| 2801 | sandblasted+ssp | 1 |
| 2802 | sbcl5 | 1 |
| 2803 | scfts | 1 |
| 2804 | scombrotoxin | 1 |
| 2805 | secondary/central | 1 |
| 2806 | secundi- | 1 |
| 2807 | self-centred | 1 |
| 2808 | self-complementarity | 1 |
| 2809 | self-presenting | 1 |
| 2810 | self-used | 1 |
| 2811 | semicoma | 1 |
| 2812 | semipoisons | 1 |
| 2813 | serogroup-c-meningococcal-conjugate-vaccine | 1 |
| 2814 | severe-cyclers | 1 |
| 2815 | severe-tbi | 1 |
| 2816 | sevo-des | 1 |
| 2817 | sevoflurane-opioid | 1 |
| 2818 | sham-anaesthetised | 1 |
| 2819 | sham-aw | 1 |
| 2820 | sham-devices | 1 |
| 2821 | sham-nf | 1 |
| 2822 | sham-nrt | 1 |
| 2823 | sheet-like/lamellated | 1 |
| 2824 | sheikhas | 1 |
| 2825 | shi-hung-one | 1 |
| 2826 | sho-seiru-to | 1 |
| 2827 | sigirr | 1 |
| 2828 | sildenafil-citrate | 1 |
| 2829 | silylether | 1 |
| 2830 | simvastotin | 1 |
| 2831 | sirt+mfolfox6 | 1 |
| 2832 | six-hole | 1 |
| 2833 | skin/structure | 1 |
| 2834 | sl-04 | 1 |
| 2835 | slogp | 1 |
| 2836 | slope=-2.03 | 1 |
| 2837 | sloppiness | 1 |
| 2838 | sm+sm | 1 |
| 2839 | small-goals | 1 |
| 2840 | small-series | 1 |
| 2841 | smartconsents | 1 |
| 2842 | snorted | 1 |
| 2843 | socialise | 1 |
| 2844 | sodb-s | 1 |
| 2845 | sordariales | 1 |
| 2846 | spirotetrahydrofuran | 1 |
| 2847 | spk-transplanted | 1 |
| 2848 | sr142801 | 1 |
| 2849 | staffing/equipment | 1 |
| 2850 | standard-suture | 1 |
| 2851 | states/provinces | 1 |
| 2852 | statin+ezetimibe | 1 |
| 2853 | statins++ | 1 |
| 2854 | stavudine/lamivudine/efavirenz | 1 |
| 2855 | sterofundine-g-5 | 1 |
| 2856 | steroid-continuing | 1 |
| 2857 | stomatologist | 1 |
| 2858 | sucrose-based | 1 |
| 2859 | sufentanil-vecuronium | 1 |
| 2860 | sulbactam/penicillin | 1 |
| 2861 | sulphonylmethyl | 1 |
| 2862 | supraliminally | 1 |
| 2863 | supraperiostally | 1 |
| 2864 | swearing | 1 |
| 2865 | sweat-feeding | 1 |
| 2866 | synexin | 1 |
| 2867 | t-depleted | 1 |
| 2868 | t-incision | 1 |
| 2869 | t-nts | 1 |
| 2870 | t1-2=3.62 | 1 |
| 2871 | t7-8 | 1 |
| 2872 | t97a | 1 |
| 2873 | tablet/lyophilisate | 1 |
| 2874 | tac/mmf/st | 1 |
| 2875 | tacrolimus/methotrexate/sirolimus | 1 |
| 2876 | tamoxifen+prednisolone | 1 |
| 2877 | target-achievement | 1 |
| 2878 | tattoed | 1 |
| 2879 | tau+mct | 1 |
| 2880 | taxane/doxorubicin | 1 |
| 2881 | tbt/la | 1 |
| 2882 | tcf/pangolin | 1 |
| 2883 | tdf/ftc/efv | 1 |
| 2884 | tearmist | 1 |
| 2885 | tetracyanobuta-1,3-dienes | 1 |
| 2886 | tetrahydroneopterin | 1 |
| 2887 | tetraparetic | 1 |
| 2888 | tetravisc | 1 |
| 2889 | tfv-diphosphate | 1 |
| 2890 | tg+ | 1 |
| 2891 | thaumarchaeol | 1 |
| 2892 | thermal/evaporative | 1 |
| 2893 | thermotube | 1 |
| 2894 | thiopental-placebo | 1 |
| 2895 | thp+imp | 1 |
| 2896 | three-portal | 1 |
| 2897 | thymoquinone-4-palmitoylhydrazone | 1 |
| 2898 | tiaprid | 1 |
| 2899 | tincet | 1 |
| 2900 | tlr2/4 | 1 |
| 2901 | tm-smx | 1 |
| 2902 | tnfα/cycloheximide | 1 |
| 2903 | tobramycin/clindamycin | 1 |
| 2904 | toe-strike | 1 |
| 2905 | topotecan-etoposide | 1 |
| 2906 | toxins/drugs | 1 |
| 2907 | trail/ccb | 1 |
| 2908 | training-esa | 1 |
| 2909 | trans-3,4',5-trihydroxystilbene | 1 |
| 2910 | trans-4-hydroxyproline | 1 |
| 2911 | transinstitutionalization | 1 |
| 2912 | transsexuality | 1 |
| 2913 | transtympanically | 1 |
| 2914 | tresosulfan+/-etoposide | 1 |
| 2915 | trimagant | 1 |
| 2916 | trimetaphan | 1 |
| 2917 | trimethoprim-sulfameth-oxazole | 1 |
| 2918 | trimethoprim/sulfamethopyrazine | 1 |
| 2919 | trimethoprime-sulfamethoxazole | 1 |
| 2920 | triplications | 1 |
| 2921 | trα-knock-out | 1 |
| 2922 | tssu | 1 |
| 2923 | tt,1.637 | 1 |
| 2924 | tt-ps | 1 |
| 2925 | tu.xs | 1 |
| 2926 | tubocurarine | 1 |
| 2927 | u.o.c | 1 |
| 2928 | ubiquitin-tagged | 1 |
| 2929 | ubp1112 | 1 |
| 2930 | uft/leucovorin/oxaliplatin | 1 |
| 2931 | ugt1a1*60 | 1 |
| 2932 | ultrafiltation | 1 |
| 2933 | un-cross-linked | 1 |
| 2934 | uncoated-stent | 1 |
| 2935 | under-anticoagulation | 1 |
| 2936 | under-cooked | 1 |
| 2937 | under-immunised | 1 |
| 2938 | under-resuscitation | 1 |
| 2939 | underemployed | 1 |
| 2940 | undertectable | 1 |
| 2941 | undressing | 1 |
| 2942 | unfulfilling | 1 |
| 2943 | unintelligent | 1 |
| 2944 | unmatched-bias | 1 |
| 2945 | unspeeded-unspeeded | 1 |
| 2946 | upper-income/middle-income | 1 |
| 2947 | urethropexia | 1 |
| 2948 | uv/mv | 1 |
| 2949 | vac+dfm | 1 |
| 2950 | vaccination.conclusion | 1 |
| 2951 | valence-judgments | 1 |
| 2952 | vancomycinceftazidime | 1 |
| 2953 | vegf-a/c | 1 |
| 2954 | venesections | 1 |
| 2955 | venlafaxine+cbt | 1 |
| 2956 | venlafaxine-extended-release | 1 |
| 2957 | very-low-dose-methotrexate | 1 |
| 2958 | vgpr/pr | 1 |
| 2959 | vincristine-mitoxantrone-dexamethasone | 1 |
| 2960 | vinorelbine/carboplatin | 1 |
| 2961 | vistascan | 1 |
| 2962 | vurs | 1 |
| 2963 | water-brash | 1 |
| 2964 | wilcoxon-rank-sum-test | 1 |
| 2965 | wrist- | 1 |
| 2966 | x/x | 1 |
| 2967 | xanthen-9h-ones | 1 |
| 2968 | xenophagy | 1 |
| 2969 | xing-ren | 1 |
| 2970 | y310 | 1 |
| 2971 | y90+sorafenib | 1 |
| 2972 | yi-jing | 1 |
| 2973 | ymca/ywca | 1 |
| 2974 | ymfl | 1 |
| 2975 | z+ | 1 |
| 2976 | zalcitabine/zdv | 1 |
| 2977 | zero-na | 1 |
| 2978 | znpicolinate | 1 |
| 2979 | £10,459 | 1 |
| 2980 | £1005.91 | 1 |
| 2981 | £11,715 | 1 |
| 2982 | £117 | 1 |
| 2983 | £189.91 | 1 |
| 2984 | £251.62 | 1 |
| 2985 | £4413 | 1 |
| 2986 | £6.62 | 1 |
| 2987 | ß-oxidation | 1 |
| 2988 | α-phenyl | 1 |
| 2989 | α-substituted-α-hydroxy-β | 1 |
| 2990 | α1,3-linkages | 1 |
| 2991 | α2→6 | 1 |
| 2992 | α4β2nachr | 1 |
| 2993 | αvβ8 | 1 |
| 2994 | βarrestin1 | 1 |
| 2995 | β₄-subunits | 1 |
| 2996 | γ-csp | 1 |
| 2997 | δtnf-α | 1 |
| 2998 | μct-80 | 1 |
| 2999 | σ-re-x | 1 |
| 3000 | €1,316 | 1 |
| 3001 | €1.595 | 1 |
| 3002 | €109.10 | 1 |
| 3003 | €14,911 | 1 |
| 3004 | €17,643 | 1 |
| 3005 | €181 | 1 |
| 3006 | €1882 | 1 |
| 3007 | €2130.01 | 1 |
| 3008 | €2700 | 1 |
| 3009 | €3,527 | 1 |
| 3010 | €3.346 | 1 |
| 3011 | €3075 | 1 |
| 3012 | €32,657,590 | 1 |
| 3013 | €35,335 | 1 |
| 3014 | €381.34 | 1 |
| 3015 | €4527 | 1 |
| 3016 | €4801 | 1 |
| 3017 | €52,479 | 1 |
| 3018 | €5267 | 1 |
| 3019 | €595 | 1 |
| 3020 | €7908 | 1 |
| 3021 | ∆triglyceride | 1 |
| 3022 | ≤1.13 | 1 |
| 3023 | ≤3-point | 1 |
| 3024 | ≤50×10 | 1 |
| 3025 | ≥20×10 | 1 |
| 3026 | ≥37°c | 1 |
| 1 | 'pca | 1 |
| 2 | 'saline | 2 |
| 3 | 'uncaring | 1 |
| 4 | *01:02 | 1 |
| 5 | *i-ib-mal-d-geeek-nanobody | 1 |
| 6 | +0.02±0.29 | 1 |
| 7 | +0.94 | 2 |
| 8 | +10.2±12.8 | 1 |
| 9 | +106.3 | 1 |
| 10 | +247 | 2 |
| 11 | +3610 | 1 |
| 12 | +6424 | 1 |
| 13 | +9.3±13.9 | 1 |
| 14 | -.054 | 1 |
| 15 | -0.02+/-0.07 | 1 |
| 16 | -0.03±0.31 | 1 |
| 17 | -0.04±0.21 | 1 |
| 18 | -0.04±0.38ms | 1 |
| 19 | -0.08±0.26 | 2 |
| 20 | -0.12±0.69 | 1 |
| 21 | -0.17±0.30 | 1 |
| 22 | -0.23±0.19 | 1 |
| 23 | -0.41±0.21 | 1 |
| 24 | -0.41±0.43 | 1 |
| 25 | -0.42+/-0.13 | 1 |
| 26 | -0.51/second | 1 |
| 27 | -0.6+/-0 | 1 |
| 28 | -0.61±0.90 | 1 |
| 29 | -0.84±0.09 | 1 |
| 30 | -0.89±0.13 | 1 |
| 31 | -0.99±0.09 | 1 |
| 32 | -1.589 | 1 |
| 33 | -1.7±0.5 | 1 |
| 34 | -11.4±1.3 | 1 |
| 35 | -134.7 | 1 |
| 36 | -13·42 | 1 |
| 37 | -16.72 | 2 |
| 38 | -169.3 | 1 |
| 39 | -20.3+/-12.7 | 1 |
| 40 | -2·73 | 2 |
| 41 | -3.6±6.8mm | 1 |
| 42 | -306.4 | 1 |
| 43 | -32°c | 1 |
| 44 | -4.8±3.1° | 1 |
| 45 | -4.9+/-5.7 | 1 |
| 46 | -6/min | 1 |
| 47 | -7/8 | 1 |
| 48 | -8.20±1.28 | 1 |
| 49 | -8.26±1.24 | 1 |
| 50 | -87.2 | 1 |
| 51 | -930.2 | 1 |
| 52 | -alkylamino-1,2,3,4-tetrahydropyridines | 1 |
| 53 | -dna-positive | 1 |
| 54 | -elbow | 1 |
| 55 | -hemorrhage | 1 |
| 56 | -i.p | 1 |
| 57 | -lbp/+brace | 2 |
| 58 | -sc | 1 |
| 59 | -tachycardia | 1 |
| 60 | -tn | 3 |
| 61 | -vildaglitpin | 1 |
| 62 | .68±.92 | 1 |
| 63 | 0,393 | 1 |
| 64 | 0.00291+/-0.00041 | 1 |
| 65 | 0.00322+/-0.00050 | 1 |
| 66 | 0.004+/-0.001 | 1 |
| 67 | 0.01*10 | 1 |
| 68 | 0.01±0.2 | 1 |
| 69 | 0.02+/-0.14 | 1 |
| 70 | 0.039+/-0.008 | 1 |
| 71 | 0.03±0.16 | 1 |
| 72 | 0.03±0.31 | 1 |
| 73 | 0.04±2.19×10 | 1 |
| 74 | 0.06-0.51 | 2 |
| 75 | 0.071±0.12 | 1 |
| 76 | 0.0772 | 1 |
| 77 | 0.10±1.08 | 1 |
| 78 | 0.13±0.40 | 1 |
| 79 | 0.17-0.32 | 1 |
| 80 | 0.19+/-0.09 | 1 |
| 81 | 0.23+/-0.22 | 1 |
| 82 | 0.24/patient/year | 1 |
| 83 | 0.28±0.18 | 1 |
| 84 | 0.31+/-0.04 | 1 |
| 85 | 0.31±0.12°c | 1 |
| 86 | 0.32±0.05 | 1 |
| 87 | 0.354+/-0.041 | 1 |
| 88 | 0.35kg | 1 |
| 89 | 0.35±0.14°c | 1 |
| 90 | 0.36+/-0.03 | 1 |
| 91 | 0.3±17.2 | 1 |
| 92 | 0.41±0.2 | 1 |
| 93 | 0.45±0.11 | 1 |
| 94 | 0.46±0.11 | 1 |
| 95 | 0.48+/-0.10 | 1 |
| 96 | 0.49±0.10 | 1 |
| 97 | 0.49±0.12 | 1 |
| 98 | 0.5-mg/kg | 2 |
| 99 | 0.50±0.11 | 2 |
| 100 | 0.52+/-0.08n | 1 |
| 101 | 0.52+/-0.45 | 1 |
| 102 | 0.52log | 1 |
| 103 | 0.57±0.09 | 1 |
| 104 | 0.59±0.16 | 1 |
| 105 | 0.6+/-0.3 | 1 |
| 106 | 0.6+/-0.5 | 1 |
| 107 | 0.6cm | 1 |
| 108 | 0.71±0.27 | 1 |
| 109 | 0.73+/-0.07 | 1 |
| 110 | 0.75±1.2 | 1 |
| 111 | 0.76±1.16 | 1 |
| 112 | 0.79±0.26 | 1 |
| 113 | 0.82+/-0.05 | 1 |
| 114 | 0.83±0.24 | 1 |
| 115 | 0.89-3.63 | 1 |
| 116 | 0.9+/-0.5s | 1 |
| 117 | 0/119 | 1 |
| 118 | 0/123 | 1 |
| 119 | 0/210 | 2 |
| 120 | 0/211 | 1 |
| 121 | 0/259 | 1 |
| 122 | 0/86 | 1 |
| 123 | 0·256 | 1 |
| 124 | 0·346 | 1 |
| 125 | 1,0,1/t | 1 |
| 126 | 1,10-phenan-throline | 1 |
| 127 | 1,2-dihydroanthracene | 1 |
| 128 | 1,2-dioleoyl-3-trimethylammonium-propane | 1 |
| 129 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 3 |
| 130 | 1,2-enediols | 1 |
| 131 | 1,3-di-oleoyloxy-2- | 1 |
| 132 | 1,4-benzenedithiol | 1 |
| 133 | 1,4-bisnucleophiles | 1 |
| 134 | 1,9-nonanediol | 1 |
| 135 | 1-branched | 3 |
| 136 | 1-butylimidazole | 1 |
| 137 | 1-lysophosphatidylethanolamine | 1 |
| 138 | 1-methylsilene | 1 |
| 139 | 1-octadecanol | 2 |
| 140 | 1.00+/-0.67 | 2 |
| 141 | 1.01+/-0.18 | 1 |
| 142 | 1.05+/-0.1 | 1 |
| 143 | 1.05×10 | 1 |
| 144 | 1.0±3.2 | 1 |
| 145 | 1.15/year | 1 |
| 146 | 1.17±0.37 | 1 |
| 147 | 1.1±3.6 | 1 |
| 148 | 1.20-1.28 | 1 |
| 149 | 1.21mg/l | 1 |
| 150 | 1.24+/-0.15 | 1 |
| 151 | 1.251 | 2 |
| 152 | 1.27±0.9 | 1 |
| 153 | 1.28±0.64 | 1 |
| 154 | 1.30±0.13 | 1 |
| 155 | 1.33±0.82 | 1 |
| 156 | 1.35mmol/l | 1 |
| 157 | 1.37-/+0.64 | 1 |
| 158 | 1.37±6.4mm | 1 |
| 159 | 1.3±0.5 | 3 |
| 160 | 1.3±1.7 | 1 |
| 161 | 1.41° | 1 |
| 162 | 1.42±0.53 | 1 |
| 163 | 1.46+/-0.12 | 1 |
| 164 | 1.50±0.95 | 1 |
| 165 | 1.55±0.17 | 1 |
| 166 | 1.57mmol/l | 1 |
| 167 | 1.58±0.03 | 1 |
| 168 | 1.5±1.4 | 2 |
| 169 | 1.67+/-0.08 | 1 |
| 170 | 1.68-10 | 2 |
| 171 | 1.7+/-0.6 | 1 |
| 172 | 1.721 | 1 |
| 173 | 1.72±0.18m | 1 |
| 174 | 1.749 | 1 |
| 175 | 1.74°/s | 1 |
| 176 | 1.74±0.22 | 1 |
| 177 | 1.77+/-0.13 | 1 |
| 178 | 1.774 | 3 |
| 179 | 1.780 | 1 |
| 180 | 1.78±0.02 | 1 |
| 181 | 1.8/1,000 | 1 |
| 182 | 1.888 | 2 |
| 183 | 1.8min+/-0.9 | 1 |
| 184 | 1.9/patient | 1 |
| 185 | 1.958 | 1 |
| 186 | 1.99-1.16 | 1 |
| 187 | 1.996.500€ | 1 |
| 188 | 1/142 | 1 |
| 189 | 1/181 | 3 |
| 190 | 1/259 | 1 |
| 191 | 1/349 | 1 |
| 192 | 1/4707 | 1 |
| 193 | 1/579 | 1 |
| 194 | 1/74 | 1 |
| 195 | 1/76 | 1 |
| 196 | 1/86 | 1 |
| 197 | 1/mm2 | 1 |
| 198 | 10,000/microl | 2 |
| 199 | 10.0±4.5 | 1 |
| 200 | 10.2±2.9μg/ml | 1 |
| 201 | 10.34°/s | 1 |
| 202 | 10.5±2.8° | 1 |
| 203 | 10.6min | 1 |
| 204 | 10.7/h | 1 |
| 205 | 10.7±2.8µmol/l | 1 |
| 206 | 10.7±2.9µmol/l | 1 |
| 207 | 10.8+/-0.8 | 1 |
| 208 | 10.9months | 1 |
| 209 | 10/34 | 3 |
| 210 | 10/358 | 2 |
| 211 | 10/80-mg | 1 |
| 212 | 10/95 | 1 |
| 213 | 100ml/kg/day | 2 |
| 214 | 100nm | 8 |
| 215 | 101.7±31.5 | 1 |
| 216 | 103/270 | 1 |
| 217 | 104.1+/-43.4 | 1 |
| 218 | 105/154 | 1 |
| 219 | 105/362 | 1 |
| 220 | 106.38 | 1 |
| 221 | 1065.9 | 1 |
| 222 | 107/687 | 1 |
| 223 | 108+/-36 | 1 |
| 224 | 108/130 | 1 |
| 225 | 11-c2 | 2 |
| 226 | 11.0+/-5.8 | 1 |
| 227 | 11.0±1.2 | 1 |
| 228 | 11.175 | 1 |
| 229 | 11.3+/-4.1 | 2 |
| 230 | 11.4±19.6 | 1 |
| 231 | 11.51±15.04 | 1 |
| 232 | 11/136 | 1 |
| 233 | 11/193 | 1 |
| 234 | 110.4±25.0 | 1 |
| 235 | 111±71pg/ml | 1 |
| 236 | 112±33 | 1 |
| 237 | 113/2,465 | 1 |
| 238 | 113/422 | 1 |
| 239 | 114±13mmhg | 1 |
| 240 | 115.7±59.9 | 1 |
| 241 | 1151/1848 | 1 |
| 242 | 116.39 | 1 |
| 243 | 117.05±12.74le | 1 |
| 244 | 117.5±36.5cmh | 1 |
| 245 | 117.93±13.13 | 1 |
| 246 | 117/1653 | 1 |
| 247 | 118.6g/m | 1 |
| 248 | 118/151 | 1 |
| 249 | 119/147 | 1 |
| 250 | 119/496 | 1 |
| 251 | 1193±263nmolesca | 1 |
| 252 | 11:12 | 1 |
| 253 | 11α- | 1 |
| 254 | 12+/-3.8 | 1 |
| 255 | 12,138 | 1 |
| 256 | 12.026 | 1 |
| 257 | 12.0±5.1 | 1 |
| 258 | 12.3±2.8µmol/l | 1 |
| 259 | 12.5° | 3 |
| 260 | 12.680 | 1 |
| 261 | 12.7months | 1 |
| 262 | 12.8±1.5 | 1 |
| 263 | 12.9±5.4 | 1 |
| 264 | 12/100,100 | 1 |
| 265 | 12/134 | 1 |
| 266 | 12/352 | 1 |
| 267 | 12/47 | 1 |
| 268 | 120+/-20 | 1 |
| 269 | 120/175 | 1 |
| 270 | 120/576 | 1 |
| 271 | 123/443 | 1 |
| 272 | 125/150 | 1 |
| 273 | 125:1 | 1 |
| 274 | 126/75 | 1 |
| 275 | 127/208 | 1 |
| 276 | 127/380 | 1 |
| 277 | 128h | 1 |
| 278 | 128mmhg | 1 |
| 279 | 128° | 6 |
| 280 | 12gray | 1 |
| 281 | 13'-cis-lutein | 1 |
| 282 | 13'-cis-β-carotene | 1 |
| 283 | 13.0+/-6.2 | 1 |
| 284 | 13.0±0.57 | 1 |
| 285 | 13.28+/-9.7micromol/l/13.15 | 1 |
| 286 | 13.2±3.8 | 1 |
| 287 | 13.4±0.46 | 1 |
| 288 | 13.5±2.3kg | 1 |
| 289 | 13.6months | 1 |
| 290 | 13.70h | 1 |
| 291 | 13/124 | 2 |
| 292 | 13/349 | 1 |
| 293 | 132/180 | 1 |
| 294 | 132/292 | 1 |
| 295 | 1327/3075 | 1 |
| 296 | 1348.6 | 1 |
| 297 | 135.1±7.8mmhg | 1 |
| 298 | 136.05 | 1 |
| 299 | 136.9±16.9 | 1 |
| 300 | 13n-ammonia | 3 |
| 301 | 13·33 | 1 |
| 302 | 14.3+/-8.5 | 1 |
| 303 | 14.409 | 1 |
| 304 | 14.4±1.8pg/ml | 1 |
| 305 | 14.9±1.7° | 1 |
| 306 | 14/107 | 1 |
| 307 | 14/173 | 1 |
| 308 | 14/179 | 1 |
| 309 | 14/210 | 1 |
| 310 | 140℃ | 2 |
| 311 | 145.4±22.9g | 1 |
| 312 | 145/212 | 1 |
| 313 | 146/1118 | 2 |
| 314 | 146/353 | 1 |
| 315 | 148±14.24 | 1 |
| 316 | 149+/-21 | 1 |
| 317 | 149+/-47 | 1 |
| 318 | 14951 | 1 |
| 319 | 14c-thymidine | 1 |
| 320 | 14rpm | 1 |
| 321 | 15,000/microl | 2 |
| 322 | 15-gy | 3 |
| 323 | 15.2±5.1 | 1 |
| 324 | 15.9±6.3×10 | 1 |
| 325 | 15/110 | 2 |
| 326 | 15/152 | 1 |
| 327 | 15/205 | 1 |
| 328 | 150.7mg | 1 |
| 329 | 152.95 | 1 |
| 330 | 153±46min | 1 |
| 331 | 154/398 | 1 |
| 332 | 1544.4miu/ml | 1 |
| 333 | 1559,4 | 1 |
| 334 | 157.0±18.1/mm | 1 |
| 335 | 16-hr | 4 |
| 336 | 16.2±10.0 | 1 |
| 337 | 16.356 | 1 |
| 338 | 16.6pg/ml | 1 |
| 339 | 16.7-38.1 | 1 |
| 340 | 16.7±5.4 | 1 |
| 341 | 16.8±3.8 | 1 |
| 342 | 16/105 | 1 |
| 343 | 16/150 | 1 |
| 344 | 16/682 | 1 |
| 345 | 16/82 | 1 |
| 346 | 160/215 | 1 |
| 347 | 160/5144 | 1 |
| 348 | 1625.7 | 1 |
| 349 | 163.3° | 1 |
| 350 | 164/259 | 1 |
| 351 | 166.0+/-169.5 | 1 |
| 352 | 166/309 | 1 |
| 353 | 16±5mm | 1 |
| 354 | 17+/-10x10 | 1 |
| 355 | 17.0±7.8 | 1 |
| 356 | 17.1fold | 1 |
| 357 | 17.5±10.4 | 1 |
| 358 | 17.5±5.2 | 1 |
| 359 | 17.8±7.5 | 1 |
| 360 | 17.9‰ | 1 |
| 361 | 17/176 | 2 |
| 362 | 17/179 | 1 |
| 363 | 17/347 | 1 |
| 364 | 173/240 | 1 |
| 365 | 1737/2721 | 1 |
| 366 | 174/244 | 1 |
| 367 | 175/1873 | 1 |
| 368 | 176/211 | 1 |
| 369 | 17beta-e2 | 1 |
| 370 | 17ß-estradiol | 1 |
| 371 | 18.1+/-7.8 | 1 |
| 372 | 18.4±7.7 | 1 |
| 373 | 18/211 | 1 |
| 374 | 18/352 | 1 |
| 375 | 18/634 | 1 |
| 376 | 18/867 | 1 |
| 377 | 181.6° | 1 |
| 378 | 18103 | 1 |
| 379 | 182±110 | 1 |
| 380 | 185/242 | 1 |
| 381 | 185/7668 | 1 |
| 382 | 186/649 | 1 |
| 383 | 188.4mg | 1 |
| 384 | 18:2δ4,9 | 1 |
| 385 | 19.0±12.6 | 1 |
| 386 | 19.21+/-2.8 | 1 |
| 387 | 19.4°±11.4° | 1 |
| 388 | 19.7+/-8.4 | 2 |
| 389 | 19.7min | 1 |
| 390 | 19/250 | 2 |
| 391 | 19/54 | 1 |
| 392 | 191.4pg/ml | 1 |
| 393 | 1933/24,983 | 1 |
| 394 | 194.8pg/ml | 1 |
| 395 | 1943/100,000 | 1 |
| 396 | 1943/25,348 | 1 |
| 397 | 1957-2000 | 1 |
| 398 | 19beta | 1 |
| 399 | 19q13.43 | 1 |
| 400 | 19±0.8ml | 1 |
| 401 | 1:1.1 | 1 |
| 402 | 1:12.5 | 1 |
| 403 | 1dpc | 1 |
| 404 | 1mamp | 2 |
| 405 | 1·22/week | 1 |
| 406 | 2,1,3-benzoselenadiazole | 1 |
| 407 | 2,3,4,4',5-pentachlorobiphenyl | 1 |
| 408 | 2,3,4,5-tetrahydro-2,8-dimethyl-5- | 1 |
| 409 | 2,5-di- | 1 |
| 410 | 2,665.57 | 1 |
| 411 | 2-chloro-4-pyridinyl | 1 |
| 412 | 2-furylcarbene | 1 |
| 413 | 2-furyldiazomethane | 1 |
| 414 | 2-methf | 1 |
| 415 | 2-methyl-2-pentenal | 1 |
| 416 | 2.05±1.19 | 1 |
| 417 | 2.0847 | 1 |
| 418 | 2.0±0.2 | 1 |
| 419 | 2.0±0.9 | 1 |
| 420 | 2.0±2.3 | 1 |
| 421 | 2.12+/-0.40 | 1 |
| 422 | 2.12-5.84 | 1 |
| 423 | 2.171 | 1 |
| 424 | 2.19±0.06 | 1 |
| 425 | 2.1±1.5 | 1 |
| 426 | 2.2/1,000 | 1 |
| 427 | 2.23±0.73 | 1 |
| 428 | 2.27+/-0.8 | 1 |
| 429 | 2.286 | 1 |
| 430 | 2.3.2.2 | 1 |
| 431 | 2.342 | 1 |
| 432 | 2.379 | 1 |
| 433 | 2.4+0.8 | 1 |
| 434 | 2.4-6.8 | 1 |
| 435 | 2.46/wk | 1 |
| 436 | 2.48±3.89 | 1 |
| 437 | 2.5. | 1 |
| 438 | 2.504 | 1 |
| 439 | 2.507 | 2 |
| 440 | 2.52-5.27 | 1 |
| 441 | 2.5±2 | 1 |
| 442 | 2.66±0.50 | 1 |
| 443 | 2.743 | 1 |
| 444 | 2.797 | 1 |
| 445 | 2.7±0.5mm | 1 |
| 446 | 2.8+/-3.2 | 1 |
| 447 | 2.89/5 | 1 |
| 448 | 2.9-2.6 | 1 |
| 449 | 2.955 | 1 |
| 450 | 2/112 | 1 |
| 451 | 2/49 | 2 |
| 452 | 2/75 | 1 |
| 453 | 20,000/microl | 3 |
| 454 | 20.0min | 1 |
| 455 | 20.59+/-2.1 | 1 |
| 456 | 20/1694 | 1 |
| 457 | 20/170 | 1 |
| 458 | 20/197 | 1 |
| 459 | 20/47 | 1 |
| 460 | 20/5mg | 4 |
| 461 | 200-u | 6 |
| 462 | 200/110 | 1 |
| 463 | 2007/25,020 | 1 |
| 464 | 201.7 | 1 |
| 465 | 203.52×10 | 1 |
| 466 | 204/729 | 1 |
| 467 | 205.0 | 1 |
| 468 | 206/257 | 2 |
| 469 | 206±67min | 1 |
| 470 | 207/496 | 1 |
| 471 | 208/255 | 1 |
| 472 | 20±7.5days | 1 |
| 473 | 21.6±30.4 | 1 |
| 474 | 21/204 | 1 |
| 475 | 21/226 | 1 |
| 476 | 21/85 | 2 |
| 477 | 211.41+/-71.28 | 1 |
| 478 | 211/743 | 1 |
| 479 | 217/1624 | 1 |
| 480 | 21:00h | 1 |
| 481 | 22.2±8.2 | 1 |
| 482 | 22/103 | 2 |
| 483 | 22/41 | 1 |
| 484 | 22/61 | 1 |
| 485 | 22/62 | 1 |
| 486 | 2296.3 | 1 |
| 487 | 23+/-4.2x10 | 1 |
| 488 | 23.87±11.96 | 1 |
| 489 | 23/1082 | 1 |
| 490 | 23/120 | 2 |
| 491 | 23/13/10/4 | 1 |
| 492 | 23/332 | 1 |
| 493 | 23/61 | 1 |
| 494 | 235·2 | 1 |
| 495 | 23·38 | 2 |
| 496 | 24+/-5bpm | 1 |
| 497 | 24.0° | 2 |
| 498 | 24.1±4.7 | 1 |
| 499 | 24.2+/-4bpm | 1 |
| 500 | 24.9+/-4.3 | 1 |
| 501 | 24/125 | 1 |
| 502 | 24/358 | 1 |
| 503 | 242±141s | 1 |
| 504 | 249/597 | 1 |
| 505 | 24±1cm | 1 |
| 506 | 25/72 | 1 |
| 507 | 250µg | 1 |
| 508 | 252.5 | 1 |
| 509 | 255°c | 1 |
| 510 | 256/308 | 1 |
| 511 | 259/7660 | 1 |
| 512 | 26.3+/-5.1 | 1 |
| 513 | 26.9+/-3.7 | 1 |
| 514 | 26/106 | 1 |
| 515 | 26/73 | 4 |
| 516 | 264/599 | 1 |
| 517 | 266.19 | 1 |
| 518 | 268.5±8.6pg/ml | 1 |
| 519 | 269.8μmol/l | 1 |
| 520 | 26mg/m | 1 |
| 521 | 27.2±5.0 | 1 |
| 522 | 27.8+/-4 | 1 |
| 523 | 27.8kg/m | 1 |
| 524 | 27.8±9.4msv | 1 |
| 525 | 27/841 | 1 |
| 526 | 270° | 6 |
| 527 | 272/355 | 1 |
| 528 | 274.2±23.9mm | 1 |
| 529 | 274.6 | 2 |
| 530 | 275/307 | 1 |
| 531 | 28.0+/-7.8 | 1 |
| 532 | 28.1min | 1 |
| 533 | 28.7+/-5.7 | 1 |
| 534 | 28.97+/-4.96 | 2 |
| 535 | 28/144 | 1 |
| 536 | 28/52 | 1 |
| 537 | 28/62 | 1 |
| 538 | 28/86 | 1 |
| 539 | 282/1194 | 1 |
| 540 | 284±77 | 1 |
| 541 | 28:1 | 1 |
| 542 | 29.3° | 1 |
| 543 | 29.6°c | 3 |
| 544 | 29/109 | 1 |
| 545 | 29/161 | 1 |
| 546 | 29/61 | 1 |
| 547 | 293/2777 | 1 |
| 548 | 296/352 | 1 |
| 549 | 2nrti/etr/efv-placebo | 1 |
| 550 | 2nrtis+pi | 1 |
| 551 | 2×week | 1 |
| 552 | 3'-acetyl | 1 |
| 553 | 3,000/microliters | 2 |
| 554 | 3-ab+suc | 1 |
| 555 | 3-acyl-4-aryldihydroquinolin-2 | 1 |
| 556 | 3-branched | 5 |
| 557 | 3.0±2.9 | 1 |
| 558 | 3.100 | 1 |
| 559 | 3.13±3.1 | 1 |
| 560 | 3.1g/day | 1 |
| 561 | 3.21±1.70×10 | 1 |
| 562 | 3.22±0.16 | 1 |
| 563 | 3.3+/-0.3 | 1 |
| 564 | 3.37°c | 1 |
| 565 | 3.388 | 1 |
| 566 | 3.3±3.9 | 1 |
| 567 | 3.4+/-0.3 | 1 |
| 568 | 3.4mo | 1 |
| 569 | 3.4±0.9 | 2 |
| 570 | 3.501 | 1 |
| 571 | 3.54±0.14 | 1 |
| 572 | 3.58±1.47×10 | 1 |
| 573 | 3.59-12.96 | 1 |
| 574 | 3.620 | 3 |
| 575 | 3.638 | 1 |
| 576 | 3.674 | 1 |
| 577 | 3.727 | 1 |
| 578 | 3.8gy | 1 |
| 579 | 3.8±1.9 | 2 |
| 580 | 3.90±1.46 | 1 |
| 581 | 3.92-20.99 | 1 |
| 582 | 3/137 | 1 |
| 583 | 3/15,369 | 1 |
| 584 | 3/295 | 2 |
| 585 | 3/380 | 2 |
| 586 | 30.13 | 1 |
| 587 | 30.311 | 1 |
| 588 | 30.56+/-2.1 | 1 |
| 589 | 30/29 | 1 |
| 590 | 3000/mm3 | 1 |
| 591 | 300mg/kg/day | 4 |
| 592 | 305/377 | 1 |
| 593 | 30gy | 8 |
| 594 | 31.1±2.4 | 1 |
| 595 | 31.22+/-1.7 | 1 |
| 596 | 31.3° | 2 |
| 597 | 31/1118 | 2 |
| 598 | 31/151 | 1 |
| 599 | 31/169 | 1 |
| 600 | 31/295 | 2 |
| 601 | 31/77 | 2 |
| 602 | 310-320°c | 1 |
| 603 | 311/3169 | 1 |
| 604 | 32.2±16.5 | 1 |
| 605 | 32.6±4.7kg/m | 1 |
| 606 | 32.75+/-3.0 | 1 |
| 607 | 32.9°c | 1 |
| 608 | 32/mm | 1 |
| 609 | 323.4±40.6pg/ml | 1 |
| 610 | 325/356 | 1 |
| 611 | 329.1 | 1 |
| 612 | 3292±943 | 1 |
| 613 | 33.3±20.3 | 1 |
| 614 | 33.9+/-6.5 | 1 |
| 615 | 33/83 | 1 |
| 616 | 330/1424 | 1 |
| 617 | 34,585 | 1 |
| 618 | 34.5±2.8 | 1 |
| 619 | 34/179 | 1 |
| 620 | 35.19+/-4.5 | 1 |
| 621 | 35.4°c | 1 |
| 622 | 35/30°c | 2 |
| 623 | 350/1522 | 1 |
| 624 | 354/1239 | 1 |
| 625 | 356/3146 | 1 |
| 626 | 36,404 | 1 |
| 627 | 36.7+/-16.3mgh/l | 1 |
| 628 | 36/205 | 1 |
| 629 | 362/526 | 1 |
| 630 | 37-39°c | 1 |
| 631 | 37.37 | 2 |
| 632 | 37.4+/-9.2 | 1 |
| 633 | 37.7±0.4°c | 1 |
| 634 | 37.8+/-10.5 | 1 |
| 635 | 37/218 | 1 |
| 636 | 37/295 | 2 |
| 637 | 37/362 | 1 |
| 638 | 37/585 | 1 |
| 639 | 375mg/m | 1 |
| 640 | 377.1 | 1 |
| 641 | 379/1710 | 1 |
| 642 | 38,267 | 1 |
| 643 | 38.5c | 2 |
| 644 | 38/124 | 1 |
| 645 | 38/144 | 1 |
| 646 | 3804+/-494jsprint | 1 |
| 647 | 382.45 | 1 |
| 648 | 382/415 | 1 |
| 649 | 386/429 | 1 |
| 650 | 39.04 | 2 |
| 651 | 39.4+/-12.18 | 1 |
| 652 | 39.65 | 1 |
| 653 | 39/102 | 1 |
| 654 | 39/343 | 1 |
| 655 | 39:11 | 1 |
| 656 | 3h/day | 1 |
| 657 | 3·15 | 2 |
| 658 | 3·80 | 1 |
| 659 | 3μg.kg | 2 |
| 660 | 4+/-4cm | 1 |
| 661 | 4,340/38,110 | 1 |
| 662 | 4-bromophenacyl | 1 |
| 663 | 4-chloro-3-hydroxyanthranilate | 1 |
| 664 | 4-hydroperoxycyclophosphamide | 2 |
| 665 | 4-morpholino | 1 |
| 666 | 4-nitrotoluene | 1 |
| 667 | 4-toluidine | 1 |
| 668 | 4.00±0 | 2 |
| 669 | 4.07±0.52 | 1 |
| 670 | 4.169 | 1 |
| 671 | 4.179 | 1 |
| 672 | 4.25+/-0.17 | 1 |
| 673 | 4.25±0.07 | 1 |
| 674 | 4.261 | 1 |
| 675 | 4.27±1.75×10 | 1 |
| 676 | 4.336 | 1 |
| 677 | 4.33±6.56 | 1 |
| 678 | 4.34+/-0.25 | 1 |
| 679 | 4.375 | 1 |
| 680 | 4.4+/-0.36 | 1 |
| 681 | 4.430 | 1 |
| 682 | 4.464 | 1 |
| 683 | 4.4h | 1 |
| 684 | 4.500 | 1 |
| 685 | 4.524 | 1 |
| 686 | 4.6+/-1.1ms/hz | 1 |
| 687 | 4.630 | 1 |
| 688 | 4.694 | 1 |
| 689 | 4.6±1.9 | 1 |
| 690 | 4.70+/-0.76 | 1 |
| 691 | 4.732 | 1 |
| 692 | 4.744 | 1 |
| 693 | 4.7±2.7h | 1 |
| 694 | 4.8±1.4 | 1 |
| 695 | 4.9+/-1.67 | 1 |
| 696 | 4/181 | 1 |
| 697 | 4/185 | 1 |
| 698 | 4/882 | 1 |
| 699 | 4/99 | 1 |
| 700 | 40.06°c | 1 |
| 701 | 40/552 | 1 |
| 702 | 40/82 | 1 |
| 703 | 40/minute | 1 |
| 704 | 400.8±579.8 | 1 |
| 705 | 400/1039 | 1 |
| 706 | 4079±333s | 1 |
| 707 | 409/2176 | 2 |
| 708 | 40×10 | 2 |
| 709 | 41.33±7.44 | 1 |
| 710 | 41/103 | 2 |
| 711 | 41/118 | 1 |
| 712 | 41/123 | 1 |
| 713 | 41/83 | 1 |
| 714 | 41/92 | 2 |
| 715 | 411.1 | 1 |
| 716 | 416/497 | 1 |
| 717 | 42.1+/-16.9/mul | 1 |
| 718 | 42.9±11.2 | 1 |
| 719 | 42/151 | 1 |
| 720 | 420.2 | 1 |
| 721 | 422/18,161 | 1 |
| 722 | 427/463 | 1 |
| 723 | 42:36 | 1 |
| 724 | 43/1648 | 1 |
| 725 | 43/214 | 1 |
| 726 | 439/3302 | 1 |
| 727 | 43±23 | 1 |
| 728 | 44/104 | 1 |
| 729 | 44/319 | 1 |
| 730 | 447/628 | 1 |
| 731 | 44±9 | 1 |
| 732 | 45.4cm | 1 |
| 733 | 45.5±5.5 | 1 |
| 734 | 45/279 | 1 |
| 735 | 455.8 | 1 |
| 736 | 458/576 | 1 |
| 737 | 459/2399 | 1 |
| 738 | 45±16 | 1 |
| 739 | 46.6±9.8 | 1 |
| 740 | 46/692 | 1 |
| 741 | 46/87 | 1 |
| 742 | 465mg | 1 |
| 743 | 47.1±10.6 | 1 |
| 744 | 47.46±7.31 | 1 |
| 745 | 47.80±8.45 | 1 |
| 746 | 47/1119 | 1 |
| 747 | 47/181 | 1 |
| 748 | 47/296 | 2 |
| 749 | 47/297 | 2 |
| 750 | 47/350 | 1 |
| 751 | 47040 | 1 |
| 752 | 48.605 | 1 |
| 753 | 48.6±10.1g | 1 |
| 754 | 48/70 | 1 |
| 755 | 49.1° | 1 |
| 756 | 49/181 | 1 |
| 757 | 49/380 | 2 |
| 758 | 49° | 2 |
| 759 | 4egi-1 | 1 |
| 760 | 4l-peg | 5 |
| 761 | 4mgday | 1 |
| 762 | 4plc | 40 |
| 763 | 5'-hydroxyomeprazole | 1 |
| 764 | 5-fluorouracil/cisplatin | 2 |
| 765 | 5-fluorouracil/leucovorin/irinotecan | 1 |
| 766 | 5-fu/heparin | 2 |
| 767 | 5-nitro-8-hydroxyquinoline | 2 |
| 768 | 5.03+/-1.97 | 1 |
| 769 | 5.05-6.11 | 1 |
| 770 | 5.06+/-0 | 1 |
| 771 | 5.0±1.7h | 1 |
| 772 | 5.0±15.6 | 1 |
| 773 | 5.139 | 1 |
| 774 | 5.27°c | 1 |
| 775 | 5.4+/-0.3 | 1 |
| 776 | 5.440 | 1 |
| 777 | 5.75±1.39 | 1 |
| 778 | 5.7ml/min/1.73m | 1 |
| 779 | 5.87-fold | 1 |
| 780 | 5.9±2.7 | 1 |
| 781 | 5/111 | 1 |
| 782 | 5/129 | 1 |
| 783 | 5/208 | 1 |
| 784 | 5/233 | 1 |
| 785 | 5/239 | 1 |
| 786 | 5/245 | 1 |
| 787 | 5/455 | 1 |
| 788 | 5/70 | 5 |
| 789 | 5/98 | 1 |
| 790 | 5/hpf | 3 |
| 791 | 50/25-mg/d | 1 |
| 792 | 501/mm2 | 1 |
| 793 | 505/356,654 | 1 |
| 794 | 508±149dayg/ml | 1 |
| 795 | 51.2±18.9s | 1 |
| 796 | 51.44±18.98 | 1 |
| 797 | 51/338 | 1 |
| 798 | 517μa/cm | 1 |
| 799 | 518,000 | 1 |
| 800 | 52/194 | 1 |
| 801 | 52/59 | 1 |
| 802 | 52/80 | 1 |
| 803 | 525·0 | 1 |
| 804 | 529/1245 | 1 |
| 805 | 529±61 | 1 |
| 806 | 52weeks | 2 |
| 807 | 53.1±4.7 | 1 |
| 808 | 53/157 | 1 |
| 809 | 53/62 | 1 |
| 810 | 54.6° | 2 |
| 811 | 54/83 | 1 |
| 812 | 54:1 | 1 |
| 813 | 556.x | 1 |
| 814 | 56.7±10.1 | 1 |
| 815 | 56/153 | 1 |
| 816 | 57+/-8.2g | 1 |
| 817 | 57.7+/-0.8l/d | 1 |
| 818 | 57.7±3.2 | 1 |
| 819 | 57.9cm | 1 |
| 820 | 57/848 | 1 |
| 821 | 57±4.7 | 1 |
| 822 | 582.3 | 1 |
| 823 | 58±3 | 1 |
| 824 | 59/214 | 1 |
| 825 | 5fu-ccrt | 6 |
| 826 | 5fu-mitomycin | 1 |
| 827 | 5fu/mtx | 4 |
| 828 | 5gl | 1 |
| 829 | 5±2.3mm | 1 |
| 830 | 5·02 | 1 |
| 831 | 5·55 | 1 |
| 832 | 6,077/47,814 | 1 |
| 833 | 6-activity | 2 |
| 834 | 6.062 | 1 |
| 835 | 6.0gy | 1 |
| 836 | 6.18+/-0.25 | 1 |
| 837 | 6.24-70.27 | 1 |
| 838 | 6.25+/-0.18 | 1 |
| 839 | 6.34-fold | 1 |
| 840 | 6.361 | 1 |
| 841 | 6.3±2.5 | 1 |
| 842 | 6.4+/-0.9 | 1 |
| 843 | 6.47±0.31 | 1 |
| 844 | 6.5+/-0.3 | 1 |
| 845 | 6.56m/s | 1 |
| 846 | 6.5±2.4 | 1 |
| 847 | 6.8±2 | 1 |
| 848 | 6.9±0.9×10 | 1 |
| 849 | 6/2264 | 1 |
| 850 | 6/60 | 21 |
| 851 | 60.32+/-3.5 | 1 |
| 852 | 60/362 | 1 |
| 853 | 60/477 | 1 |
| 854 | 60u/kg | 1 |
| 855 | 60±11mmhg | 1 |
| 856 | 60×10 | 2 |
| 857 | 61.0±14.2 | 1 |
| 858 | 61.3+/-8.6 | 1 |
| 859 | 61.4+/-16.9 | 1 |
| 860 | 61/130 | 2 |
| 861 | 61/169 | 1 |
| 862 | 61/37 | 1 |
| 863 | 613.0 | 1 |
| 864 | 614/26,800 | 1 |
| 865 | 617.88 | 1 |
| 866 | 62.2°c | 1 |
| 867 | 62.8-84 | 1 |
| 868 | 62/867 | 1 |
| 869 | 63/286 | 1 |
| 870 | 634/22,206 | 1 |
| 871 | 64+/-18 | 1 |
| 872 | 64+/-19 | 1 |
| 873 | 64.3±6.4 | 2 |
| 874 | 64.6° | 1 |
| 875 | 64.7±14.0 | 1 |
| 876 | 64/181 | 1 |
| 877 | 64±4 | 1 |
| 878 | 65,100 | 1 |
| 879 | 65.8±27.0 | 1 |
| 880 | 65/166 | 1 |
| 881 | 654.00 | 1 |
| 882 | 668/842 | 1 |
| 883 | 67.5±3.3 | 1 |
| 884 | 67.7±13.8 | 1 |
| 885 | 67/358 | 2 |
| 886 | 677/78960 | 1 |
| 887 | 67·5 | 1 |
| 888 | 68,5 | 1 |
| 889 | 68.0+/-11 | 1 |
| 890 | 68.18+/-2.8 | 1 |
| 891 | 68/99 | 1 |
| 892 | 69.0±10.8 | 1 |
| 893 | 69.5-17 | 1 |
| 894 | 69/117 | 1 |
| 895 | 6:1-om3 | 3 |
| 896 | 6g/kg/day | 2 |
| 897 | 6mp/aza | 2 |
| 898 | 6·92 | 1 |
| 899 | 6·94 | 1 |
| 900 | 7,739 | 2 |
| 901 | 7.0°±4.6° | 1 |
| 902 | 7.0±3.6 | 1 |
| 903 | 7.2+/-3.2 | 1 |
| 904 | 7.25min | 2 |
| 905 | 7.3±2.3 | 1 |
| 906 | 7.464 | 1 |
| 907 | 7.4min | 1 |
| 908 | 7.4±2.6msv | 1 |
| 909 | 7.51+/-.10 | 1 |
| 910 | 7.7+/-4.8 | 1 |
| 911 | 7.7±2.5 | 1 |
| 912 | 7.84±1.44 | 1 |
| 913 | 7.84±2.44 | 1 |
| 914 | 7/166 | 1 |
| 915 | 7/235 | 2 |
| 916 | 7/393 | 1 |
| 917 | 7/95 | 1 |
| 918 | 70.5±22g/m | 1 |
| 919 | 70.8±33.7 | 1 |
| 920 | 700mg/kg | 1 |
| 921 | 703±179 | 1 |
| 922 | 705.61 | 1 |
| 923 | 71/204 | 1 |
| 924 | 72/756 | 1 |
| 925 | 724.2 | 1 |
| 926 | 730.84 | 1 |
| 927 | 732/1100 | 1 |
| 928 | 74/3343 | 1 |
| 929 | 747+130n | 1 |
| 930 | 74·0 | 1 |
| 931 | 75·1 | 1 |
| 932 | 76.6±10.7 | 1 |
| 933 | 76/338 | 1 |
| 934 | 761/134529 | 1 |
| 935 | 767/3346 | 1 |
| 936 | 76°±3° | 1 |
| 937 | 77.0cm | 1 |
| 938 | 77.2/99.5/63.5 | 1 |
| 939 | 77.4min | 1 |
| 940 | 77/99 | 1 |
| 941 | 78.20 | 1 |
| 942 | 78/372 | 2 |
| 943 | 78/826 | 1 |
| 944 | 79/108 | 1 |
| 945 | 79/756 | 1 |
| 946 | 7mg/ | 1 |
| 947 | 8.068 | 1 |
| 948 | 8.1months | 1 |
| 949 | 8.2±0.3s | 1 |
| 950 | 8.7±3.9hours | 1 |
| 951 | 8.95±2.08 | 1 |
| 952 | 8/149 | 1 |
| 953 | 8/157 | 1 |
| 954 | 8/63 | 1 |
| 955 | 8/81 | 1 |
| 956 | 8/85 | 1 |
| 957 | 8/d | 1 |
| 958 | 80-age | 1 |
| 959 | 80-microg/kg | 1 |
| 960 | 80.0beats/min | 1 |
| 961 | 81.5h | 1 |
| 962 | 82±12 | 1 |
| 963 | 83.9±23.3 | 1 |
| 964 | 83/140 | 1 |
| 965 | 83/216 | 1 |
| 966 | 84.42 | 1 |
| 967 | 84.5° | 1 |
| 968 | 843ml | 1 |
| 969 | 847/1546 | 1 |
| 970 | 86/153 | 1 |
| 971 | 86/617 | 1 |
| 972 | 86/857 | 1 |
| 973 | 86/86 | 2 |
| 974 | 8696 | 2 |
| 975 | 87/226 | 1 |
| 976 | 89/706 | 1 |
| 977 | 8·46 | 1 |
| 978 | 9'-cis-lutein | 1 |
| 979 | 9'-cis-β-carotene | 1 |
| 980 | 9.1+/-13.1 | 1 |
| 981 | 9.11+/-1.24 | 1 |
| 982 | 9.1±4.7×10 | 1 |
| 983 | 9.2+/-1.5 | 1 |
| 984 | 9.26±3 | 1 |
| 985 | 9.3±2.6° | 1 |
| 986 | 9.9±2.61 | 1 |
| 987 | 9/148 | 1 |
| 988 | 9/154 | 1 |
| 989 | 9/161 | 1 |
| 990 | 9/175 | 1 |
| 991 | 9/208 | 1 |
| 992 | 9/279 | 1 |
| 993 | 9/2953 | 1 |
| 994 | 9/62 | 1 |
| 995 | 90.5° | 1 |
| 996 | 90/137 | 1 |
| 997 | 907/100,000 | 1 |
| 998 | 90μmolphotonsm | 1 |
| 999 | 91.63 | 1 |
| 1000 | 91/397 | 1 |
| 1001 | 92.5±15.9 | 1 |
| 1002 | 92.9±21.4cmh | 1 |
| 1003 | 92/20,746 | 1 |
| 1004 | 92/397 | 1 |
| 1005 | 93.72 | 1 |
| 1006 | 95.0+/-4.9 | 1 |
| 1007 | 95/306 | 1 |
| 1008 | 95/96 | 1 |
| 1009 | 96.04±8.94 | 1 |
| 1010 | 96.0±3.6 | 1 |
| 1011 | 98.2±20.7g | 1 |
| 1012 | 98/156 | 1 |
| 1013 | 98/172 | 1 |
| 1014 | 98/186 | 1 |
| 1015 | 98/765 | 2 |
| 1016 | 985±463ml | 1 |
| 1017 | 987/mm | 1 |
| 1018 | 989.80 | 1 |
| 1019 | 9:11 | 1 |
| 1020 | 9:16 | 1 |
| 1021 | 9l/d | 1 |
| 1022 | 9·90 | 1 |
| 1023 | 9×7 | 1 |
| 1024 | 9α,11β-pgf | 1 |
| 1025 | =-2.0 | 2 |
| 1026 | =0.879 | 1 |
| 1027 | =1.626 | 1 |
| 1028 | =1.70mmol | 1 |
| 1029 | =1.893 | 1 |
| 1030 | =10-mm | 3 |
| 1031 | =100-cell/mm | 1 |
| 1032 | =100mg/dl | 3 |
| 1033 | =160mg/dl | 1 |
| 1034 | =2.10 | 1 |
| 1035 | =2.640 | 1 |
| 1036 | =2.75x10 | 1 |
| 1037 | =20.23 | 1 |
| 1038 | =200/ml | 1 |
| 1039 | =30kg/m | 1 |
| 1040 | =3h | 1 |
| 1041 | =5.18mmol | 1 |
| 1042 | =55mmhg | 1 |
| 1043 | =7,000 | 2 |
| 1044 | =8.224 | 1 |
| 1045 | =90mmhg | 1 |
| 1046 | =cin-2 | 1 |
| 1047 | =p75 | 1 |
| 1048 | a+m | 6 |
| 1049 | a-code | 1 |
| 1050 | a-gi | 4 |
| 1051 | a/hk/415742/09 | 1 |
| 1052 | a/uruguay/h3n2 | 1 |
| 1053 | a2064g | 1 |
| 1054 | a358a | 1 |
| 1055 | a_rimidex | 1 |
| 1056 | aab2 | 1 |
| 1057 | aav2-cox8-mcherry | 2 |
| 1058 | abacavir-lamivudine | 28 |
| 1059 | abacavir/lamivudine/efavirenz | 1 |
| 1060 | abacavir/zidovudine/lamivudine | 3 |
| 1061 | abc/3tc+atv | 7 |
| 1062 | absti* | 1 |
| 1063 | abstracts-only | 3 |
| 1064 | abt-199 | 1 |
| 1065 | acaa | 1 |
| 1066 | acarophobia | 1 |
| 1067 | acceptability/tolerability | 4 |
| 1068 | acei/β-blocker | 1 |
| 1069 | aceis/aras | 1 |
| 1070 | acels | 5 |
| 1071 | acepromazine-methadone | 1 |
| 1072 | aci.fhh-rf1b | 1 |
| 1073 | aclacinomycin-a | 1 |
| 1074 | acrypoint | 1 |
| 1075 | act-hib+viscogel | 3 |
| 1076 | active-caspase-3 | 2 |
| 1077 | active-commute | 1 |
| 1078 | active-medication | 2 |
| 1079 | ad-hpap | 2 |
| 1080 | ada160/80 | 5 |
| 1081 | adalimumab-continuation | 5 |
| 1082 | adalimumab-withdrawal | 1 |
| 1083 | adapalene/bpo | 5 |
| 1084 | adaptive-avd | 1 |
| 1085 | adas-cog12 | 3 |
| 1086 | ademetionin | 2 |
| 1087 | adenoitonsillectomy | 1 |
| 1088 | adhd-ct | 4 |
| 1089 | adlacz | 6 |
| 1090 | adp-actin | 1 |
| 1091 | adq | 3 |
| 1092 | adults.well-designed | 1 |
| 1093 | aecus | 9 |
| 1094 | aerobic+resistance | 1 |
| 1095 | ag/agcl/kcl | 1 |
| 1096 | ag2co3 | 3 |
| 1097 | ages-mf30 | 2 |
| 1098 | aggregated-ldl | 1 |
| 1099 | aggression/hostility | 1 |
| 1100 | aggressor | 7 |
| 1101 | agitation-aggression | 2 |
| 1102 | agn43b | 1 |
| 1103 | ags4 | 2 |
| 1104 | aicds | 1 |
| 1105 | air-cf2 | 1 |
| 1106 | akiva | 1 |
| 1107 | alanyl-leucine | 1 |
| 1108 | alc-cho | 5 |
| 1109 | alcohol-fixed | 1 |
| 1110 | alemtuzumab/tacrolimus | 1 |
| 1111 | alinamin-f | 1 |
| 1112 | alk-tkis | 1 |
| 1113 | alkalization-therapy-alone | 1 |
| 1114 | allergenes | 1 |
| 1115 | alpha-aminopropiophenone | 1 |
| 1116 | alpha2,6-linkage | 1 |
| 1117 | alphacd2 | 1 |
| 1118 | alphacypermethrin | 2 |
| 1119 | am+cba | 3 |
| 1120 | amicacin | 2 |
| 1121 | amisulprideagain | 1 |
| 1122 | aml+hctz | 5 |
| 1123 | aml/hctz | 3 |
| 1124 | amlodipine/hydrochlorothiazide | 5 |
| 1125 | amodiaquine+artesunate | 4 |
| 1126 | ampicillin-tobramycin | 1 |
| 1127 | amx-cl | 6 |
| 1128 | amytriptyline | 3 |
| 1129 | anechogenic | 1 |
| 1130 | anergy/apoptosis | 1 |
| 1131 | aneurine | 1 |
| 1132 | anger/depression | 1 |
| 1133 | angioconray | 3 |
| 1134 | angiodema | 1 |
| 1135 | angioguard | 9 |
| 1136 | angiorrhaphy | 1 |
| 1137 | angiotensin-receptor-blockers | 4 |
| 1138 | angularity | 1 |
| 1139 | antagonists+clonidine+1c | 1 |
| 1140 | anthracycline+atra | 1 |
| 1141 | anti-science | 1 |
| 1142 | antiabortifacients | 1 |
| 1143 | antibiot* | 4 |
| 1144 | anticlotting | 2 |
| 1145 | antimellin | 1 |
| 1146 | antioxidant-fortified | 1 |
| 1147 | antipathogens | 1 |
| 1148 | antiplatelet-therapy | 1 |
| 1149 | antiplatelets/anticoagulants | 1 |
| 1150 | anxiety/nervousness | 1 |
| 1151 | aplanatic | 1 |
| 1152 | apo-rbp | 1 |
| 1153 | apoe*2 | 1 |
| 1154 | aqdsh | 1 |
| 1155 | aqiva | 1 |
| 1156 | arbitrage | 1 |
| 1157 | arbs+ccbs | 1 |
| 1158 | arip | 5 |
| 1159 | aristololactam-i | 1 |
| 1160 | ariva | 3 |
| 1161 | arrthymia | 2 |
| 1162 | arsenite-specific | 1 |
| 1163 | arthodesis | 1 |
| 1164 | arvt+jobelyn | 2 |
| 1165 | as02 | 14 |
| 1166 | as02b | 6 |
| 1167 | as2o5 | 7 |
| 1168 | asdas-low | 4 |
| 1169 | asdn | 2 |
| 1170 | asn656/asn656 | 1 |
| 1171 | aspirin+phytosterols | 1 |
| 1172 | aspirin-monotherapy | 3 |
| 1173 | aspirine | 5 |
| 1174 | asystolia | 2 |
| 1175 | atazanavir-ritonavir | 8 |
| 1176 | aten | 14 |
| 1177 | atenolol/hydrochlorothiazide | 2 |
| 1178 | atfd2 | 1 |
| 1179 | atheist | 1 |
| 1180 | athenolol | 2 |
| 1181 | athsp90 | 3 |
| 1182 | ato+atra+chemotherapy | 1 |
| 1183 | atopy/inflammation | 1 |
| 1184 | atp2a2 | 2 |
| 1185 | atropine-plus-pralidoxime | 1 |
| 1186 | atsumo3 | 1 |
| 1187 | atv+allo | 3 |
| 1188 | atv/rtv+ftc/tdf | 4 |
| 1189 | at→cmx | 2 |
| 1190 | auc-low | 3 |
| 1191 | aurothioglucose | 1 |
| 1192 | auto-hmscs | 1 |
| 1193 | auto-polymerised | 1 |
| 1194 | axospinous | 1 |
| 1195 | azithromycin-atovaquone | 1 |
| 1196 | azq | 4 |
| 1197 | azt+ddc | 2 |
| 1198 | azt+lcm | 3 |
| 1199 | azt/3tc | 8 |
| 1200 | azt/sdnvp | 4 |
| 1201 | b+h | 12 |
| 1202 | b-a-a | 1 |
| 1203 | b-beam | 7 |
| 1204 | b-cpap | 5 |
| 1205 | b2-antagonist | 1 |
| 1206 | baby-massage | 3 |
| 1207 | back-school | 1 |
| 1208 | bacop | 2 |
| 1209 | bacteremia/urosepsis | 1 |
| 1210 | badc | 1 |
| 1211 | bak-tafluprost | 2 |
| 1212 | band-aids | 1 |
| 1213 | bap+β-carotene | 3 |
| 1214 | baralgin | 2 |
| 1215 | basal+ | 5 |
| 1216 | bav308 | 2 |
| 1217 | bav851 | 3 |
| 1218 | bb536-h | 5 |
| 1219 | bcd+lcn | 4 |
| 1220 | bcg-ifn-α | 1 |
| 1221 | bee×1.1 | 1 |
| 1222 | bellovac | 5 |
| 1223 | bellyaches | 1 |
| 1224 | bencao-gangmu | 1 |
| 1225 | beractant | 41 |
| 1226 | berocca™ | 4 |
| 1227 | besafibrate | 3 |
| 1228 | beschitin-f | 2 |
| 1229 | beschitin-f® | 3 |
| 1230 | beta-blockers/diuretics | 2 |
| 1231 | bev-cap | 4 |
| 1232 | bevacizumab-capecitabine | 1 |
| 1233 | bevacizumab-folfiri | 5 |
| 1234 | bevacizumab-pemetrexed | 7 |
| 1235 | bevacizumab-xelox | 7 |
| 1236 | bevacizumab/paclitaxel/carboplatin | 2 |
| 1237 | bezafibrate-fed | 2 |
| 1238 | bfhx | 6 |
| 1239 | bi/trisegmentectomy | 1 |
| 1240 | biagents | 1 |
| 1241 | biasp1-2-3 | 6 |
| 1242 | bifonazole-urea | 6 |
| 1243 | bilevel-st | 7 |
| 1244 | binifibrate | 3 |
| 1245 | bionators | 2 |
| 1246 | biopsy/surgery | 2 |
| 1247 | biperiden | 22 |
| 1248 | bismuth-metronidazole-tetracycline-ranitidine | 1 |
| 1249 | bisoprolol-first | 5 |
| 1250 | bite-blocks | 2 |
| 1251 | biteplane | 1 |
| 1252 | blank-sap | 1 |
| 1253 | bmi≥35kg/m | 1 |
| 1254 | bms/des | 4 |
| 1255 | body-optimized | 6 |
| 1256 | bolus-infusion | 7 |
| 1257 | bonviva | 4 |
| 1258 | bortezomib-td | 1 |
| 1259 | boswagade | 1 |
| 1260 | boy/girlfriends | 1 |
| 1261 | breast/endometrial | 1 |
| 1262 | breed-associated | 1 |
| 1263 | bronchiolits | 1 |
| 1264 | bst-100 | 5 |
| 1265 | bst-50 | 5 |
| 1266 | bt-cottonseed | 1 |
| 1267 | btx-b5 | 1 |
| 1268 | budesonide+formoterol | 2 |
| 1269 | buffer/cpm | 3 |
| 1270 | buildability | 1 |
| 1271 | bunsimgi-eum | 2 |
| 1272 | bupivacaine/fentanyl | 5 |
| 1273 | butm | 1 |
| 1274 | butorphanol-medetomidine | 1 |
| 1275 | c-hf | 3 |
| 1276 | c-hypotensive | 1 |
| 1277 | c-pdt | 5 |
| 1278 | c/abpm | 7 |
| 1279 | c2bn2 | 1 |
| 1280 | c33 | 4 |
| 1281 | c34 | 1 |
| 1282 | c3c4 | 1 |
| 1283 | c5a- | 2 |
| 1284 | c6-7 | 2 |
| 1285 | ca-125+/tvu+ | 2 |
| 1286 | cag+pci | 1 |
| 1287 | caif | 4 |
| 1288 | cam3noa1 | 1 |
| 1289 | cannualaide® | 2 |
| 1290 | cap45 | 3 |
| 1291 | capecitabine-lapatinib | 1 |
| 1292 | capox50 | 3 |
| 1293 | captoril | 5 |
| 1294 | caragher | 1 |
| 1295 | carbcountabc | 6 |
| 1296 | carboplatin-docetaxel | 6 |
| 1297 | carboplatin-irinotecan | 1 |
| 1298 | carboplatin/paclitaxel/sorafenib | 1 |
| 1299 | cardiopalmus | 1 |
| 1300 | care-as-usual | 48 |
| 1301 | carfentanil-xylazine | 1 |
| 1302 | caspase-3+calpastatin | 1 |
| 1303 | caspases-6 | 1 |
| 1304 | catechin/theanine | 4 |
| 1305 | caudo-ventro-lateral | 1 |
| 1306 | cav3.1 | 4 |
| 1307 | cb+cbm | 2 |
| 1308 | cbdca/ptx | 4 |
| 1309 | cbevacizumab | 1 |
| 1310 | cbt+cm | 5 |
| 1311 | cc-pt | 3 |
| 1312 | cc5-mrsa-i/ii/iv | 1 |
| 1313 | cd79α | 1 |
| 1314 | cddgs | 2 |
| 1315 | cdiets | 3 |
| 1316 | cecum/colon | 2 |
| 1317 | cee-mpa | 2 |
| 1318 | cefacetrile | 1 |
| 1319 | cefazolin/metronidazole | 1 |
| 1320 | cefepime-tazobactam | 1 |
| 1321 | ceftezole | 3 |
| 1322 | ceftriaxone/tobramycin | 2 |
| 1323 | celtect | 2 |
| 1324 | cemt-pi-l | 6 |
| 1325 | cephamandole | 9 |
| 1326 | cerebritis | 1 |
| 1327 | cervex-brush® | 2 |
| 1328 | cf-wbi | 10 |
| 1329 | cfc-mdi | 7 |
| 1330 | cftdna | 6 |
| 1331 | chadv63 | 1 |
| 1332 | change-trials | 1 |
| 1333 | changmei | 7 |
| 1334 | chemotherapy/autologoussct | 1 |
| 1335 | chictr-trc-00000032 | 1 |
| 1336 | chitosan-hexamer | 1 |
| 1337 | chloraprep | 6 |
| 1338 | chloroquine-primaquine | 1 |
| 1339 | chop-r | 17 |
| 1340 | chp2 | 2 |
| 1341 | ciclosporin/azathioprine/prednisone | 1 |
| 1342 | cidr+hcg | 2 |
| 1343 | cinnovex® | 1 |
| 1344 | circoflex-vaccinated | 2 |
| 1345 | cis-dichlorodiamineplatinum | 1 |
| 1346 | cisplatin-paclitaxel | 4 |
| 1347 | cisplatin/firocoxib | 2 |
| 1348 | cisplatin/leucovorin/5-fu | 1 |
| 1349 | cisplatin/paclitaxel/ifosfamide | 1 |
| 1350 | citr | 1 |
| 1351 | ckd/hs | 1 |
| 1352 | cl316243 | 1 |
| 1353 | clarithyromicin | 1 |
| 1354 | claritromycin | 1 |
| 1355 | climiphene | 1 |
| 1356 | clinic-managed | 3 |
| 1357 | clnp-bpo2.5/tz | 3 |
| 1358 | clomifene-resistance | 1 |
| 1359 | clonidine/methyldopa | 2 |
| 1360 | clotrimazole-ointments | 1 |
| 1361 | cluster-set | 1 |
| 1362 | cm-treated | 2 |
| 1363 | cni-withdrawal | 2 |
| 1364 | cnidocyte | 1 |
| 1365 | cnot10 | 1 |
| 1366 | cns=9.75 | 1 |
| 1367 | co-amilozide | 12 |
| 1368 | co-codamol | 7 |
| 1369 | co-habitating | 1 |
| 1370 | co-indications | 1 |
| 1371 | co-toxicity | 1 |
| 1372 | coach-prescribed | 1 |
| 1373 | cobra-pla | 1 |
| 1374 | cocaine/dexmedetomidine | 1 |
| 1375 | cocr-zes | 7 |
| 1376 | coeruloplasmin | 1 |
| 1377 | colace | 2 |
| 1378 | cold-break | 1 |
| 1379 | cold/dry | 1 |
| 1380 | colocolostomy | 1 |
| 1381 | cometabolism | 2 |
| 1382 | comorbities | 1 |
| 1383 | compli* | 3 |
| 1384 | comti | 8 |
| 1385 | con-lc | 4 |
| 1386 | conceptrol | 4 |
| 1387 | concise® | 1 |
| 1388 | conf | 5 |
| 1389 | confocal/two-photon | 1 |
| 1390 | conglomerations | 1 |
| 1391 | connexin32 | 1 |
| 1392 | continuous=0.90 | 2 |
| 1393 | control-therapy | 2 |
| 1394 | control/dhf | 1 |
| 1395 | control/sham | 6 |
| 1396 | controlthere | 1 |
| 1397 | conventional-schedule | 1 |
| 1398 | copper-iud | 1 |
| 1399 | corral | 1 |
| 1400 | cortico-subcortically | 2 |
| 1401 | corticodependence | 1 |
| 1402 | cotrimexazole | 2 |
| 1403 | counsel* | 3 |
| 1404 | counseling-as-usual | 1 |
| 1405 | cpg-treatments | 2 |
| 1406 | cpr-only | 3 |
| 1407 | cprmeter | 7 |
| 1408 | cpv-2c | 4 |
| 1409 | cq-pq | 8 |
| 1410 | cr-after | 1 |
| 1411 | craniocaudal-view | 1 |
| 1412 | creaking | 1 |
| 1413 | creationism | 1 |
| 1414 | cribs | 9 |
| 1415 | crossed-path | 1 |
| 1416 | crs7270101 | 1 |
| 1417 | crt-pacemaker | 3 |
| 1418 | crtcp | 1 |
| 1419 | cryoshock | 1 |
| 1420 | cs-t1 | 1 |
| 1421 | csa-aza-mp | 1 |
| 1422 | csd+caffeine | 2 |
| 1423 | cst+os | 3 |
| 1424 | ctbe | 4 |
| 1425 | ctl-std | 1 |
| 1426 | ctla | 9 |
| 1427 | ctr+hr | 1 |
| 1428 | ctx-m-9-group | 1 |
| 1429 | cucl2·2h2o | 2 |
| 1430 | cullin-type | 1 |
| 1431 | cutting/stepping | 1 |
| 1432 | cvt-mdi | 10 |
| 1433 | cy-flu-atg | 8 |
| 1434 | cyc/aza | 8 |
| 1435 | cyclocreatine | 1 |
| 1436 | cyclophosphamide-vincristine-doxorubicin-dexamethasone | 6 |
| 1437 | cyclophosphamide/csa | 1 |
| 1438 | cyclophosphomide-methotrexate-5 | 1 |
| 1439 | cyclorphan | 1 |
| 1440 | cyclosporine/azathioprine | 1 |
| 1441 | cyclosporine/sirolimus | 4 |
| 1442 | cyp175a1 | 1 |
| 1443 | cyp2j6-like | 2 |
| 1444 | cystadenofibroma | 2 |
| 1445 | czon+mino | 4 |
| 1446 | d-fish-bm | 5 |
| 1447 | d-fish-pb | 5 |
| 1448 | d.i.v. | 1 |
| 1449 | d0-re | 2 |
| 1450 | d1246y | 2 |
| 1451 | d=≥65 | 1 |
| 1452 | dac-placebo | 3 |
| 1453 | daclizumab/tacrolimus/mycophenolate | 1 |
| 1454 | dalotuzumab/ridaforolimus | 1 |
| 1455 | daph | 1 |
| 1456 | dapsone-pyrimethamine | 1 |
| 1457 | dapsone/pyrimethamine | 6 |
| 1458 | darunavir-rtv | 1 |
| 1459 | daunorubicin/clofarabine | 1 |
| 1460 | daytime-wetting | 2 |
| 1461 | dc+cm | 1 |
| 1462 | dcg-iv | 1 |
| 1463 | dcu/gangrene | 1 |
| 1464 | dddr-40 | 2 |
| 1465 | ddiet | 6 |
| 1466 | ddp-pdc | 1 |
| 1467 | decamers | 1 |
| 1468 | dectin-2 | 4 |
| 1469 | deferrioxamine | 6 |
| 1470 | defibrillation-first | 2 |
| 1471 | demeaning | 1 |
| 1472 | densiron | 8 |
| 1473 | denuded-endothelium | 1 |
| 1474 | deontologic | 1 |
| 1475 | deoxycoformycin | 5 |
| 1476 | deoxycorticosterone/salt | 4 |
| 1477 | depain-x | 8 |
| 1478 | depressed/suicidal | 2 |
| 1479 | derivable | 1 |
| 1480 | dermabondtm | 1 |
| 1481 | dermamatrix | 3 |
| 1482 | dermatovenerologists | 1 |
| 1483 | dermofasciectomy | 3 |
| 1484 | desacyl-ghrelin | 6 |
| 1485 | desciclovir | 7 |
| 1486 | desensiti* | 1 |
| 1487 | desmosterolosis | 1 |
| 1488 | detoxification-only | 3 |
| 1489 | detrusorhyperreflexia | 1 |
| 1490 | dexmedetomidine-ketamine-midazolam | 1 |
| 1491 | dexmedetomidine-sevoflurane | 1 |
| 1492 | dgct-d1 | 1 |
| 1493 | dgct-d2 | 1 |
| 1494 | dgia | 6 |
| 1495 | dha+aa | 5 |
| 1496 | dhf/control | 1 |
| 1497 | diabetes/igt | 3 |
| 1498 | diatoric | 3 |
| 1499 | diazemuls | 5 |
| 1500 | dicaine | 6 |
| 1501 | diclofenac-gel | 4 |
| 1502 | diclofenac/ha | 4 |
| 1503 | dicyclanil | 4 |
| 1504 | didanosine/lamivudine/tenofovir | 1 |
| 1505 | didanosine/stavudine | 3 |
| 1506 | diet+exercise | 3 |
| 1507 | diet+g | 1 |
| 1508 | diet+metformin | 1 |
| 1509 | diffuse-cad | 6 |
| 1510 | dihydrotachysterol | 3 |
| 1511 | dimethyloxalylglycine | 1 |
| 1512 | dingzhongxian | 3 |
| 1513 | dinoprostone-only | 5 |
| 1514 | dipyrone/spasmolytics | 5 |
| 1515 | disability/dependency | 2 |
| 1516 | disajustment | 1 |
| 1517 | dishcloth-gourd-shaped | 1 |
| 1518 | diskinesia | 1 |
| 1519 | disophenol | 1 |
| 1520 | disrobing | 1 |
| 1521 | diuretics/beta-blockers | 7 |
| 1522 | divalproex* | 1 |
| 1523 | dl-diltiazem | 1 |
| 1524 | dm+chd | 1 |
| 1525 | dm/t | 7 |
| 1526 | dmbi | 12 |
| 1527 | dmte | 9 |
| 1528 | dndd | 1 |
| 1529 | dnr/ara | 6 |
| 1530 | dobrava | 1 |
| 1531 | doca-vehicle | 3 |
| 1532 | docetaxel-placebo | 2 |
| 1533 | doctor-counselor | 1 |
| 1534 | donor-seropositive | 1 |
| 1535 | dosulepin | 7 |
| 1536 | down-conditioned | 1 |
| 1537 | downtitrate | 1 |
| 1538 | doxorubicin-pemetrexed | 1 |
| 1539 | doxorubicin/cisplatin/paclitaxel | 1 |
| 1540 | doxorubicin/pemetrexed | 1 |
| 1541 | dragonfish | 1 |
| 1542 | dre/trus | 1 |
| 1543 | drospirenone+ethinylestradiol | 3 |
| 1544 | drug-vehicle | 1 |
| 1545 | dryvax | 4 |
| 1546 | dsbcs | 4 |
| 1547 | dtmu | 1 |
| 1548 | dtmu/trx | 1 |
| 1549 | dtp-ipv | 4 |
| 1550 | duramorph | 4 |
| 1551 | dvd-irv | 1 |
| 1552 | dyestuffs | 1 |
| 1553 | dynamised | 1 |
| 1554 | dysorgasmia | 1 |
| 1555 | dysperistalsis | 1 |
| 1556 | dysplastic/neoplastic | 1 |
| 1557 | dysthymi* | 3 |
| 1558 | dzp-iv | 5 |
| 1559 | d₄₂ | 1 |
| 1560 | e2- | 3 |
| 1561 | earex | 1 |
| 1562 | easyfour | 4 |
| 1563 | ec-p | 10 |
| 1564 | ecdfs | 1 |
| 1565 | ed-sbp | 6 |
| 1566 | education-alone | 1 |
| 1567 | ee+hs | 1 |
| 1568 | ef-rt.crt | 1 |
| 1569 | efavirenz/tenofovir/emtricitabine | 8 |
| 1570 | efv+ftc/tdf | 7 |
| 1571 | efv/ftc/tdf | 27 |
| 1572 | eg-arms | 1 |
| 1573 | egbs | 8 |
| 1574 | egfp-cre | 1 |
| 1575 | egfr+ | 2 |
| 1576 | eglu | 1 |
| 1577 | elcatonin | 27 |
| 1578 | electrocauter | 1 |
| 1579 | embosurgery | 1 |
| 1580 | emd/dfdba | 8 |
| 1581 | emerg* | 1 |
| 1582 | enalapril-first | 4 |
| 1583 | encephabol | 3 |
| 1584 | end-goals | 2 |
| 1585 | endoduplication | 1 |
| 1586 | endoserter | 5 |
| 1587 | engerix-b™ | 6 |
| 1588 | enoxaparin-idrabiotaparinux | 2 |
| 1589 | enoxaparin/placebo | 3 |
| 1590 | enoxaparin/vka | 11 |
| 1591 | epi-adt | 2 |
| 1592 | epipen | 26 |
| 1593 | eplin | 1 |
| 1594 | epotilones | 1 |
| 1595 | equuli | 1 |
| 1596 | er/rfa | 6 |
| 1597 | ergotamine/caffeine | 1 |
| 1598 | erlotinib-arm | 1 |
| 1599 | erp+placebo | 1 |
| 1600 | error-strewn | 1 |
| 1601 | erv14p | 1 |
| 1602 | erypo®/eprex® | 11 |
| 1603 | erythritol/maltitol | 4 |
| 1604 | escitalopram+ipt | 2 |
| 1605 | escitalopram-paroxetine | 1 |
| 1606 | espc | 1 |
| 1607 | especially-developed | 1 |
| 1608 | estazolam | 35 |
| 1609 | et+mt | 9 |
| 1610 | et-b | 9 |
| 1611 | ethinylestradiol/norgestimate | 1 |
| 1612 | ethoglucid | 7 |
| 1613 | etoposide-carboplatin | 2 |
| 1614 | etr/darunavir | 1 |
| 1615 | etravirine-darunavir-ritonavir | 2 |
| 1616 | euflavine | 8 |
| 1617 | euro1729+/-1209 | 1 |
| 1618 | euro2904+/-1510 | 1 |
| 1619 | european-made | 1 |
| 1620 | even-days | 1 |
| 1621 | event-recorder | 2 |
| 1622 | everolimus-continuation | 4 |
| 1623 | eversion-endarterectomy | 1 |
| 1624 | every-three-week | 1 |
| 1625 | evolocumab+soc | 4 |
| 1626 | ex-boyfriends | 1 |
| 1627 | exendin-4- | 1 |
| 1628 | exitus | 1 |
| 1629 | exon9 | 1 |
| 1630 | experimental/before | 1 |
| 1631 | external/controlled | 1 |
| 1632 | extraturbinally | 1 |
| 1633 | extreme/unable | 2 |
| 1634 | ezetimibe/atorvastatin | 2 |
| 1635 | f-tests | 2 |
| 1636 | f1-generations | 1 |
| 1637 | fasting/interprandial | 1 |
| 1638 | fb-rt | 7 |
| 1639 | fc+/fc | 1 |
| 1640 | fccam | 7 |
| 1641 | fcdt | 24 |
| 1642 | fec-dh | 6 |
| 1643 | femoral/sciatic | 1 |
| 1644 | fenestration/coagulation | 6 |
| 1645 | fenofibrate/bezafibrate | 1 |
| 1646 | fentanyl/droperidol | 2 |
| 1647 | ffns-treatment | 1 |
| 1648 | fibrothecomas | 1 |
| 1649 | filmstrip | 3 |
| 1650 | filter-leukoreduced | 1 |
| 1651 | flagellin-deficient | 1 |
| 1652 | flesh-colored | 1 |
| 1653 | flex-d. | 2 |
| 1654 | flortec | 9 |
| 1655 | flu-25 | 4 |
| 1656 | flu/itra | 8 |
| 1657 | fluordeoxyuridine- | 1 |
| 1658 | fluoride-rinse | 1 |
| 1659 | fluoroquinolone-resistance | 1 |
| 1660 | fluorouracil/doxorubicin/cyclophosphamide | 3 |
| 1661 | flupentixol/melitracen | 2 |
| 1662 | fluvastatin-alone | 1 |
| 1663 | folfiri-alone | 1 |
| 1664 | folfox/bev | 4 |
| 1665 | folfox4/ptk/zk | 4 |
| 1666 | foreignization | 1 |
| 1667 | forteo® | 2 |
| 1668 | fortune-teller | 1 |
| 1669 | foscan | 1 |
| 1670 | fp-bi | 5 |
| 1671 | fracture/dislocation | 2 |
| 1672 | free-forms | 1 |
| 1673 | free-jaw | 2 |
| 1674 | free-regimens | 1 |
| 1675 | freeze-killing | 2 |
| 1676 | fresubin | 5 |
| 1677 | fructose/min | 1 |
| 1678 | fsh-ctp | 1 |
| 1679 | fu+lv | 9 |
| 1680 | full-intervention | 3 |
| 1681 | g+b | 6 |
| 1682 | g12r | 1 |
| 1683 | g12s | 1 |
| 1684 | galactography | 5 |
| 1685 | galantamine/placebo | 1 |
| 1686 | galnac-gd1a | 4 |
| 1687 | gantaile | 3 |
| 1688 | ge-dsc | 2 |
| 1689 | gem/other | 2 |
| 1690 | gemcitabine-ifosfamide-vinorelbine | 1 |
| 1691 | gemcitabine/paclitaxel | 10 |
| 1692 | gentamicin/clindamycin | 4 |
| 1693 | geranylgeranyl-pyrophosphate | 1 |
| 1694 | gfn | 8 |
| 1695 | gh/cs | 7 |
| 1696 | gh/pl | 3 |
| 1697 | ghr+phosphate-sandoz | 2 |
| 1698 | gill-over-the-ground | 1 |
| 1699 | gillnets | 2 |
| 1700 | gla-100 | 19 |
| 1701 | glargine/aspart | 2 |
| 1702 | glargine/detemir-aspart | 1 |
| 1703 | glf | 1 |
| 1704 | glimepiride+metformin | 3 |
| 1705 | glipizide | 210 |
| 1706 | glua1-4 | 1 |
| 1707 | glycation/glycoxidation | 1 |
| 1708 | gog-182 | 2 |
| 1709 | gp39 | 1 |
| 1710 | grandiosity/excitement | 1 |
| 1711 | grandmother-in-law | 1 |
| 1712 | group-threat | 2 |
| 1713 | gtp-gamma-s | 2 |
| 1714 | h-0 | 1 |
| 1715 | h-meals | 3 |
| 1716 | h596 | 1 |
| 1717 | haemtocrit | 4 |
| 1718 | hal2mg+pim20mg | 1 |
| 1719 | halakhah | 1 |
| 1720 | halland | 1 |
| 1721 | havrix-havrix | 1 |
| 1722 | havrix-healive | 2 |
| 1723 | hb-200 | 6 |
| 1724 | hbo-4 | 8 |
| 1725 | hbsag-eng | 18 |
| 1726 | hcn2-hcn4 | 2 |
| 1727 | hcp-laiv | 5 |
| 1728 | hctz/bena | 1 |
| 1729 | head-brace | 1 |
| 1730 | headgear | 95 |
| 1731 | healon5 | 6 |
| 1732 | heartfailure | 1 |
| 1733 | hemcon | 8 |
| 1734 | hemopneumothorax | 2 |
| 1735 | hemosol-b0 | 7 |
| 1736 | heparin/warfarin | 3 |
| 1737 | herb-like | 1 |
| 1738 | heretic | 1 |
| 1739 | hetero-dimers | 1 |
| 1740 | hetero-nuclei | 1 |
| 1741 | heterospecifics | 1 |
| 1742 | hextend® | 7 |
| 1743 | hfrt/afrt | 1 |
| 1744 | hfsa-only | 1 |
| 1745 | hi-asca | 1 |
| 1746 | hiberix™ | 7 |
| 1747 | hie2 | 2 |
| 1748 | high-cadence | 1 |
| 1749 | high-cfdna | 1 |
| 1750 | higher-carbohydrate | 4 |
| 1751 | histamine-receptor-2 | 1 |
| 1752 | hlar-spn | 1 |
| 1753 | hm-off | 5 |
| 1754 | hmpsa | 3 |
| 1755 | hna-1b/-1c | 1 |
| 1756 | ho-ors | 6 |
| 1757 | homoproparglyglycine | 2 |
| 1758 | hotpack | 2 |
| 1759 | hotpack+exercise | 1 |
| 1760 | hplchol | 4 |
| 1761 | hpv-persistent | 1 |
| 1762 | hrp102 | 6 |
| 1763 | hrt+bezafibrate | 3 |
| 1764 | hs/tnf | 1 |
| 1765 | hsf3-gus | 1 |
| 1766 | hsf4-gus | 1 |
| 1767 | hsfd/streptozotocin | 1 |
| 1768 | htia | 1 |
| 1769 | hurricaine® | 3 |
| 1770 | hvpd | 5 |
| 1771 | hxp | 5 |
| 1772 | hydride-generation | 1 |
| 1773 | hydrochlorothiazide/benazepril | 2 |
| 1774 | hydrocholorothiazide | 1 |
| 1775 | hydrocolpometra | 1 |
| 1776 | hydrocolpometras | 1 |
| 1777 | hydrogenated-vegetable-fat | 1 |
| 1778 | hydrothermablation | 6 |
| 1779 | hydroxyapatite-cement | 1 |
| 1780 | hydroxyethyl-starch | 1 |
| 1781 | hypafix-elefix | 2 |
| 1782 | hyper-kinesis | 1 |
| 1783 | hyperpotass* | 1 |
| 1784 | hyperthyroiditis | 1 |
| 1785 | hypo-pharynx | 1 |
| 1786 | hypoalbuninaemia | 1 |
| 1787 | hypomenorrhoe | 1 |
| 1788 | hyposphagma | 1 |
| 1789 | hypothalamo-pituitary-adrenal-axis | 2 |
| 1790 | i+iv | 1 |
| 1791 | i-butene | 1 |
| 1792 | i150 | 6 |
| 1793 | ia-placebo | 3 |
| 1794 | ia-sa | 4 |
| 1795 | ibdq-social | 1 |
| 1796 | ic50=1.6μm | 1 |
| 1797 | ice-popsicles | 2 |
| 1798 | ics+labas | 2 |
| 1799 | ics/salmeterol | 3 |
| 1800 | icsi-only | 2 |
| 1801 | ideg+iasp | 4 |
| 1802 | ifn-α/placebo | 1 |
| 1803 | ifn/bevacizumab | 5 |
| 1804 | iggma | 6 |
| 1805 | iglar | 117 |
| 1806 | ii-l | 1 |
| 1807 | ii-low | 1 |
| 1808 | iiv3-sd | 5 |
| 1809 | il-1beta/tnf-alpha | 5 |
| 1810 | il-2/ifn | 3 |
| 1811 | illness-detecting | 1 |
| 1812 | imagevis3d | 1 |
| 1813 | imatinib+interferon | 1 |
| 1814 | imatinib+peg-ifn-α2b | 1 |
| 1815 | imidamides | 1 |
| 1816 | imiglucerase | 19 |
| 1817 | immunace | 3 |
| 1818 | immuno-chemotherapy | 11 |
| 1819 | immuno-pathological | 1 |
| 1820 | immunosuppressing | 2 |
| 1821 | inaccurate/lagging | 1 |
| 1822 | inconsistent/nonusers | 1 |
| 1823 | indeterminate-probability | 1 |
| 1824 | indirect-induction | 1 |
| 1825 | infanrix-hexa | 7 |
| 1826 | infliximab/azathioprine | 2 |
| 1827 | infliximab/mtx | 2 |
| 1828 | information-gathering | 1 |
| 1829 | infra-systolic | 1 |
| 1830 | infratentorially | 1 |
| 1831 | inguinal-subcutaneous | 1 |
| 1832 | injected-cured | 1 |
| 1833 | inratio | 1 |
| 1834 | insuplant | 6 |
| 1835 | integrated-low | 2 |
| 1836 | interleukine-2 | 1 |
| 1837 | intragroups | 1 |
| 1838 | intramuscularly-administered | 1 |
| 1839 | intranasally.overall | 1 |
| 1840 | inunction | 2 |
| 1841 | ipt+escitalopram | 1 |
| 1842 | irinotecan+5fu/lv | 1 |
| 1843 | irinotecan+fu/lv | 1 |
| 1844 | irinotecan/capecitabine | 1 |
| 1845 | irinotecan/fu/fa | 2 |
| 1846 | irrelevant/noisy | 1 |
| 1847 | isoretinoin | 1 |
| 1848 | isosthenuria | 2 |
| 1849 | it+mgn-3 | 2 |
| 1850 | itnis | 1 |
| 1851 | itopride.nevertheless | 1 |
| 1852 | iui-coh | 2 |
| 1853 | iv-pb | 5 |
| 1854 | ivacaftor-to-ivacaftor | 2 |
| 1855 | ivcy | 4 |
| 1856 | ivig+rituximab | 5 |
| 1857 | jamshidi | 4 |
| 1858 | jaukay | 1 |
| 1859 | jelled-type | 1 |
| 1860 | jev-gcc | 4 |
| 1861 | juca | 2 |
| 1862 | k-712 | 7 |
| 1863 | k2m′′cl4 | 1 |
| 1864 | kangulamira | 1 |
| 1865 | kardonit | 1 |
| 1866 | kbh₄ | 1 |
| 1867 | keels | 2 |
| 1868 | keishinieppiittokaryojutsubu | 2 |
| 1869 | ketofol | 56 |
| 1870 | ketoprofen-oxymorphone | 3 |
| 1871 | ki/edta | 1 |
| 1872 | kjai | 5 |
| 1873 | knee-disarticulation | 1 |
| 1874 | kpms | 1 |
| 1875 | krt17 | 1 |
| 1876 | kw-4354 | 2 |
| 1877 | kynurenine-3-monooxygenase | 1 |
| 1878 | kyposcoliosis | 1 |
| 1879 | l-685,458 | 1 |
| 1880 | l-avd | 4 |
| 1881 | l-carnitine-supplemented | 1 |
| 1882 | l-d+ | 2 |
| 1883 | l-dopa/benserazide | 1 |
| 1884 | l-dopa/carbidopa/entacapone | 2 |
| 1885 | l-meals | 1 |
| 1886 | la/la+g/a | 1 |
| 1887 | lac2e | 3 |
| 1888 | lactose/mcc | 1 |
| 1889 | lai-risperidone | 2 |
| 1890 | lam/tdf | 2 |
| 1891 | land-basedthere | 1 |
| 1892 | lap+cap | 6 |
| 1893 | lapatinib-capecitabine | 11 |
| 1894 | laporotomy | 1 |
| 1895 | laser-etch | 1 |
| 1896 | lassbio-1471 | 4 |
| 1897 | last-observations-carried-forward | 1 |
| 1898 | later.2 | 1 |
| 1899 | later.3 | 1 |
| 1900 | latina/hispanic | 1 |
| 1901 | lavandulyl | 2 |
| 1902 | lay-off | 1 |
| 1903 | lc+ep | 3 |
| 1904 | lc-ioes | 5 |
| 1905 | lc-lcbde | 5 |
| 1906 | lch-ii | 5 |
| 1907 | ldac+ato | 1 |
| 1908 | ldl-radius | 1 |
| 1909 | ldr-icbt | 3 |
| 1910 | ldv/sof+rbv | 2 |
| 1911 | lechatelierite | 1 |
| 1912 | lentisk | 1 |
| 1913 | less/ml | 1 |
| 1914 | leto-gbs | 1 |
| 1915 | letrezole | 2 |
| 1916 | letrozole/placebo | 2 |
| 1917 | leukotoxin-negative | 2 |
| 1918 | levobopivacaine | 1 |
| 1919 | levosulpiride | 5 |
| 1920 | lg-sil | 3 |
| 1921 | lgj | 5 |
| 1922 | li-nppv | 10 |
| 1923 | li/li | 2 |
| 1924 | li120 | 3 |
| 1925 | lidocaine-ketamine-dexmedetomidine | 1 |
| 1926 | life-as-usual | 1 |
| 1927 | ligand-to-ligand | 1 |
| 1928 | linear/micronodular | 2 |
| 1929 | lisinopril-telmisartan | 2 |
| 1930 | live-caught | 1 |
| 1931 | lkess | 2 |
| 1932 | lm/mm55 | 1 |
| 1933 | lma.however | 1 |
| 1934 | lmw-heparinoid | 2 |
| 1935 | lmwh+gcs | 1 |
| 1936 | lmwh/vka | 7 |
| 1937 | ln=y | 1 |
| 1938 | lng- | 3 |
| 1939 | lo-output | 1 |
| 1940 | locator® | 6 |
| 1941 | locularity | 2 |
| 1942 | loperamide-treated | 1 |
| 1943 | lopinavir-ritonavir | 18 |
| 1944 | lopinavir/ritonavir+efavirenz | 1 |
| 1945 | lopinavirritonavir | 2 |
| 1946 | lopinavir–ritonavir | 1 |
| 1947 | loracarbef-resistant | 1 |
| 1948 | losartan/hct | 4 |
| 1949 | low+ | 3 |
| 1950 | low-cavity | 1 |
| 1951 | low-cho/high-monounsaturated-fat | 1 |
| 1952 | low-fat/sedentary | 1 |
| 1953 | low-flavanone | 2 |
| 1954 | low-pa/high-oa | 2 |
| 1955 | low-protein/lgi | 1 |
| 1956 | low-suppressed | 1 |
| 1957 | low-weight-loss | 1 |
| 1958 | lower-rate | 3 |
| 1959 | lpv/r+tdf/ftc | 6 |
| 1960 | lqt-3 | 1 |
| 1961 | lrsb | 9 |
| 1962 | ls+et | 2 |
| 1963 | ltd₄ | 1 |
| 1964 | lumbosciatica | 2 |
| 1965 | lvad+ccp | 2 |
| 1966 | lympho-lipedema | 1 |
| 1967 | lysine-aspirin | 1 |
| 1968 | lz37 | 1 |
| 1969 | m-cavi | 6 |
| 1970 | m-er | 5 |
| 1971 | m-substituents | 1 |
| 1972 | maa-alb | 2 |
| 1973 | macro-ethics | 1 |
| 1974 | mact+ta | 1 |
| 1975 | maleficio | 1 |
| 1976 | malignity | 4 |
| 1977 | maltorsion | 1 |
| 1978 | manic/mania | 1 |
| 1979 | manual-control | 2 |
| 1980 | manufacturer-designed | 1 |
| 1981 | maobi | 14 |
| 1982 | maoris | 1 |
| 1983 | map-alone | 3 |
| 1984 | marsupialisation | 1 |
| 1985 | matched-placebo | 3 |
| 1986 | matt | 15 |
| 1987 | matti | 2 |
| 1988 | maxilla/mandible | 1 |
| 1989 | mbt-iop | 3 |
| 1990 | mean=-0.7 | 1 |
| 1991 | mean=0.79 | 1 |
| 1992 | med16 | 1 |
| 1993 | medline+handsearching | 1 |
| 1994 | mei-cap | 5 |
| 1995 | meibopatch | 2 |
| 1996 | melphalan/dexamethasone/thalidomide | 1 |
| 1997 | menacwy-d | 15 |
| 1998 | menps | 21 |
| 1999 | mentalism | 1 |
| 2000 | meoc+p | 8 |
| 2001 | meperedine | 4 |
| 2002 | mephenytoin | 1 |
| 2003 | mequitazine | 3 |
| 2004 | merck-20c | 9 |
| 2005 | mesnex | 2 |
| 2006 | meso-h4dmsa | 1 |
| 2007 | met+pio45 | 2 |
| 2008 | meta-characteristics | 1 |
| 2009 | metformin-xr | 2 |
| 2010 | metformin/placebo | 9 |
| 2011 | methotrexate+placebo-adalimumab | 1 |
| 2012 | methotrexate-doxorubicin | 7 |
| 2013 | methotrexate/carboplatin/vinblastine | 1 |
| 2014 | methotrexate/tacrolimus | 7 |
| 2015 | methrorraghia | 2 |
| 2016 | methscopolamine | 6 |
| 2017 | methycobal | 6 |
| 2018 | methyljasmonate | 1 |
| 2019 | methylphenidate-only | 4 |
| 2020 | methylphenidate-placebo | 1 |
| 2021 | metorpolol | 1 |
| 2022 | mexilitene | 1 |
| 2023 | mfg-standard | 3 |
| 2024 | mfolfox6/bevacizumab | 3 |
| 2025 | mi+ns | 1 |
| 2026 | mi-act | 6 |
| 2027 | mi-high | 2 |
| 2028 | micro-implant | 5 |
| 2029 | microinvasions | 1 |
| 2030 | micromaterials | 1 |
| 2031 | micromitophagy | 1 |
| 2032 | microtrabeculectomy | 4 |
| 2033 | midazolam-fentanyl | 15 |
| 2034 | midazolam-morphine | 1 |
| 2035 | midazolam/fentanyl | 12 |
| 2036 | midodrine-octreotide | 3 |
| 2037 | midpuberty | 1 |
| 2038 | mifl | 11 |
| 2039 | mild/early | 6 |
| 2040 | mini-octr | 3 |
| 2041 | mini-parapatellar | 3 |
| 2042 | minicones | 1 |
| 2043 | mipt | 4 |
| 2044 | mission/shelter | 1 |
| 2045 | mitomycin/ifosfamide/cisplatin | 1 |
| 2046 | mitomycin/vinblastine | 1 |
| 2047 | mitoxantrone-prednisone | 6 |
| 2048 | mkp-2 | 2 |
| 2049 | mmf- | 1 |
| 2050 | mmf/cni | 9 |
| 2051 | mmf/myf | 1 |
| 2052 | mmn-2 | 5 |
| 2053 | mmrii® | 1 |
| 2054 | mo-salts | 1 |
| 2055 | mobicox | 2 |
| 2056 | mock-radiation | 1 |
| 2057 | modafinil+escitalopram | 1 |
| 2058 | moderate-resistance-high-endurance | 1 |
| 2059 | molixan | 3 |
| 2060 | monacolins-washout-placebo | 1 |
| 2061 | mono-methoxy | 1 |
| 2062 | monoproducts | 1 |
| 2063 | mont+ics | 2 |
| 2064 | moodswings-plus | 3 |
| 2065 | mosaicplasty | 18 |
| 2066 | mosapramine | 2 |
| 2067 | mp/ifn | 5 |
| 2068 | mr=0 | 1 |
| 2069 | mtx+placebo | 1 |
| 2070 | mtx+placebo-cya | 1 |
| 2071 | mtx+twhf | 4 |
| 2072 | mtx-cdp-adm | 2 |
| 2073 | mtx/tacrolimus | 1 |
| 2074 | mtz+amoxicillin | 1 |
| 2075 | mtz-placebo | 2 |
| 2076 | multi-gravidae | 1 |
| 2077 | multi-rc | 8 |
| 2078 | multimin90 | 1 |
| 2079 | musculoskeletal-related | 1 |
| 2080 | music-headphones | 1 |
| 2081 | mva-f6-sfmr | 1 |
| 2082 | mvr-pp | 3 |
| 2083 | mycophenolate/dexamethasone | 5 |
| 2084 | n-acetyl-asp-glu-val-asp-cho | 1 |
| 2085 | n-acetyl-carnitine | 2 |
| 2086 | n-acetyl-β-end | 1 |
| 2087 | n-cyclohexylcarboxamidine | 1 |
| 2088 | n-ifn-beta | 1 |
| 2089 | n-methyl-dehydroalanine | 1 |
| 2090 | n70 | 1 |
| 2091 | n=1553 | 1 |
| 2092 | na-1 | 7 |
| 2093 | na-hy | 8 |
| 2094 | na2m | 1 |
| 2095 | na77 | 5 |
| 2096 | nacr | 10 |
| 2097 | naloxonazine | 1 |
| 2098 | naltriben | 1 |
| 2099 | nap+ifn-α | 1 |
| 2100 | naphthylacyl | 2 |
| 2101 | naturopath | 4 |
| 2102 | na₂seo₃ | 5 |
| 2103 | nbca-ms | 10 |
| 2104 | nbce1 | 1 |
| 2105 | nbhsp | 1 |
| 2106 | nd-vaccinated | 2 |
| 2107 | near-planar | 1 |
| 2108 | nebivolol/hydrochlorothiazide | 1 |
| 2109 | nefopam-paracetamol | 1 |
| 2110 | negative-angry | 1 |
| 2111 | neo-adjuvantly | 1 |
| 2112 | neochlamydia | 1 |
| 2113 | neostigmine/glycopyrrolate | 4 |
| 2114 | neostomia | 2 |
| 2115 | nerve-myocyte | 1 |
| 2116 | neurobloc/myobloc | 1 |
| 2117 | neurostan | 5 |
| 2118 | never/rarely | 3 |
| 2119 | newly-launched | 1 |
| 2120 | nfjxy | 1 |
| 2121 | ngrt | 6 |
| 2122 | ngxml-1xh-1 | 2 |
| 2123 | nidcap/experimental | 1 |
| 2124 | nihh | 4 |
| 2125 | nilestriol | 5 |
| 2126 | no-acei/arb | 2 |
| 2127 | no-am | 2 |
| 2128 | no-ap | 9 |
| 2129 | no-asa | 7 |
| 2130 | no-bpd | 5 |
| 2131 | no-brace | 12 |
| 2132 | no-bracing | 1 |
| 2133 | no-burping | 1 |
| 2134 | no-cancer | 1 |
| 2135 | no-cpap | 2 |
| 2136 | no-diabetes | 3 |
| 2137 | no-ets | 2 |
| 2138 | no-fes | 5 |
| 2139 | no-hme | 2 |
| 2140 | no-menthol | 1 |
| 2141 | no-mm | 3 |
| 2142 | no-steroid | 9 |
| 2143 | no-str | 2 |
| 2144 | nobex | 4 |
| 2145 | nodulosis | 1 |
| 2146 | nogo-repeat | 1 |
| 2147 | non-activity | 1 |
| 2148 | non-adenocarcinoma | 10 |
| 2149 | non-age-matched | 1 |
| 2150 | non-apex | 2 |
| 2151 | non-apn | 2 |
| 2152 | non-asa | 3 |
| 2153 | non-atopy | 1 |
| 2154 | non-bds | 1 |
| 2155 | non-block | 1 |
| 2156 | non-btl | 2 |
| 2157 | non-carbapenems | 2 |
| 2158 | non-celebrities | 1 |
| 2159 | non-cm | 15 |
| 2160 | non-cohabitant | 1 |
| 2161 | non-concomitant | 1 |
| 2162 | non-concomitantly | 2 |
| 2163 | non-consistent | 2 |
| 2164 | non-cp | 6 |
| 2165 | non-dc | 2 |
| 2166 | non-dialysis-related | 1 |
| 2167 | non-division | 2 |
| 2168 | non-documented | 1 |
| 2169 | non-ecf | 2 |
| 2170 | non-ee | 1 |
| 2171 | non-emr | 1 |
| 2172 | non-endorsers | 2 |
| 2173 | non-epidural | 6 |
| 2174 | non-household | 3 |
| 2175 | non-iabp | 4 |
| 2176 | non-icm | 12 |
| 2177 | non-icm.1 | 1 |
| 2178 | non-inflammation | 1 |
| 2179 | non-initiators | 4 |
| 2180 | non-intensively | 2 |
| 2181 | non-interventions | 1 |
| 2182 | non-irinotecan | 1 |
| 2183 | non-kyds | 2 |
| 2184 | non-lasting | 1 |
| 2185 | non-leukoreduction | 1 |
| 2186 | non-losses | 1 |
| 2187 | non-meningitis | 4 |
| 2188 | non-mixed | 3 |
| 2189 | non-mtd | 1 |
| 2190 | non-mvd | 2 |
| 2191 | non-packed | 2 |
| 2192 | non-packing | 2 |
| 2193 | non-pathcr | 1 |
| 2194 | non-platinum- | 1 |
| 2195 | non-producer | 1 |
| 2196 | non-pst | 3 |
| 2197 | non-rhg-csf | 2 |
| 2198 | non-ripc | 2 |
| 2199 | non-ruptured | 1 |
| 2200 | non-rvd | 1 |
| 2201 | non-smbg | 2 |
| 2202 | non-spanish-speaking | 1 |
| 2203 | non-st-elevation-acs | 1 |
| 2204 | non-stenting | 2 |
| 2205 | non-suction | 3 |
| 2206 | non-suturing | 4 |
| 2207 | non-ta | 8 |
| 2208 | non-tcfa | 3 |
| 2209 | non-titrated | 3 |
| 2210 | non-twhf | 2 |
| 2211 | non-vest | 1 |
| 2212 | non-vestib | 3 |
| 2213 | non-wlff | 4 |
| 2214 | nonaminobisphosphonate | 1 |
| 2215 | nonanemia | 2 |
| 2216 | nonaspirating | 1 |
| 2217 | nonaspiration | 1 |
| 2218 | nonbracing | 1 |
| 2219 | nonbreastfeeding | 1 |
| 2220 | noncandidates | 3 |
| 2221 | nonceliotomy | 1 |
| 2222 | nonclopidogrel | 1 |
| 2223 | nondihydropyridines | 2 |
| 2224 | nondisclosers | 1 |
| 2225 | nondisinfection | 1 |
| 2226 | nonemulsified | 1 |
| 2227 | nonenzyme-treated | 1 |
| 2228 | nonfluoroscopy | 2 |
| 2229 | nonhaptics-trained | 1 |
| 2230 | nonhydrated | 3 |
| 2231 | noninducers | 1 |
| 2232 | nonirrigation | 1 |
| 2233 | nonlinemen | 1 |
| 2234 | nonnucleosides | 3 |
| 2235 | nonradicals | 1 |
| 2236 | nonreduction | 1 |
| 2237 | nonresurfacoing | 1 |
| 2238 | nonspontaneous | 3 |
| 2239 | nonstarters | 1 |
| 2240 | nonsuccess | 4 |
| 2241 | nonsuccessful | 1 |
| 2242 | nonswaddling | 1 |
| 2243 | nonusefulness | 1 |
| 2244 | nonylphenylethers | 1 |
| 2245 | nootropil | 2 |
| 2246 | noplug | 6 |
| 2247 | norbni | 2 |
| 2248 | norepinephrine-dobutamine | 13 |
| 2249 | norepineprhine | 1 |
| 2250 | normal-testosterone | 1 |
| 2251 | normofiltration | 1 |
| 2252 | norx | 4 |
| 2253 | nosiheptide | 6 |
| 2254 | not-coached | 2 |
| 2255 | not-follow | 1 |
| 2256 | not-sudden | 1 |
| 2257 | not-treated | 3 |
| 2258 | novofine | 1 |
| 2259 | np-28rnp | 1 |
| 2260 | npsv | 7 |
| 2261 | ns+e | 4 |
| 2262 | ns-nsaid | 1 |
| 2263 | nudsa | 8 |
| 2264 | nurse-qodd | 1 |
| 2265 | nϵ- | 1 |
| 2266 | o+g+t | 9 |
| 2267 | o-blood | 1 |
| 2268 | oaps | 7 |
| 2269 | oats-fed | 1 |
| 2270 | obac | 4 |
| 2271 | obag | 4 |
| 2272 | obese-3 | 5 |
| 2273 | obtrusion | 1 |
| 2274 | occlusion-2 | 1 |
| 2275 | octanol-aqueous | 1 |
| 2276 | octreotide-everolimus | 1 |
| 2277 | ofd-group | 3 |
| 2278 | olanzapine+placebo | 3 |
| 2279 | olanzapine+topiramate | 1 |
| 2280 | olfactory+gustatory | 1 |
| 2281 | olive-oil-enriched | 1 |
| 2282 | olmesertan | 1 |
| 2283 | ols-si | 2 |
| 2284 | on-warfarin | 1 |
| 2285 | onca | 2 |
| 2286 | once-a-wk | 1 |
| 2287 | oncoprotein-18 | 1 |
| 2288 | ooxy | 6 |
| 2289 | opcab-surgery | 1 |
| 2290 | opticol® | 2 |
| 2291 | oral-only | 4 |
| 2292 | oraquick | 4 |
| 2293 | oscillation+rotation | 2 |
| 2294 | osteopaenic | 1 |
| 2295 | other-than-placebo | 1 |
| 2296 | otorragy | 1 |
| 2297 | over-reciprocating | 1 |
| 2298 | ovoids | 1 |
| 2299 | oxa-carbapenemases | 1 |
| 2300 | oxc-ir | 9 |
| 2301 | oxliplatin | 1 |
| 2302 | oxy40 | 7 |
| 2303 | oxycodone/acetaminophen | 9 |
| 2304 | oxyplatin | 1 |
| 2305 | ozena | 1 |
| 2306 | p-28rnp | 1 |
| 2307 | p-dihydroxyborylphenylalanine | 1 |
| 2308 | p-nitrophenyl-α-d-galactoside | 1 |
| 2309 | p-placebo | 2 |
| 2310 | p94 | 1 |
| 2311 | pac+cb+bev | 7 |
| 2312 | paccbev | 6 |
| 2313 | pacebo | 2 |
| 2314 | pacemaker-defibrillator | 1 |
| 2315 | paclitaxel+cisplatin | 2 |
| 2316 | paclitaxel/gemcitabine | 3 |
| 2317 | pancreatico-splenectomy | 4 |
| 2318 | pancreatojejunostomy | 6 |
| 2319 | paracematol | 1 |
| 2320 | parametrectomy | 1 |
| 2321 | paranodes | 1 |
| 2322 | paraparetic | 1 |
| 2323 | paraxially | 1 |
| 2324 | parecoxib/valdecoxib | 8 |
| 2325 | paricalcitol- | 2 |
| 2326 | paroxetine+quetiapine | 1 |
| 2327 | pash-1 | 1 |
| 2328 | passive-rtms | 8 |
| 2329 | pathological-and | 1 |
| 2330 | pb-pes | 5 |
| 2331 | pbo+exe | 5 |
| 2332 | pbo+li/dvp | 6 |
| 2333 | pbo-sc | 10 |
| 2334 | pbo-tnk-tnk | 3 |
| 2335 | pbo/mtx | 5 |
| 2336 | pbp2xhis₆ | 1 |
| 2337 | pbs-immunized | 3 |
| 2338 | pcv13+p80 | 1 |
| 2339 | pd-apcc | 7 |
| 2340 | pds® | 1 |
| 2341 | pdt/ivb/ivt | 1 |
| 2342 | pe1.3 | 3 |
| 2343 | pedialyte | 8 |
| 2344 | peg-ifnα-2a/rbv/fluvastatin | 1 |
| 2345 | peg-ifnα2b/rbv | 2 |
| 2346 | peg-infα-2b | 3 |
| 2347 | pegfp-c1 | 5 |
| 2348 | peginterferon-alpha-2b | 2 |
| 2349 | pelvitrainer | 2 |
| 2350 | pemetrexed+erlotinib | 7 |
| 2351 | pemetrexed/bevacizumab | 4 |
| 2352 | pemetrexed/carboplatin/bevacizumab | 2 |
| 2353 | pepsi® | 1 |
| 2354 | per. | 2 |
| 2355 | peridinioids | 1 |
| 2356 | peritrochanter | 1 |
| 2357 | peritumorally | 1 |
| 2358 | pertofran | 3 |
| 2359 | pertuzumab-docetaxel | 1 |
| 2360 | pes/ses | 5 |
| 2361 | pet28b-tvcp3c | 1 |
| 2362 | pfp×c18 | 1 |
| 2363 | ph-sbp | 6 |
| 2364 | phaco-trabeculectomy | 5 |
| 2365 | pharm-cat | 4 |
| 2366 | phe-cys-tyr-trp-orn-thr-pen-thr-nh2 | 1 |
| 2367 | phenocoumaron | 1 |
| 2368 | philadelphia-chromosome | 2 |
| 2369 | phosphate-buffer | 1 |
| 2370 | phosphoantigens | 1 |
| 2371 | photoallergenic | 1 |
| 2372 | photoepilation | 2 |
| 2373 | photophores | 1 |
| 2374 | phyllocontin | 2 |
| 2375 | phytohaemagglutinin | 15 |
| 2376 | pi/nnrti | 5 |
| 2377 | pias3 | 4 |
| 2378 | piko/software | 2 |
| 2379 | pill-placebo | 13 |
| 2380 | pinda | 3 |
| 2381 | pinnules | 1 |
| 2382 | pip/taz-amc | 6 |
| 2383 | pipobroman | 8 |
| 2384 | pivampicillin/pivmecillinam | 6 |
| 2385 | pl-mis | 2 |
| 2386 | pla+dtic | 1 |
| 2387 | pla-cebo | 1 |
| 2388 | pla3 | 2 |
| 2389 | placebo | 87,219 |
| 2390 | placebo+adt | 3 |
| 2391 | placebo+dsr | 2 |
| 2392 | placebo+lifestyle | 1 |
| 2393 | placebo+ms | 2 |
| 2394 | placebo+mtx | 12 |
| 2395 | placebo+obt | 1 |
| 2396 | placebo+risperidone | 3 |
| 2397 | placebo+snri | 2 |
| 2398 | placebo-cisplatin | 10 |
| 2399 | placebo-cpap | 3 |
| 2400 | placebo-doxycycline | 2 |
| 2401 | placebo-dronabinol | 1 |
| 2402 | placebo-fulvestrant | 2 |
| 2403 | placebo-imt | 4 |
| 2404 | placebo-methylphenidate | 1 |
| 2405 | placebo-mtx | 6 |
| 2406 | placebo-plus-bwl | 1 |
| 2407 | placebo-prednisone | 4 |
| 2408 | placebo-primed | 1 |
| 2409 | placebo-sham | 5 |
| 2410 | placebo-stimulation | 1 |
| 2411 | placebo-tens | 14 |
| 2412 | placebo-teriparatide | 10 |
| 2413 | placebo-treatment | 10 |
| 2414 | placebo-uvc | 2 |
| 2415 | placebo-walnuts | 1 |
| 2416 | placebo/adalimumab | 3 |
| 2417 | placebo/amlodipine | 3 |
| 2418 | placebo/cbt | 1 |
| 2419 | placebo/control | 48 |
| 2420 | placebo/dtic | 1 |
| 2421 | placebo/ezetimibe | 2 |
| 2422 | placebo/gemcitabine | 4 |
| 2423 | placebo/ibuprofen | 2 |
| 2424 | placebo/moxifloxacin | 2 |
| 2425 | placebo/pr | 3 |
| 2426 | placebo/prednisone | 1 |
| 2427 | placebo/sertraline | 1 |
| 2428 | placebo/statin | 2 |
| 2429 | placebo/steroids | 1 |
| 2430 | placebo/vehicle | 5 |
| 2431 | placebo/washout/nac | 1 |
| 2432 | plastificants | 1 |
| 2433 | platinum-responsiveness | 1 |
| 2434 | platinum/vinorelbine | 1 |
| 2435 | play-as-usual | 2 |
| 2436 | play-audiometry | 1 |
| 2437 | playstation2 | 6 |
| 2438 | plc-pmr | 2 |
| 2439 | pm/em | 1 |
| 2440 | pnd21-42 | 1 |
| 2441 | pnd42 | 1 |
| 2442 | po+pr | 1 |
| 2443 | poly-chemotherapies | 1 |
| 2444 | poly-phyletic | 1 |
| 2445 | poly-victimization | 1 |
| 2446 | poly/bac | 14 |
| 2447 | polyleucine | 1 |
| 2448 | polymer-only | 2 |
| 2449 | polymethoxychalcones | 2 |
| 2450 | polyoxytetramethylenediols | 1 |
| 2451 | polyphenyl | 2 |
| 2452 | polytetrafluoroethelene | 1 |
| 2453 | polytypism | 1 |
| 2454 | polyvinylpyrolidone | 1 |
| 2455 | poorly-reported | 1 |
| 2456 | porfiromycin | 2 |
| 2457 | post-incision | 7 |
| 2458 | post-last-dose | 1 |
| 2459 | post-nac | 5 |
| 2460 | post-ps | 1 |
| 2461 | post-studies | 1 |
| 2462 | post-synaptically | 1 |
| 2463 | post-tdcs | 4 |
| 2464 | postacclimatization | 2 |
| 2465 | postprocedures | 1 |
| 2466 | postpyloris | 1 |
| 2467 | power-modes | 1 |
| 2468 | pp+map | 3 |
| 2469 | pp-ees | 11 |
| 2470 | pph33-03 | 7 |
| 2471 | pq1wc | 1 |
| 2472 | pr+/her2+ | 1 |
| 2473 | pr+/her2- | 1 |
| 2474 | pre-cirrhosis | 1 |
| 2475 | pre-conceptually | 1 |
| 2476 | pre-delinquents | 2 |
| 2477 | pre-mix | 14 |
| 2478 | pre-stratification | 2 |
| 2479 | prednimustine | 1 |
| 2480 | prednisolone/mps | 1 |
| 2481 | preef | 7 |
| 2482 | preleukemia | 1 |
| 2483 | premphase | 1 |
| 2484 | prentice-wilcoxon | 1 |
| 2485 | pressurelike | 1 |
| 2486 | prevention/mediation | 1 |
| 2487 | prilocaine-phenylephrine | 1 |
| 2488 | primatrix | 3 |
| 2489 | principal/secondary | 1 |
| 2490 | pro/prebiotics | 3 |
| 2491 | proactiv | 4 |
| 2492 | probable/possible-ptb | 1 |
| 2493 | progression-control | 1 |
| 2494 | progression-controls | 1 |
| 2495 | prolaps | 2 |
| 2496 | prolastin® | 2 |
| 2497 | pronase/bicarbonate/simethicone | 1 |
| 2498 | propofol+alfentanil | 2 |
| 2499 | propofol/fentanyl/placebo-saline | 1 |
| 2500 | prosigne | 7 |
| 2501 | prostaglandinanalogue | 1 |
| 2502 | prostate-vesiculo-epididymitis | 2 |
| 2503 | protease-activated-receptor-2 | 1 |
| 2504 | prp/bdx | 3 |
| 2505 | pseudallescheria | 1 |
| 2506 | pseudo-ea | 8 |
| 2507 | pseudo-randomisation | 1 |
| 2508 | pseudo-relapse | 1 |
| 2509 | pseudoepiphysis | 1 |
| 2510 | pseudohematuria | 1 |
| 2511 | pseudooxynicotine | 1 |
| 2512 | pseudophosphatases | 1 |
| 2513 | psgag | 3 |
| 2514 | psos | 1 |
| 2515 | pss-c | 2 |
| 2516 | pstae-yoghurt | 1 |
| 2517 | psychological-mindset | 1 |
| 2518 | pt2b/pt3 | 1 |
| 2519 | ptany | 1 |
| 2520 | pueperium | 1 |
| 2521 | pvax1-ori-g-ltb | 2 |
| 2522 | pvi+ll | 6 |
| 2523 | pxl01 | 9 |
| 2524 | pylorus-removal | 1 |
| 2525 | pyrimathamine+clindamycin | 1 |
| 2526 | pyruvate-lactate | 3 |
| 2527 | p≤0.0025 | 1 |
| 2528 | q-1,000 | 8 |
| 2529 | q1000 | 3 |
| 2530 | q148r | 1 |
| 2531 | qr/rr192 | 1 |
| 2532 | quantitative-measured | 1 |
| 2533 | quinine-tetracycline | 1 |
| 2534 | r-af | 6 |
| 2535 | r-cells | 1 |
| 2536 | r-chop21 | 8 |
| 2537 | r-dhap | 11 |
| 2538 | r-γ | 1 |
| 2539 | r2.5/e10 | 4 |
| 2540 | r56865 | 1 |
| 2541 | radiation.mcnu.interferon-beta | 1 |
| 2542 | radio-isotopes | 1 |
| 2543 | radmhe2 | 1 |
| 2544 | raktadushti | 1 |
| 2545 | randomised-response | 1 |
| 2546 | rapid-weight-reduction | 1 |
| 2547 | rarc/plnd | 1 |
| 2548 | rasc | 3 |
| 2549 | rawness | 1 |
| 2550 | rba/pba | 5 |
| 2551 | rbca | 1 |
| 2552 | rcht-treated | 1 |
| 2553 | rct-s | 6 |
| 2554 | re-draping | 1 |
| 2555 | re-offend | 3 |
| 2556 | re4 | 2 |
| 2557 | readmissions/patient | 1 |
| 2558 | red-clover | 1 |
| 2559 | redef | 8 |
| 2560 | reexplorations | 1 |
| 2561 | referred-care | 1 |
| 2562 | reflect-3 | 3 |
| 2563 | relapse/reactivation | 1 |
| 2564 | rem4 | 3 |
| 2565 | ren2-eta/etb | 1 |
| 2566 | renting | 1 |
| 2567 | renutrition | 1 |
| 2568 | reovirus-1 | 1 |
| 2569 | repaglinide-only | 2 |
| 2570 | restudying | 5 |
| 2571 | restylane® | 5 |
| 2572 | retinectomy | 1 |
| 2573 | revivification | 1 |
| 2574 | rhcl3·3h2o | 1 |
| 2575 | ribbling | 1 |
| 2576 | rif-mmx | 8 |
| 2577 | rifampin-treated | 2 |
| 2578 | right-noncoronary | 1 |
| 2579 | rimonabant/ | 1 |
| 2580 | risperidone-lai | 2 |
| 2581 | rituximab-chlorambucil | 4 |
| 2582 | rituximab-cyclophosphamide | 1 |
| 2583 | riukiu-yomogi | 1 |
| 2584 | rmsp1-19 | 1 |
| 2585 | rns10.3 | 1 |
| 2586 | ro-3306 | 1 |
| 2587 | romifidine-ketamine | 1 |
| 2588 | rosiglitazone/placebo | 2 |
| 2589 | rostellum | 1 |
| 2590 | rosuvastatin/exercise | 1 |
| 2591 | rp-8-br-camps | 1 |
| 2592 | rt-hyperthermia | 1 |
| 2593 | rtsi | 4 |
| 2594 | rtv/sqv/d4t | 5 |
| 2595 | rtv/sqv/stavudine | 1 |
| 2596 | s-1+cisplatin | 6 |
| 2597 | s-1/psk | 3 |
| 2598 | s-273 | 2 |
| 2599 | s-asa | 4 |
| 2600 | s-cpr | 15 |
| 2601 | s-imrt | 4 |
| 2602 | s-l- | 2 |
| 2603 | s-scls | 4 |
| 2604 | s-tna | 2 |
| 2605 | s/s+a/a | 1 |
| 2606 | s1179 | 1 |
| 2607 | sab5 | 2 |
| 2608 | sabeluzole | 5 |
| 2609 | saber-placebo | 3 |
| 2610 | sabethes | 1 |
| 2611 | saf-t-coil | 2 |
| 2612 | sagb® | 2 |
| 2613 | salazopyrin | 7 |
| 2614 | saline-atropine | 1 |
| 2615 | saline-placebo | 1 |
| 2616 | saline/gentamicin | 2 |
| 2617 | saline±r-tpa | 1 |
| 2618 | salm/fp | 5 |
| 2619 | salpingits | 1 |
| 2620 | salpingo | 1 |
| 2621 | sandblasted+ssp | 1 |
| 2622 | saquinavir/ritonavir | 6 |
| 2623 | sb-p/c | 17 |
| 2624 | sb-pc | 13 |
| 2625 | sb415286 | 6 |
| 2626 | sbcl5 | 1 |
| 2627 | sbeg | 6 |
| 2628 | sbnocp | 4 |
| 2629 | sbp+rm | 2 |
| 2630 | scfts | 1 |
| 2631 | scombrotoxin | 1 |
| 2632 | sd-dn | 4 |
| 2633 | secondary/central | 1 |
| 2634 | secundi- | 1 |
| 2635 | segd | 15 |
| 2636 | self-centred | 1 |
| 2637 | self-complementarity | 1 |
| 2638 | self-perspectives | 2 |
| 2639 | self-presenting | 1 |
| 2640 | self-used | 1 |
| 2641 | semicoma | 1 |
| 2642 | semipoisons | 1 |
| 2643 | serogroup-c-meningococcal-conjugate-vaccine | 1 |
| 2644 | serotonergics | 2 |
| 2645 | severe-cyclers | 1 |
| 2646 | severe-tbi | 1 |
| 2647 | sevo-des | 1 |
| 2648 | sevoflurane-opioid | 1 |
| 2649 | sevoflurane/opioid | 3 |
| 2650 | sevoflurane | 5 |
| 2651 | sfa- | 3 |
| 2652 | sg+gg | 2 |
| 2653 | sg-ssg | 7 |
| 2654 | sg-t0 | 2 |
| 2655 | sham-acupuncture | 35 |
| 2656 | sham-anaesthetised | 1 |
| 2657 | sham-aw | 1 |
| 2658 | sham-bsa | 4 |
| 2659 | sham-devices | 1 |
| 2660 | sham-emt | 6 |
| 2661 | sham-exposure | 2 |
| 2662 | sham-imt | 3 |
| 2663 | sham-irradiation | 3 |
| 2664 | sham-nf | 1 |
| 2665 | sham-nrt | 1 |
| 2666 | sham-rtms | 8 |
| 2667 | sham-stimulation | 5 |
| 2668 | sham-tdcs | 12 |
| 2669 | sham-ultrasound | 7 |
| 2670 | sheet-like/lamellated | 1 |
| 2671 | sheikhas | 1 |
| 2672 | shi-hung-one | 1 |
| 2673 | sho-seiru-to | 1 |
| 2674 | shr-h | 3 |
| 2675 | si/ho | 3 |
| 2676 | sigirr | 1 |
| 2677 | sildenafil-citrate | 1 |
| 2678 | silylether | 1 |
| 2679 | simeprevir/pr | 5 |
| 2680 | simvastatin/placebo | 3 |
| 2681 | simvastotin | 1 |
| 2682 | sirt+mfolfox6 | 1 |
| 2683 | sisb | 10 |
| 2684 | siui | 8 |
| 2685 | six-hole | 1 |
| 2686 | skin/structure | 1 |
| 2687 | sl-04 | 1 |
| 2688 | sl-uvcs | 4 |
| 2689 | slogp | 1 |
| 2690 | slope=-2.03 | 1 |
| 2691 | sloppiness | 1 |
| 2692 | slvsd | 4 |
| 2693 | sm+sm | 1 |
| 2694 | small-goals | 1 |
| 2695 | small-series | 1 |
| 2696 | smartconsents | 1 |
| 2697 | smdxr | 2 |
| 2698 | snorted | 1 |
| 2699 | socialise | 1 |
| 2700 | sodb-s | 1 |
| 2701 | sofosbuvir-ribavirin | 4 |
| 2702 | soft-brace | 3 |
| 2703 | sorbalgon | 4 |
| 2704 | sordariales | 1 |
| 2705 | soy-oil | 3 |
| 2706 | sp+as+pq | 2 |
| 2707 | sp-aq | 6 |
| 2708 | spco2 | 6 |
| 2709 | spirotetrahydrofuran | 1 |
| 2710 | spk-transplanted | 1 |
| 2711 | spongostan | 17 |
| 2712 | spoon-feeding | 5 |
| 2713 | sr142801 | 1 |
| 2714 | srl+csa | 6 |
| 2715 | ssri- | 5 |
| 2716 | st-pd | 4 |
| 2717 | staffing/equipment | 1 |
| 2718 | standard-aa | 3 |
| 2719 | standard-detection | 4 |
| 2720 | standard-suture | 1 |
| 2721 | states/provinces | 1 |
| 2722 | statin+ezetimibe | 1 |
| 2723 | statins++ | 1 |
| 2724 | stavudine/lamivudine/efavirenz | 1 |
| 2725 | std-cpr | 15 |
| 2726 | stentplacement | 4 |
| 2727 | sterofundine-g-5 | 1 |
| 2728 | steroid-continuing | 1 |
| 2729 | sti571 | 6 |
| 2730 | stilbestrol | 2 |
| 2731 | stomatologist | 1 |
| 2732 | stomatovis | 4 |
| 2733 | structum® | 4 |
| 2734 | sub-systems | 2 |
| 2735 | sucrose-based | 1 |
| 2736 | sufentanil-vecuronium | 1 |
| 2737 | sugar-water | 2 |
| 2738 | sulbactam/penicillin | 1 |
| 2739 | sulbenicillin | 2 |
| 2740 | sulfaclomid | 2 |
| 2741 | sulfasalazine+hydroxychloroquine | 2 |
| 2742 | sulphinpyrazone | 5 |
| 2743 | sulphonylmethyl | 1 |
| 2744 | super-eba | 2 |
| 2745 | superior+occi | 2 |
| 2746 | supraliminally | 1 |
| 2747 | supraperiostally | 1 |
| 2748 | surgery-alone | 29 |
| 2749 | survanta® | 2 |
| 2750 | suture-anchors | 2 |
| 2751 | swearing | 1 |
| 2752 | sweat-feeding | 1 |
| 2753 | synexin | 1 |
| 2754 | t-buli | 3 |
| 2755 | t-cef | 2 |
| 2756 | t-depleted | 1 |
| 2757 | t-fec | 9 |
| 2758 | t-incision | 1 |
| 2759 | t-nts | 1 |
| 2760 | t1-2=3.62 | 1 |
| 2761 | t3cdm | 3 |
| 2762 | t4a | 3 |
| 2763 | t5-fu | 5 |
| 2764 | t7-8 | 1 |
| 2765 | t97a | 1 |
| 2766 | ta-ir | 10 |
| 2767 | tablet/lyophilisate | 1 |
| 2768 | tac/mmf | 30 |
| 2769 | tac/mmf/st | 1 |
| 2770 | tacrolimus/methotrexate/sirolimus | 1 |
| 2771 | tacrolimus/sirolimus | 13 |
| 2772 | tamoxifen+prednisolone | 1 |
| 2773 | tamsulosin/placebo | 4 |
| 2774 | tanezumab+dsr | 3 |
| 2775 | tangmaikang | 3 |
| 2776 | target-achievement | 1 |
| 2777 | tattoed | 1 |
| 2778 | tau+mct | 1 |
| 2779 | tau-only | 5 |
| 2780 | tau-positive | 3 |
| 2781 | tau/wl | 4 |
| 2782 | taurolin | 2 |
| 2783 | taxane/doxorubicin | 1 |
| 2784 | tbt/la | 1 |
| 2785 | tcas/oads | 3 |
| 2786 | tcf/pangolin | 1 |
| 2787 | tcp+ca+orc | 2 |
| 2788 | tcz-iv | 10 |
| 2789 | tdf/emtricitabine | 4 |
| 2790 | tdf/ftc/efv | 1 |
| 2791 | tearmist | 1 |
| 2792 | technetium-stress | 3 |
| 2793 | temporal+occi | 2 |
| 2794 | tenofovir/lamivudine | 3 |
| 2795 | teprenone | 13 |
| 2796 | tetracyanobuta-1,3-dienes | 1 |
| 2797 | tetrahydroneopterin | 1 |
| 2798 | tetraparetic | 1 |
| 2799 | tetravisc | 1 |
| 2800 | tfv-diphosphate | 1 |
| 2801 | tg+ | 1 |
| 2802 | thalidomide-dexamethasone | 9 |
| 2803 | thalidomide/dexamethasone | 2 |
| 2804 | thaumarchaeol | 1 |
| 2805 | theophylline- | 2 |
| 2806 | thermal/evaporative | 1 |
| 2807 | thermotube | 1 |
| 2808 | thiopental-placebo | 1 |
| 2809 | thioproline | 6 |
| 2810 | thp+imp | 1 |
| 2811 | three-portal | 1 |
| 2812 | thymoquinone-4-palmitoylhydrazone | 1 |
| 2813 | tianquan | 2 |
| 2814 | tiaprid | 1 |
| 2815 | tid40w | 2 |
| 2816 | time-control | 5 |
| 2817 | timolol/dorzolamide | 3 |
| 2818 | tincet | 1 |
| 2819 | tio+for | 5 |
| 2820 | tipranavir-ritonavir | 10 |
| 2821 | tissucol | 5 |
| 2822 | tiv-2 | 4 |
| 2823 | tlls- | 6 |
| 2824 | tlr2/4 | 1 |
| 2825 | tm-smx | 1 |
| 2826 | tmp-smx-gentamicin | 4 |
| 2827 | tmz-21 | 4 |
| 2828 | tnfα/cycloheximide | 1 |
| 2829 | tobramycin/clindamycin | 1 |
| 2830 | toe-strike | 1 |
| 2831 | topical/intracameral | 2 |
| 2832 | topotecan-etoposide | 1 |
| 2833 | torcetrapib/atorvastatin | 4 |
| 2834 | toxins/drugs | 1 |
| 2835 | tp/at | 8 |
| 2836 | tprop | 5 |
| 2837 | tr-fec | 7 |
| 2838 | trabeculectomy-alt-trabeculectomy | 2 |
| 2839 | trail/ccb | 1 |
| 2840 | training-as-usual | 5 |
| 2841 | training-esa | 1 |
| 2842 | trans-3,4',5-trihydroxystilbene | 1 |
| 2843 | trans-4-hydroxyproline | 1 |
| 2844 | transinstitutionalization | 1 |
| 2845 | transsexuality | 1 |
| 2846 | transtympanically | 1 |
| 2847 | trastuzumab-capecitabine | 8 |
| 2848 | treatment-as-usual | 170 |
| 2849 | tresosulfan+/-etoposide | 1 |
| 2850 | trichlormethiazide | 19 |
| 2851 | triclofos | 6 |
| 2852 | trimagant | 1 |
| 2853 | trimetaphan | 1 |
| 2854 | trimethoprim-sulfameth-oxazole | 1 |
| 2855 | trimethoprim/sulfamethopyrazine | 1 |
| 2856 | trimethoprime-sulfamethoxazole | 1 |
| 2857 | trimethoprimsulfamethoxazole | 11 |
| 2858 | triple-immunotherapy | 2 |
| 2859 | triplications | 1 |
| 2860 | tritanrix™-hbv/hib | 3 |
| 2861 | trusopt | 10 |
| 2862 | trα-knock-out | 1 |
| 2863 | tsga | 5 |
| 2864 | tssu | 1 |
| 2865 | tt,1.637 | 1 |
| 2866 | tt-ps | 1 |
| 2867 | tu.xs | 1 |
| 2868 | tubocurarine | 1 |
| 2869 | tubotomy | 4 |
| 2870 | tupkp | 12 |
| 2871 | tvr/pr | 3 |
| 2872 | ty-51469 | 9 |
| 2873 | tzp-amc | 4 |
| 2874 | u.o.c | 1 |
| 2875 | ubiquitin-tagged | 1 |
| 2876 | ubp1112 | 1 |
| 2877 | ucort | 2 |
| 2878 | uft/leucovorin/oxaliplatin | 1 |
| 2879 | ugt1a1*60 | 1 |
| 2880 | ukallxii/e2993 | 2 |
| 2881 | ultrafiltation | 1 |
| 2882 | un-cross-linked | 1 |
| 2883 | uncoated-stent | 1 |
| 2884 | under-anticoagulation | 1 |
| 2885 | under-cooked | 1 |
| 2886 | under-immunised | 1 |
| 2887 | under-resuscitation | 1 |
| 2888 | underemployed | 1 |
| 2889 | undertectable | 1 |
| 2890 | undressing | 1 |
| 2891 | unfulfilling | 1 |
| 2892 | unintelligent | 1 |
| 2893 | unmatched-bias | 1 |
| 2894 | unshared | 2 |
| 2895 | unspeeded-unspeeded | 1 |
| 2896 | uobc | 5 |
| 2897 | upper-income | 2 |
| 2898 | upper-income/middle-income | 1 |
| 2899 | urethropexia | 1 |
| 2900 | usual-care-treated | 2 |
| 2901 | usual-practice | 2 |
| 2902 | usualcare | 2 |
| 2903 | uv/mv | 1 |
| 2904 | uva2 | 2 |
| 2905 | uvh | 6 |
| 2906 | v160+hctz12.5 | 5 |
| 2907 | vac+dfm | 1 |
| 2908 | vac- | 3 |
| 2909 | vaccination.conclusion | 1 |
| 2910 | vace | 6 |
| 2911 | valence-judgments | 1 |
| 2912 | valsartan-hctz | 2 |
| 2913 | vancomycinceftazidime | 1 |
| 2914 | vapo-coolant | 2 |
| 2915 | vcpap | 4 |
| 2916 | vcu200 | 3 |
| 2917 | vegf-a/c | 1 |
| 2918 | venesections | 1 |
| 2919 | venlafaxine+cbt | 1 |
| 2920 | venlafaxine-extended-release | 1 |
| 2921 | verorab | 22 |
| 2922 | very-low-dose-methotrexate | 1 |
| 2923 | vgpr/pr | 1 |
| 2924 | vial-and-syringe | 6 |
| 2925 | vibration/pd | 4 |
| 2926 | vinc | 5 |
| 2927 | vincristine-mitoxantrone-dexamethasone | 1 |
| 2928 | vindesine/cisplatin | 5 |
| 2929 | vinorelbin/cisplatin | 2 |
| 2930 | vinorelbine/carboplatin | 1 |
| 2931 | vinorelbine/ifosfamide | 3 |
| 2932 | visine | 3 |
| 2933 | vistascan | 1 |
| 2934 | vivostat | 11 |
| 2935 | vocals | 3 |
| 2936 | vr-cap | 8 |
| 2937 | vurs | 1 |
| 2938 | walk* | 4 |
| 2939 | water-brash | 1 |
| 2940 | weight-management-plus-exercise | 2 |
| 2941 | weo | 7 |
| 2942 | wilcoxon-rank-sum-test | 1 |
| 2943 | wm-treated | 9 |
| 2944 | wp-crt | 9 |
| 2945 | wrist- | 1 |
| 2946 | x/x | 1 |
| 2947 | xalatan | 19 |
| 2948 | xanthen-9h-ones | 1 |
| 2949 | xeliri-bev | 7 |
| 2950 | xelox/bev | 4 |
| 2951 | xenophagy | 1 |
| 2952 | xeromammograms | 2 |
| 2953 | xeromammography | 2 |
| 2954 | xing-ren | 1 |
| 2955 | y310 | 1 |
| 2956 | y90+sorafenib | 1 |
| 2957 | yeast-se | 4 |
| 2958 | yi-jing | 1 |
| 2959 | ymca/ywca | 1 |
| 2960 | ymfl | 1 |
| 2961 | youthful/active | 2 |
| 2962 | yvoire® | 2 |
| 2963 | z+ | 1 |
| 2964 | zalcitabine/zdv | 1 |
| 2965 | zdv+ddi | 5 |
| 2966 | zdv/3tc- | 2 |
| 2967 | zdv/3tc/nfv | 2 |
| 2968 | zdv/3tc/nvp | 4 |
| 2969 | zdv/nvp | 7 |
| 2970 | zero-na | 1 |
| 2971 | zinc-ors | 5 |
| 2972 | zn-ppix | 2 |
| 2973 | znpicolinate | 1 |
| 2974 | zorubicin | 4 |
| 2975 | £10,459 | 1 |
| 2976 | £1005.91 | 1 |
| 2977 | £11,715 | 1 |
| 2978 | £117 | 1 |
| 2979 | £189.91 | 1 |
| 2980 | £251.62 | 1 |
| 2981 | £4,619 | 2 |
| 2982 | £4413 | 1 |
| 2983 | £6.62 | 1 |
| 2984 | ß-oxidation | 1 |
| 2985 | α-phenyl | 1 |
| 2986 | α-substituted-α-hydroxy-β | 1 |
| 2987 | α1,3-linkages | 1 |
| 2988 | α2→6 | 1 |
| 2989 | α4β2nachr | 1 |
| 2990 | αb-crystallins | 3 |
| 2991 | αvβ8 | 1 |
| 2992 | βarrestin1 | 1 |
| 2993 | β₄-subunits | 1 |
| 2994 | γ-csp | 1 |
| 2995 | δtnf-α | 1 |
| 2996 | λ-signs | 2 |
| 2997 | μct-80 | 1 |
| 2998 | σ-re-x | 1 |
| 2999 | ω3fa | 5 |
| 3000 | €1,316 | 1 |
| 3001 | €1.595 | 1 |
| 3002 | €109.10 | 1 |
| 3003 | €14,911 | 1 |
| 3004 | €17,643 | 1 |
| 3005 | €181 | 1 |
| 3006 | €1882 | 1 |
| 3007 | €2130.01 | 1 |
| 3008 | €2700 | 1 |
| 3009 | €3,527 | 1 |
| 3010 | €3.346 | 1 |
| 3011 | €3075 | 1 |
| 3012 | €32,657,590 | 1 |
| 3013 | €35,335 | 1 |
| 3014 | €381.34 | 1 |
| 3015 | €4527 | 1 |
| 3016 | €4801 | 1 |
| 3017 | €52,479 | 1 |
| 3018 | €5267 | 1 |
| 3019 | €595 | 1 |
| 3020 | €7908 | 1 |
| 3021 | ∆triglyceride | 1 |
| 3022 | ≤1.13 | 1 |
| 3023 | ≤3-point | 1 |
| 3024 | ≤50×10 | 1 |
| 3025 | ≥20×10 | 1 |
| 3026 | ≥37°c | 1 |
| 1 | emerg* | 1 |
| 2 | compli* | 3 |
| 3 | dysthymi* | 3 |
| 4 | desensiti* | 1 |
| 5 | absti* | 1 |
| 6 | walk* | 4 |
| 7 | counsel* | 3 |
| 8 | hyperpotass* | 1 |
| 9 | antibiot* | 4 |
| 10 | divalproex* | 1 |
| 11 | statins++ | 1 |
| 12 | pr+/her2+ | 1 |
| 13 | l-d+ | 2 |
| 14 | tg+ | 1 |
| 15 | basal+ | 5 |
| 16 | egfr+ | 2 |
| 17 | ca-125+/tvu+ | 2 |
| 18 | low+ | 3 |
| 19 | z+ | 1 |
| 20 | 1,3-di-oleoyloxy-2- | 1 |
| 21 | e2- | 3 |
| 22 | pr+/her2- | 1 |
| 23 | exendin-4- | 1 |
| 24 | 2,3,4,5-tetrahydro-2,8-dimethyl-5- | 1 |
| 25 | c5a- | 2 |
| 26 | sfa- | 3 |
| 27 | vac- | 3 |
| 28 | zdv/3tc- | 2 |
| 29 | fluordeoxyuridine- | 1 |
| 30 | theophylline- | 2 |
| 31 | mmf- | 1 |
| 32 | lng- | 3 |
| 33 | 2,5-di- | 1 |
| 34 | secundi- | 1 |
| 35 | ssri- | 5 |
| 36 | s-l- | 2 |
| 37 | paricalcitol- | 2 |
| 38 | non-platinum- | 1 |
| 39 | tlls- | 6 |
| 40 | wrist- | 1 |
| 41 | 11α- | 1 |
| 42 | nϵ- | 1 |
| 43 | 2.5. | 1 |
| 44 | flex-d. | 2 |
| 45 | per. | 2 |
| 46 | d.i.v. | 1 |
| 47 | 7mg/ | 1 |
| 48 | rimonabant/ | 1 |
| 49 | -0.6+/-0 | 1 |
| 50 | 5.06+/-0 | 1 |
| 51 | h-0 | 1 |
| 52 | 16.2±10.0 | 1 |
| 53 | =-2.0 | 2 |
| 54 | 32.75+/-3.0 | 1 |
| 55 | 613.0 | 1 |
| 56 | 64.7±14.0 | 1 |
| 57 | 205.0 | 1 |
| 58 | 110.4±25.0 | 1 |
| 59 | 27.2±5.0 | 1 |
| 60 | 65.8±27.0 | 1 |
| 61 | 654.00 | 1 |
| 62 | 1943/100,000 | 1 |
| 63 | 907/100,000 | 1 |
| 64 | q-1,000 | 8 |
| 65 | 2.2/1,000 | 1 |
| 66 | 1.8/1,000 | 1 |
| 67 | =7,000 | 2 |
| 68 | 518,000 | 1 |
| 69 | q1000 | 3 |
| 70 | 1957-2000 | 1 |
| 71 | 12/100,100 | 1 |
| 72 | 65,100 | 1 |
| 73 | gla-100 | 19 |
| 74 | bst-100 | 5 |
| 75 | 3.100 | 1 |
| 76 | 732/1100 | 1 |
| 77 | hb-200 | 6 |
| 78 | vcu200 | 3 |
| 79 | 4.500 | 1 |
| 80 | €2700 | 1 |
| 81 | 614/26,800 | 1 |
| 82 | 0.01*10 | 1 |
| 83 | 1.68-10 | 2 |
| 84 | 7.51+/-.10 | 1 |
| 85 | 0.48+/-0.10 | 1 |
| 86 | 0.49±0.10 | 1 |
| 87 | =2.10 | 1 |
| 88 | €109.10 | 1 |
| 89 | 4,340/38,110 | 1 |
| 90 | 200/110 | 1 |
| 91 | 15/110 | 2 |
| 92 | 182±110 | 1 |
| 93 | 0/210 | 2 |
| 94 | 14/210 | 1 |
| 95 | y310 | 1 |
| 96 | euro2904+/-1510 | 1 |
| 97 | +3610 | 1 |
| 98 | 379/1710 | 1 |
| 99 | r2.5/e10 | 4 |
| 100 | cnot10 | 1 |
| 101 | 17+/-10x10 | 1 |
| 102 | 23+/-4.2x10 | 1 |
| 103 | =2.75x10 | 1 |
| 104 | ≥20×10 | 1 |
| 105 | 40×10 | 2 |
| 106 | ≤50×10 | 1 |
| 107 | 60×10 | 2 |
| 108 | 3.21±1.70×10 | 1 |
| 109 | 203.52×10 | 1 |
| 110 | 15.9±6.3×10 | 1 |
| 111 | 1.05×10 | 1 |
| 112 | 4.27±1.75×10 | 1 |
| 113 | 9.1±4.7×10 | 1 |
| 114 | 3.58±1.47×10 | 1 |
| 115 | 6.9±0.9×10 | 1 |
| 116 | 0.04±2.19×10 | 1 |
| 117 | 120+/-20 | 1 |
| 118 | 78.20 | 1 |
| 119 | 2007/25,020 | 1 |
| 120 | 23/120 | 2 |
| 121 | li120 | 3 |
| 122 | 3.620 | 3 |
| 123 | -0.17±0.30 | 1 |
| 124 | 61/130 | 2 |
| 125 | 108/130 | 1 |
| 126 | 4.430 | 1 |
| 127 | 4.630 | 1 |
| 128 | ages-mf30 | 2 |
| 129 | dddr-40 | 2 |
| 130 | 2.12+/-0.40 | 1 |
| 131 | 0.13±0.40 | 1 |
| 132 | 47040 | 1 |
| 133 | 83/140 | 1 |
| 134 | 173/240 | 1 |
| 135 | 5.440 | 1 |
| 136 | =2.640 | 1 |
| 137 | oxy40 | 7 |
| 138 | bst-50 | 5 |
| 139 | 2.66±0.50 | 1 |
| 140 | 0.00322+/-0.00050 | 1 |
| 141 | 125/150 | 1 |
| 142 | 16/150 | 1 |
| 143 | i150 | 6 |
| 144 | 19/250 | 2 |
| 145 | 47/350 | 1 |
| 146 | capox50 | 3 |
| 147 | ugt1a1*60 | 1 |
| 148 | 6/60 | 21 |
| 149 | 259/7660 | 1 |
| 150 | 677/78960 | 1 |
| 151 | 5/70 | 5 |
| 152 | 48/70 | 1 |
| 153 | 20/170 | 1 |
| 154 | 103/270 | 1 |
| 155 | n70 | 1 |
| 156 | μct-80 | 1 |
| 157 | 989.80 | 1 |
| 158 | ada160/80 | 5 |
| 159 | 52/80 | 1 |
| 160 | 132/180 | 1 |
| 161 | 3/380 | 2 |
| 162 | 127/380 | 1 |
| 163 | 49/380 | 2 |
| 164 | 12.680 | 1 |
| 165 | 1.780 | 1 |
| 166 | pcv13+p80 | 1 |
| 167 | 3·80 | 1 |
| 168 | continuous=0.90 | 2 |
| 169 | -0.61±0.90 | 1 |
| 170 | €32,657,590 | 1 |
| 171 | multimin90 | 1 |
| 172 | athsp90 | 3 |
| 173 | 9·90 | 1 |
| 174 | mr=0 | 1 |
| 175 | hemosol-b0 | 7 |
| 176 | sg-t0 | 2 |
| 177 | 4.00±0 | 2 |
| 178 | 74·0 | 1 |
| 179 | 525·0 | 1 |
| 180 | na-1 | 7 |
| 181 | pash-1 | 1 |
| 182 | ngxml-1xh-1 | 2 |
| 183 | 4egi-1 | 1 |
| 184 | reovirus-1 | 1 |
| 185 | 1.05+/-0.1 | 1 |
| 186 | 56.7±10.1 | 1 |
| 187 | 411.1 | 1 |
| 188 | 1:1.1 | 1 |
| 189 | bee×1.1 | 1 |
| 190 | 30.56+/-2.1 | 1 |
| 191 | 20.59+/-2.1 | 1 |
| 192 | 9.1+/-13.1 | 1 |
| 193 | cav3.1 | 4 |
| 194 | 3.13±3.1 | 1 |
| 195 | 11.3+/-4.1 | 2 |
| 196 | 26.3+/-5.1 | 1 |
| 197 | 12.0±5.1 | 1 |
| 198 | 15.2±5.1 | 1 |
| 199 | 377.1 | 1 |
| 200 | 16.7-38.1 | 1 |
| 201 | 329.1 | 1 |
| 202 | non-icm.1 | 1 |
| 203 | €2130.01 | 1 |
| 204 | 0.004+/-0.001 | 1 |
| 205 | crs7270101 | 1 |
| 206 | 3.501 | 1 |
| 207 | sr142801 | 1 |
| 208 | €4801 | 1 |
| 209 | pxl01 | 9 |
| 210 | 68.0+/-11 | 1 |
| 211 | 0.50±0.11 | 2 |
| 212 | 0.45±0.11 | 1 |
| 213 | 0.46±0.11 | 1 |
| 214 | 5.05-6.11 | 1 |
| 215 | 5/111 | 1 |
| 216 | 0/211 | 1 |
| 217 | 176/211 | 1 |
| 218 | 18/211 | 1 |
| 219 | 30.311 | 1 |
| 220 | €14,911 | 1 |
| 221 | 9:11 | 1 |
| 222 | 39:11 | 1 |
| 223 | 149+/-21 | 1 |
| 224 | tmz-21 | 4 |
| 225 | -0.41±0.21 | 1 |
| 226 | -0.04±0.21 | 1 |
| 227 | 1.721 | 1 |
| 228 | 1737/2721 | 1 |
| 229 | r-chop21 | 8 |
| 230 | 0.03±0.31 | 1 |
| 231 | -0.03±0.31 | 1 |
| 232 | 6.47±0.31 | 1 |
| 233 | 47.46±7.31 | 1 |
| 234 | 22/41 | 1 |
| 235 | 0.354+/-0.041 | 1 |
| 236 | 0.00291+/-0.00041 | 1 |
| 237 | 27/841 | 1 |
| 238 | 0.06-0.51 | 2 |
| 239 | 31/151 | 1 |
| 240 | 42/151 | 1 |
| 241 | 118/151 | 1 |
| 242 | 1.251 | 2 |
| 243 | bav851 | 3 |
| 244 | 14951 | 1 |
| 245 | 9.9±2.61 | 1 |
| 246 | 705.61 | 1 |
| 247 | 22/61 | 1 |
| 248 | 23/61 | 1 |
| 249 | 29/61 | 1 |
| 250 | 422/18,161 | 1 |
| 251 | 9/161 | 1 |
| 252 | 29/161 | 1 |
| 253 | 4.261 | 1 |
| 254 | 6.361 | 1 |
| 255 | 529±61 | 1 |
| 256 | 2.171 | 1 |
| 257 | lassbio-1471 | 4 |
| 258 | sti571 | 6 |
| 259 | 8/81 | 1 |
| 260 | 1/181 | 3 |
| 261 | 4/181 | 1 |
| 262 | 64/181 | 1 |
| 263 | 47/181 | 1 |
| 264 | 49/181 | 1 |
| 265 | €181 | 1 |
| 266 | £1005.91 | 1 |
| 267 | £189.91 | 1 |
| 268 | 54:1 | 1 |
| 269 | 125:1 | 1 |
| 270 | 28:1 | 1 |
| 271 | cyp175a1 | 1 |
| 272 | cam3noa1 | 1 |
| 273 | pegfp-c1 | 5 |
| 274 | dgct-d1 | 1 |
| 275 | nbce1 | 1 |
| 276 | βarrestin1 | 1 |
| 277 | cs-t1 | 1 |
| 278 | 75·1 | 1 |
| 279 | apoe*2 | 1 |
| 280 | interleukine-2 | 1 |
| 281 | =cin-2 | 1 |
| 282 | 3-acyl-4-aryldihydroquinolin-2 | 1 |
| 283 | dectin-2 | 4 |
| 284 | mmn-2 | 5 |
| 285 | occlusion-2 | 1 |
| 286 | mkp-2 | 2 |
| 287 | protease-activated-receptor-2 | 1 |
| 288 | histamine-receptor-2 | 1 |
| 289 | tiv-2 | 4 |
| 290 | 420.2 | 1 |
| 291 | -930.2 | 1 |
| 292 | 2.0±0.2 | 1 |
| 293 | 0.01±0.2 | 1 |
| 294 | 0.41±0.2 | 1 |
| 295 | 42.9±11.2 | 1 |
| 296 | 11.0±1.2 | 1 |
| 297 | 0.75±1.2 | 1 |
| 298 | 2.3.2.2 | 1 |
| 299 | 7.2+/-3.2 | 1 |
| 300 | 2.8+/-3.2 | 1 |
| 301 | 1.0±3.2 | 1 |
| 302 | 57.7±3.2 | 1 |
| 303 | 61.0±14.2 | 1 |
| 304 | 724.2 | 1 |
| 305 | 17.5±5.2 | 1 |
| 306 | 13.0+/-6.2 | 1 |
| 307 | 0.3±17.2 | 1 |
| 308 | -87.2 | 1 |
| 309 | 22.2±8.2 | 1 |
| 310 | 37.4+/-9.2 | 1 |
| 311 | later.2 | 1 |
| 312 | 1.78±0.02 | 1 |
| 313 | 39/102 | 1 |
| 314 | hrp102 | 6 |
| 315 | 439/3302 | 1 |
| 316 | *01:02 | 1 |
| 317 | as02 | 14 |
| 318 | 5·02 | 1 |
| 319 | 1.46+/-0.12 | 1 |
| 320 | 0.071±0.12 | 1 |
| 321 | 0.49±0.12 | 1 |
| 322 | 2/112 | 1 |
| 323 | ubp1112 | 1 |
| 324 | 145/212 | 1 |
| 325 | k-712 | 7 |
| 326 | 11:12 | 1 |
| 327 | adas-cog12 | 3 |
| 328 | 82±12 | 1 |
| 329 | 0.23+/-0.22 | 1 |
| 330 | 1.74±0.22 | 1 |
| 331 | 113/422 | 1 |
| 332 | 350/1522 | 1 |
| 333 | 0.17-0.32 | 1 |
| 334 | chictr-trc-00000032 | 1 |
| 335 | 23/332 | 1 |
| 336 | 4.732 | 1 |
| 337 | connexin32 | 1 |
| 338 | pnd21-42 | 1 |
| 339 | 84.42 | 1 |
| 340 | 1/142 | 1 |
| 341 | 185/242 | 1 |
| 342 | 2.342 | 1 |
| 343 | 668/842 | 1 |
| 344 | pnd42 | 1 |
| 345 | -13·42 | 1 |
| 346 | 4.07±0.52 | 1 |
| 347 | 28/52 | 1 |
| 348 | 15/152 | 1 |
| 349 | 12/352 | 1 |
| 350 | 296/352 | 1 |
| 351 | 18/352 | 1 |
| 352 | 40/552 | 1 |
| 353 | £251.62 | 1 |
| 354 | t1-2=3.62 | 1 |
| 355 | £6.62 | 1 |
| 356 | 22/62 | 1 |
| 357 | 53/62 | 1 |
| 358 | 28/62 | 1 |
| 359 | 9/62 | 1 |
| 360 | 6.062 | 1 |
| 361 | 60/362 | 1 |
| 362 | 105/362 | 1 |
| 363 | 37/362 | 1 |
| 364 | 93.72 | 1 |
| 365 | -16.72 | 2 |
| 366 | 25/72 | 1 |
| 367 | 98/172 | 1 |
| 368 | 78/372 | 2 |
| 369 | 0.0772 | 1 |
| 370 | 1.33±0.82 | 1 |
| 371 | 40/82 | 1 |
| 372 | 16/82 | 1 |
| 373 | 23/1082 | 1 |
| 374 | gog-182 | 2 |
| 375 | 16/682 | 1 |
| 376 | 4/882 | 1 |
| 377 | €1882 | 1 |
| 378 | .68±.92 | 1 |
| 379 | 41/92 | 2 |
| 380 | qr/rr192 | 1 |
| 381 | 132/292 | 1 |
| 382 | 46/692 | 1 |
| 383 | 6·92 | 1 |
| 384 | atp2a2 | 2 |
| 385 | uva2 | 2 |
| 386 | aab2 | 1 |
| 387 | 11-c2 | 2 |
| 388 | dgct-d2 | 1 |
| 389 | alphacd2 | 1 |
| 390 | atfd2 | 1 |
| 391 | 17beta-e2 | 1 |
| 392 | radmhe2 | 1 |
| 393 | hie2 | 2 |
| 394 | air-cf2 | 1 |
| 395 | phe-cys-tyr-trp-orn-thr-pen-thr-nh2 | 1 |
| 396 | 1/mm2 | 1 |
| 397 | 501/mm2 | 1 |
| 398 | a/uruguay/h3n2 | 1 |
| 399 | c2bn2 | 1 |
| 400 | playstation2 | 6 |
| 401 | spco2 | 6 |
| 402 | chp2 | 2 |
| 403 | 2.5±2 | 1 |
| 404 | 6.8±2 | 1 |
| 405 | 235·2 | 1 |
| 406 | biasp1-2-3 | 6 |
| 407 | active-caspase-3 | 2 |
| 408 | obese-3 | 5 |
| 409 | it+mgn-3 | 2 |
| 410 | reflect-3 | 3 |
| 411 | lqt-3 | 1 |
| 412 | 3.3+/-0.3 | 1 |
| 413 | 3.4+/-0.3 | 1 |
| 414 | 5.4+/-0.3 | 1 |
| 415 | 6.5+/-0.3 | 1 |
| 416 | 0.6+/-0.3 | 1 |
| 417 | rns10.3 | 1 |
| 418 | 33.3±20.3 | 1 |
| 419 | pe1.3 | 3 |
| 420 | -11.4±1.3 | 1 |
| 421 | 582.3 | 1 |
| 422 | 2.0±2.3 | 1 |
| 423 | 7.3±2.3 | 1 |
| 424 | 83.9±23.3 | 1 |
| 425 | 67.5±3.3 | 1 |
| 426 | 24.9+/-4.3 | 1 |
| 427 | +106.3 | 1 |
| 428 | 2296.3 | 1 |
| 429 | -169.3 | 1 |
| 430 | later.3 | 1 |
| 431 | pph33-03 | 7 |
| 432 | 0.36+/-0.03 | 1 |
| 433 | 1.58±0.03 | 1 |
| 434 | slope=-2.03 | 1 |
| 435 | 41/103 | 2 |
| 436 | 22/103 | 2 |
| 437 | 18103 | 1 |
| 438 | -0.42+/-0.13 | 1 |
| 439 | 1.77+/-0.13 | 1 |
| 440 | 30.13 | 1 |
| 441 | 1.30±0.13 | 1 |
| 442 | -0.89±0.13 | 1 |
| 443 | ≤1.13 | 1 |
| 444 | 117.93±13.13 | 1 |
| 445 | £4413 | 1 |
| 446 | =20.23 | 1 |
| 447 | 0/123 | 1 |
| 448 | 41/123 | 1 |
| 449 | 43±23 | 1 |
| 450 | 5/233 | 1 |
| 451 | c33 | 4 |
| 452 | 112±33 | 1 |
| 453 | 13·33 | 1 |
| 454 | -0.41±0.43 | 1 |
| 455 | 19q13.43 | 1 |
| 456 | cl316243 | 1 |
| 457 | 39/343 | 1 |
| 458 | 74/3343 | 1 |
| 459 | 123/443 | 1 |
| 460 | €17,643 | 1 |
| 461 | 2.743 | 1 |
| 462 | 211/743 | 1 |
| 463 | 3292±943 | 1 |
| 464 | 1.42±0.53 | 1 |
| 465 | 56/153 | 1 |
| 466 | 86/153 | 1 |
| 467 | 146/353 | 1 |
| 468 | n=1553 | 1 |
| 469 | 117/1653 | 1 |
| 470 | 9/2953 | 1 |
| 471 | 91.63 | 1 |
| 472 | 0.89-3.63 | 1 |
| 473 | 8/63 | 1 |
| 474 | 427/463 | 1 |
| 475 | chadv63 | 1 |
| 476 | 2.23±0.73 | 1 |
| 477 | 26/73 | 4 |
| 478 | 14/173 | 1 |
| 479 | s-273 | 2 |
| 480 | 175/1873 | 1 |
| 481 | -2·73 | 2 |
| 482 | 41/83 | 1 |
| 483 | 33/83 | 1 |
| 484 | 54/83 | 1 |
| 485 | 1933/24,983 | 1 |
| 486 | 11/193 | 1 |
| 487 | 0,393 | 1 |
| 488 | 7/393 | 1 |
| 489 | =1.893 | 1 |
| 490 | ukallxii/e2993 | 2 |
| 491 | pla3 | 2 |
| 492 | 3000/mm3 | 1 |
| 493 | 6:1-om3 | 3 |
| 494 | ag2co3 | 3 |
| 495 | atsumo3 | 1 |
| 496 | pias3 | 4 |
| 497 | pt2b/pt3 | 1 |
| 498 | 9.26±3 | 1 |
| 499 | 58±3 | 1 |
| 500 | 1559,4 | 1 |
| 501 | 27.8+/-4 | 1 |
| 502 | glua1-4 | 1 |
| 503 | hbo-4 | 8 |
| 504 | 17.5±10.4 | 1 |
| 505 | 21.6±30.4 | 1 |
| 506 | 1.5±1.4 | 2 |
| 507 | 4.8±1.4 | 1 |
| 508 | 31.1±2.4 | 1 |
| 509 | 6.5±2.4 | 1 |
| 510 | 104.1+/-43.4 | 1 |
| 511 | 16.7±5.4 | 1 |
| 512 | 12.9±5.4 | 1 |
| 513 | -306.4 | 1 |
| 514 | 64.3±6.4 | 2 |
| 515 | 19.7+/-8.4 | 2 |
| 516 | 23/13/10/4 | 1 |
| 517 | tlr2/4 | 1 |
| 518 | sl-04 | 1 |
| 519 | 0.31+/-0.04 | 1 |
| 520 | 11.51±15.04 | 1 |
| 521 | 39.04 | 2 |
| 522 | 44/104 | 1 |
| 523 | 21/204 | 1 |
| 524 | 71/204 | 1 |
| 525 | 36,404 | 1 |
| 526 | 2.504 | 1 |
| 527 | 0.02+/-0.14 | 1 |
| 528 | 3.54±0.14 | 1 |
| 529 | 43/214 | 1 |
| 530 | 59/214 | 1 |
| 531 | 6,077/47,814 | 1 |
| 532 | 0.83±0.24 | 1 |
| 533 | 9.11+/-1.24 | 1 |
| 534 | -8.26±1.24 | 1 |
| 535 | 148±14.24 | 1 |
| 536 | 13/124 | 2 |
| 537 | 38/124 | 1 |
| 538 | =8.224 | 1 |
| 539 | 330/1424 | 1 |
| 540 | +6424 | 1 |
| 541 | 4.524 | 1 |
| 542 | 217/1624 | 1 |
| 543 | €381.34 | 1 |
| 544 | 10/34 | 3 |
| 545 | 12/134 | 1 |
| 546 | 18/634 | 1 |
| 547 | c34 | 1 |
| 548 | 7.84±1.44 | 1 |
| 549 | 7.84±2.44 | 1 |
| 550 | 41.33±7.44 | 1 |
| 551 | 28/144 | 1 |
| 552 | 38/144 | 1 |
| 553 | 160/5144 | 1 |
| 554 | 174/244 | 1 |
| 555 | 4.744 | 1 |
| 556 | 19/54 | 1 |
| 557 | -.054 | 1 |
| 558 | 105/154 | 1 |
| 559 | 9/154 | 1 |
| 560 | kw-4354 | 2 |
| 561 | 505/356,654 | 1 |
| 562 | 1.37-/+0.64 | 1 |
| 563 | 1.28±0.64 | 1 |
| 564 | 6/2264 | 1 |
| 565 | 4.464 | 1 |
| 566 | 7.464 | 1 |
| 567 | 1/74 | 1 |
| 568 | 3.674 | 1 |
| 569 | 1.774 | 3 |
| 570 | 62.8-84 | 1 |
| 571 | 730.84 | 1 |
| 572 | 2.12-5.84 | 1 |
| 573 | +0.94 | 2 |
| 574 | 96.04±8.94 | 1 |
| 575 | 52/194 | 1 |
| 576 | 282/1194 | 1 |
| 577 | 4.694 | 1 |
| 578 | 20/1694 | 1 |
| 579 | p94 | 1 |
| 580 | 6·94 | 1 |
| 581 | c3c4 | 1 |
| 582 | re4 | 2 |
| 583 | k2m′′cl4 | 1 |
| 584 | rem4 | 3 |
| 585 | hcn2-hcn4 | 2 |
| 586 | ags4 | 2 |
| 587 | 64±4 | 1 |
| 588 | 68,5 | 1 |
| 589 | cyclophosphomide-methotrexate-5 | 1 |
| 590 | sterofundine-g-5 | 1 |
| 591 | 0.6+/-0.5 | 1 |
| 592 | 37.8+/-10.5 | 1 |
| 593 | 1.3±0.5 | 3 |
| 594 | -1.7±0.5 | 1 |
| 595 | 9.2+/-1.5 | 1 |
| 596 | 101.7±31.5 | 1 |
| 597 | 2.1±1.5 | 1 |
| 598 | 12.8±1.5 | 1 |
| 599 | 1:12.5 | 1 |
| 600 | v160+hctz12.5 | 5 |
| 601 | 252.5 | 1 |
| 602 | 6.3±2.5 | 1 |
| 603 | 7.7±2.5 | 1 |
| 604 | 60.32+/-3.5 | 1 |
| 605 | 77.2/99.5/63.5 | 1 |
| 606 | 35.19+/-4.5 | 1 |
| 607 | 10.0±4.5 | 1 |
| 608 | 45.5±5.5 | 1 |
| 609 | 33.9+/-6.5 | 1 |
| 610 | 32.2±16.5 | 1 |
| 611 | 17.8±7.5 | 1 |
| 612 | 14.3+/-8.5 | 1 |
| 613 | 166.0+/-169.5 | 1 |
| 614 | 2.89/5 | 1 |
| 615 | 0.82+/-0.05 | 1 |
| 616 | 0.32±0.05 | 1 |
| 617 | 136.05 | 1 |
| 618 | 16/105 | 1 |
| 619 | 15/205 | 1 |
| 620 | 36/205 | 1 |
| 621 | 48.605 | 1 |
| 622 | 1.24+/-0.15 | 1 |
| 623 | 13.28+/-9.7micromol/l/13.15 | 1 |
| 624 | 160/215 | 1 |
| 625 | 382/415 | 1 |
| 626 | £11,715 | 1 |
| 627 | 3·15 | 2 |
| 628 | flu-25 | 4 |
| 629 | 4.34+/-0.25 | 1 |
| 630 | 6.18+/-0.25 | 1 |
| 631 | p≤0.0025 | 1 |
| 632 | 24/125 | 1 |
| 633 | 7/235 | 2 |
| 634 | €35,335 | 1 |
| 635 | 0.52+/-0.45 | 1 |
| 636 | 382.45 | 1 |
| 637 | 47.80±8.45 | 1 |
| 638 | 5/245 | 1 |
| 639 | 529/1245 | 1 |
| 640 | met+pio45 | 2 |
| 641 | cap45 | 3 |
| 642 | 208/255 | 1 |
| 643 | 272/355 | 1 |
| 644 | 5/455 | 1 |
| 645 | 2.955 | 1 |
| 646 | lm/mm55 | 1 |
| 647 | 5·55 | 1 |
| 648 | 39.65 | 1 |
| 649 | 113/2,465 | 1 |
| 650 | 98/765 | 2 |
| 651 | r56865 | 1 |
| 652 | d=≥65 | 1 |
| 653 | cns=9.75 | 1 |
| 654 | 2/75 | 1 |
| 655 | 126/75 | 1 |
| 656 | 1327/3075 | 1 |
| 657 | €3075 | 1 |
| 658 | 11.175 | 1 |
| 659 | 120/175 | 1 |
| 660 | 9/175 | 1 |
| 661 | 4.375 | 1 |
| 662 | =p75 | 1 |
| 663 | 21/85 | 2 |
| 664 | 8/85 | 1 |
| 665 | 4/185 | 1 |
| 666 | 34,585 | 1 |
| 667 | 37/585 | 1 |
| 668 | 1.50±0.95 | 1 |
| 669 | 152.95 | 1 |
| 670 | 10/95 | 1 |
| 671 | 7/95 | 1 |
| 672 | 31/295 | 2 |
| 673 | 3/295 | 2 |
| 674 | 37/295 | 2 |
| 675 | €1.595 | 1 |
| 676 | €595 | 1 |
| 677 | btx-b5 | 1 |
| 678 | sab5 | 2 |
| 679 | sbcl5 | 1 |
| 680 | healon5 | 6 |
| 681 | as2o5 | 7 |
| 682 | 67·5 | 1 |
| 683 | caspases-6 | 1 |
| 684 | 1.7+/-0.6 | 1 |
| 685 | 47.1±10.6 | 1 |
| 686 | 2.9-2.6 | 1 |
| 687 | 19.0±12.6 | 1 |
| 688 | 96.0±3.6 | 1 |
| 689 | 7.0±3.6 | 1 |
| 690 | 1.1±3.6 | 1 |
| 691 | 274.6 | 2 |
| 692 | 5.0±15.6 | 1 |
| 693 | 61.3+/-8.6 | 1 |
| 694 | 1348.6 | 1 |
| 695 | 11.4±19.6 | 1 |
| 696 | 2.19±0.06 | 1 |
| 697 | 26/106 | 1 |
| 698 | 634/22,206 | 1 |
| 699 | 95/306 | 1 |
| 700 | ro-3306 | 1 |
| 701 | 89/706 | 1 |
| 702 | 3.22±0.16 | 1 |
| 703 | 0.03±0.16 | 1 |
| 704 | 0.59±0.16 | 1 |
| 705 | 1.99-1.16 | 1 |
| 706 | 0.76±1.16 | 1 |
| 707 | 83/216 | 1 |
| 708 | €1,316 | 1 |
| 709 | 9:16 | 1 |
| 710 | med16 | 1 |
| 711 | 45±16 | 1 |
| 712 | -0.08±0.26 | 2 |
| 713 | 0.79±0.26 | 1 |
| 714 | 12.026 | 1 |
| 715 | 21/226 | 1 |
| 716 | 87/226 | 1 |
| 717 | 362/526 | 1 |
| 718 | =1.626 | 1 |
| 719 | 78/826 | 1 |
| 720 | 108+/-36 | 1 |
| 721 | 4.4+/-0.36 | 1 |
| 722 | 11/136 | 1 |
| 723 | 4.336 | 1 |
| 724 | 42:36 | 1 |
| 725 | 13.4±0.46 | 1 |
| 726 | 3.90±1.46 | 1 |
| 727 | 356/3146 | 1 |
| 728 | €3.346 | 1 |
| 729 | 767/3346 | 1 |
| 730 | 0·346 | 1 |
| 731 | 847/1546 | 1 |
| 732 | 92/20,746 | 1 |
| 733 | 8·46 | 1 |
| 734 | 4.33±6.56 | 1 |
| 735 | 98/156 | 1 |
| 736 | 0·256 | 1 |
| 737 | 16.356 | 1 |
| 738 | 325/356 | 1 |
| 739 | asn656/asn656 | 1 |
| 740 | 72/756 | 1 |
| 741 | 79/756 | 1 |
| 742 | 65/166 | 1 |
| 743 | 7/166 | 1 |
| 744 | 4.70+/-0.76 | 1 |
| 745 | 1/76 | 1 |
| 746 | 17/176 | 2 |
| 747 | 409/2176 | 2 |
| 748 | 120/576 | 1 |
| 749 | 458/576 | 1 |
| 750 | 0/86 | 1 |
| 751 | 1/86 | 1 |
| 752 | 86/86 | 2 |
| 753 | 28/86 | 1 |
| 754 | 98/186 | 1 |
| 755 | 2.286 | 1 |
| 756 | 63/286 | 1 |
| 757 | sb415286 | 6 |
| 758 | 23.87±11.96 | 1 |
| 759 | 3.59-12.96 | 1 |
| 760 | 28.97+/-4.96 | 2 |
| 761 | 95/96 | 1 |
| 762 | 47/296 | 2 |
| 763 | 207/496 | 1 |
| 764 | 119/496 | 1 |
| 765 | h596 | 1 |
| 766 | 8696 | 2 |
| 767 | sirt+mfolfox6 | 1 |
| 768 | α2→6 | 1 |
| 769 | c6-7 | 2 |
| 770 | mean=-0.7 | 1 |
| 771 | 76.6±10.7 | 1 |
| 772 | 31.22+/-1.7 | 1 |
| 773 | 201.7 | 1 |
| 774 | 1.3±1.7 | 1 |
| 775 | -20.3+/-12.7 | 1 |
| 776 | 5.9±2.7 | 1 |
| 777 | 26.9+/-3.7 | 1 |
| 778 | 70.8±33.7 | 1 |
| 779 | -134.7 | 1 |
| 780 | 53.1±4.7 | 1 |
| 781 | 24.1±4.7 | 1 |
| 782 | 57±4.7 | 1 |
| 783 | 28.7+/-5.7 | 1 |
| 784 | -4.9+/-5.7 | 1 |
| 785 | 1625.7 | 1 |
| 786 | 18.4±7.7 | 1 |
| 787 | -0.02+/-0.07 | 1 |
| 788 | 0.73+/-0.07 | 1 |
| 789 | 4.25±0.07 | 1 |
| 790 | 14/107 | 1 |
| 791 | 275/307 | 1 |
| 792 | 2.507 | 2 |
| 793 | 1/4707 | 1 |
| 794 | 69.5-17 | 1 |
| 795 | 4.25+/-0.17 | 1 |
| 796 | 1.55±0.17 | 1 |
| 797 | 69/117 | 1 |
| 798 | £117 | 1 |
| 799 | 86/617 | 1 |
| 800 | krt17 | 1 |
| 801 | 6.24-70.27 | 1 |
| 802 | 0.71±0.27 | 1 |
| 803 | 2.52-5.27 | 1 |
| 804 | €3,527 | 1 |
| 805 | €4527 | 1 |
| 806 | 3.727 | 1 |
| 807 | 1.17±0.37 | 1 |
| 808 | 37.37 | 2 |
| 809 | 61/37 | 1 |
| 810 | 90/137 | 1 |
| 811 | 3/137 | 1 |
| 812 | tt,1.637 | 1 |
| 813 | lz37 | 1 |
| 814 | 149+/-47 | 1 |
| 815 | 20/47 | 1 |
| 816 | 12/47 | 1 |
| 817 | 119/147 | 1 |
| 818 | +247 | 2 |
| 819 | 17/347 | 1 |
| 820 | 2.0847 | 1 |
| 821 | 13.0±0.57 | 1 |
| 822 | 2,665.57 | 1 |
| 823 | 53/157 | 1 |
| 824 | 8/157 | 1 |
| 825 | 206/257 | 2 |
| 826 | 86/857 | 1 |
| 827 | 1.00+/-0.67 | 2 |
| 828 | 4.9+/-1.67 | 1 |
| 829 | 38,267 | 1 |
| 830 | €5267 | 1 |
| 831 | 62/867 | 1 |
| 832 | 18/867 | 1 |
| 833 | 31/77 | 2 |
| 834 | 305/377 | 1 |
| 835 | 60/477 | 1 |
| 836 | 293/2777 | 1 |
| 837 | na77 | 5 |
| 838 | 284±77 | 1 |
| 839 | 46/87 | 1 |
| 840 | 107/687 | 1 |
| 841 | 5.03+/-1.97 | 1 |
| 842 | 20/197 | 1 |
| 843 | 47/297 | 2 |
| 844 | 91/397 | 1 |
| 845 | 92/397 | 1 |
| 846 | 416/497 | 1 |
| 847 | 249/597 | 1 |
| 848 | 2.797 | 1 |
| 849 | 9×7 | 1 |
| 850 | t7-8 | 1 |
| 851 | 2.4+0.8 | 1 |
| 852 | 2.27+/-0.8 | 1 |
| 853 | 10.8+/-0.8 | 1 |
| 854 | 69.0±10.8 | 1 |
| 855 | 19.21+/-2.8 | 1 |
| 856 | 68.18+/-2.8 | 1 |
| 857 | +10.2±12.8 | 1 |
| 858 | 34.5±2.8 | 1 |
| 859 | 12+/-3.8 | 1 |
| 860 | 67.7±13.8 | 1 |
| 861 | 13.2±3.8 | 1 |
| 862 | 16.8±3.8 | 1 |
| 863 | 7.7+/-4.8 | 1 |
| 864 | 11.0+/-5.8 | 1 |
| 865 | 455.8 | 1 |
| 866 | 2.4-6.8 | 1 |
| 867 | 28.0+/-7.8 | 1 |
| 868 | 18.1+/-7.8 | 1 |
| 869 | 17.0±7.8 | 1 |
| 870 | 400.8±579.8 | 1 |
| 871 | 46.6±9.8 | 1 |
| 872 | -7/8 | 1 |
| 873 | 1.67+/-0.08 | 1 |
| 874 | 0.10±1.08 | 1 |
| 875 | 8.95±2.08 | 1 |
| 876 | 0.039+/-0.008 | 1 |
| 877 | 79/108 | 1 |
| 878 | 5/208 | 1 |
| 879 | 127/208 | 1 |
| 880 | 9/208 | 1 |
| 881 | 256/308 | 1 |
| 882 | bav308 | 2 |
| 883 | €7908 | 1 |
| 884 | 64+/-18 | 1 |
| 885 | oncoprotein-18 | 1 |
| 886 | 1.01+/-0.18 | 1 |
| 887 | 6.25+/-0.18 | 1 |
| 888 | 0.28±0.18 | 1 |
| 889 | 39.4+/-12.18 | 1 |
| 890 | 41/118 | 1 |
| 891 | 31/1118 | 2 |
| 892 | 146/1118 | 2 |
| 893 | 37/218 | 1 |
| 894 | pfp×c18 | 1 |
| 895 | 1.20-1.28 | 1 |
| 896 | 211.41+/-71.28 | 1 |
| 897 | -8.20±1.28 | 1 |
| 898 | 447/628 | 1 |
| 899 | 106.38 | 1 |
| 900 | 12,138 | 1 |
| 901 | 51/338 | 1 |
| 902 | 76/338 | 1 |
| 903 | 3.638 | 1 |
| 904 | 23·38 | 2 |
| 905 | 9/148 | 1 |
| 906 | 1943/25,348 | 1 |
| 907 | 43/1648 | 1 |
| 908 | 57/848 | 1 |
| 909 | 1151/1848 | 1 |
| 910 | 10/358 | 2 |
| 911 | 24/358 | 1 |
| 912 | 67/358 | 2 |
| 913 | l-685,458 | 1 |
| 914 | 1.958 | 1 |
| 915 | 8.068 | 1 |
| 916 | 185/7668 | 1 |
| 917 | 617.88 | 1 |
| 918 | 3.388 | 1 |
| 919 | 1.888 | 2 |
| 920 | 51.44±18.98 | 1 |
| 921 | 5/98 | 1 |
| 922 | 154/398 | 1 |
| 923 | αvβ8 | 1 |
| 924 | 18:2δ4,9 | 1 |
| 925 | 6.4+/-0.9 | 1 |
| 926 | 1.8min+/-0.9 | 1 |
| 927 | 2.0±0.9 | 1 |
| 928 | 3.4±0.9 | 2 |
| 929 | 1.27±0.9 | 1 |
| 930 | 4.6±1.9 | 1 |
| 931 | 3.8±1.9 | 2 |
| 932 | 3.0±2.9 | 1 |
| 933 | +9.3±13.9 | 1 |
| 934 | 3.3±3.9 | 1 |
| 935 | 95.0+/-4.9 | 1 |
| 936 | 92.5±15.9 | 1 |
| 937 | 1065.9 | 1 |
| 938 | 61.4+/-16.9 | 1 |
| 939 | 136.9±16.9 | 1 |
| 940 | 115.7±59.9 | 1 |
| 941 | 0.19+/-0.09 | 1 |
| 942 | -0.84±0.09 | 1 |
| 943 | 0.57±0.09 | 1 |
| 944 | -0.99±0.09 | 1 |
| 945 | a/hk/415742/09 | 1 |
| 946 | 29/109 | 1 |
| 947 | euro1729+/-1209 | 1 |
| 948 | 166/309 | 1 |
| 949 | 14.409 | 1 |
| 950 | 64+/-19 | 1 |
| 951 | rmsp1-19 | 1 |
| 952 | -0.23±0.19 | 1 |
| 953 | 2.05±1.19 | 1 |
| 954 | 266.19 | 1 |
| 955 | 0/119 | 1 |
| 956 | 47/1119 | 1 |
| 957 | 44/319 | 1 |
| 958 | £4,619 | 2 |
| 959 | +0.02±0.29 | 1 |
| 960 | 30/29 | 1 |
| 961 | 5/129 | 1 |
| 962 | 386/429 | 1 |
| 963 | 761/134529 | 1 |
| 964 | 204/729 | 1 |
| 965 | 5.75±1.39 | 1 |
| 966 | 116.39 | 1 |
| 967 | 400/1039 | 1 |
| 968 | 5.139 | 1 |
| 969 | 5/239 | 1 |
| 970 | 354/1239 | 1 |
| 971 | 7,739 | 2 |
| 972 | gp39 | 1 |
| 973 | 2/49 | 2 |
| 974 | 8/149 | 1 |
| 975 | 1/349 | 1 |
| 976 | 13/349 | 1 |
| 977 | 186/649 | 1 |
| 978 | 1.749 | 1 |
| 979 | 52/59 | 1 |
| 980 | 0/259 | 1 |
| 981 | 1/259 | 1 |
| 982 | 164/259 | 1 |
| 983 | £10,459 | 1 |
| 984 | -0.12±0.69 | 1 |
| 985 | 4.169 | 1 |
| 986 | 31/169 | 1 |
| 987 | 61/169 | 1 |
| 988 | 311/3169 | 1 |
| 989 | 3/15,369 | 1 |
| 990 | ty-51469 | 9 |
| 991 | mean=0.79 | 1 |
| 992 | 4.179 | 1 |
| 993 | 14/179 | 1 |
| 994 | 34/179 | 1 |
| 995 | 17/179 | 1 |
| 996 | s1179 | 1 |
| 997 | 703±179 | 1 |
| 998 | 45/279 | 1 |
| 999 | 9/279 | 1 |
| 1000 | 2.379 | 1 |
| 1001 | €52,479 | 1 |
| 1002 | 1/579 | 1 |
| 1003 | =0.879 | 1 |
| 1004 | 2.48±3.89 | 1 |
| 1005 | -1.589 | 1 |
| 1006 | 3.92-20.99 | 1 |
| 1007 | 4/99 | 1 |
| 1008 | 77/99 | 1 |
| 1009 | 68/99 | 1 |
| 1010 | abt-199 | 1 |
| 1011 | 459/2399 | 1 |
| 1012 | 264/599 | 1 |
| 1013 | exon9 | 1 |
| 1014 | 44±9 | 1 |
| 1015 | b-a-a | 1 |
| 1016 | aclacinomycin-a | 1 |
| 1017 | s/s+a/a | 1 |
| 1018 | la/la+g/a | 1 |
| 1019 | galnac-gd1a | 4 |
| 1020 | t4a | 3 |
| 1021 | t97a | 1 |
| 1022 | a358a | 1 |
| 1023 | dha+aa | 5 |
| 1024 | standard-aa | 3 |
| 1025 | acaa | 1 |
| 1026 | am+cba | 3 |
| 1027 | emd/dfdba | 8 |
| 1028 | super-eba | 2 |
| 1029 | rba/pba | 5 |
| 1030 | rbca | 1 |
| 1031 | lumbosciatica | 2 |
| 1032 | onca | 2 |
| 1033 | 'pca | 1 |
| 1034 | hi-asca | 1 |
| 1035 | 1193±263nmolesca | 1 |
| 1036 | juca | 2 |
| 1037 | ymca/ywca | 1 |
| 1038 | pinda | 3 |
| 1039 | pseudo-ea | 8 |
| 1040 | bifonazole-urea | 6 |
| 1041 | irinotecan/fu/fa | 2 |
| 1042 | ω3fa | 5 |
| 1043 | non-tcfa | 3 |
| 1044 | er/rfa | 6 |
| 1045 | tsga | 5 |
| 1046 | diclofenac/ha | 4 |
| 1047 | il-1beta/tnf-alpha | 5 |
| 1048 | acarophobia | 1 |
| 1049 | -tachycardia | 1 |
| 1050 | neochlamydia | 1 |
| 1051 | dgia | 6 |
| 1052 | methrorraghia | 2 |
| 1053 | asystolia | 2 |
| 1054 | hypoalbuninaemia | 1 |
| 1055 | preleukemia | 1 |
| 1056 | nonanemia | 2 |
| 1057 | neostomia | 2 |
| 1058 | rt-hyperthermia | 1 |
| 1059 | dysorgasmia | 1 |
| 1060 | arrthymia | 2 |
| 1061 | manic/mania | 1 |
| 1062 | 13n-ammonia | 3 |
| 1063 | pseudallescheria | 1 |
| 1064 | isosthenuria | 2 |
| 1065 | pseudohematuria | 1 |
| 1066 | diskinesia | 1 |
| 1067 | htia | 1 |
| 1068 | detrusorhyperreflexia | 1 |
| 1069 | urethropexia | 1 |
| 1070 | lmwh/vka | 7 |
| 1071 | enoxaparin/vka | 11 |
| 1072 | tbt/la | 1 |
| 1073 | cobra-pla | 1 |
| 1074 | ctla | 9 |
| 1075 | lympho-lipedema | 1 |
| 1076 | angiodema | 1 |
| 1077 | hyposphagma | 1 |
| 1078 | iggma | 6 |
| 1079 | semicoma | 1 |
| 1080 | non-adenocarcinoma | 10 |
| 1081 | cystadenofibroma | 2 |
| 1082 | zero-na | 1 |
| 1083 | high-cfdna | 1 |
| 1084 | cftdna | 6 |
| 1085 | hctz/bena | 1 |
| 1086 | ozena | 1 |
| 1087 | s-tna | 2 |
| 1088 | low-pa/high-oa | 2 |
| 1089 | cee-mpa | 2 |
| 1090 | clonidine/methyldopa | 2 |
| 1091 | saline±r-tpa | 1 |
| 1092 | dnr/ara | 6 |
| 1093 | kangulamira | 1 |
| 1094 | anthracycline+atra | 1 |
| 1095 | hydrocolpometra | 1 |
| 1096 | flu/itra | 8 |
| 1097 | ia-sa | 4 |
| 1098 | non-asa | 3 |
| 1099 | no-asa | 7 |
| 1100 | s-asa | 4 |
| 1101 | sham-bsa | 4 |
| 1102 | srl+csa | 6 |
| 1103 | cyclophosphamide/csa | 1 |
| 1104 | nudsa | 8 |
| 1105 | training-esa | 1 |
| 1106 | meso-h4dmsa | 1 |
| 1107 | hmpsa | 3 |
| 1108 | mact+ta | 1 |
| 1109 | non-ta | 8 |
| 1110 | ki/edta | 1 |
| 1111 | n-ifn-beta | 1 |
| 1112 | radiation.mcnu.interferon-beta | 1 |
| 1113 | 19beta | 1 |
| 1114 | dobrava | 1 |
| 1115 | akiva | 1 |
| 1116 | aqiva | 1 |
| 1117 | ariva | 3 |
| 1118 | bonviva | 4 |
| 1119 | infanrix-hexa | 7 |
| 1120 | mtx+placebo-cya | 1 |
| 1121 | cyc/aza | 8 |
| 1122 | 6mp/aza | 2 |
| 1123 | g+b | 6 |
| 1124 | et-b | 9 |
| 1125 | aci.fhh-rf1b | 1 |
| 1126 | peginterferon-alpha-2b | 2 |
| 1127 | peg-infα-2b | 3 |
| 1128 | as02b | 6 |
| 1129 | imatinib+peg-ifn-α2b | 1 |
| 1130 | agn43b | 1 |
| 1131 | ivig+rituximab | 5 |
| 1132 | methotrexate+placebo-adalimumab | 1 |
| 1133 | placebo/adalimumab | 3 |
| 1134 | mfolfox6/bevacizumab | 3 |
| 1135 | pemetrexed/bevacizumab | 4 |
| 1136 | ifn/bevacizumab | 5 |
| 1137 | pemetrexed/carboplatin/bevacizumab | 2 |
| 1138 | cbevacizumab | 1 |
| 1139 | verorab | 22 |
| 1140 | trail/ccb | 1 |
| 1141 | tritanrix™-hbv/hib | 3 |
| 1142 | y90+sorafenib | 1 |
| 1143 | carboplatin/paclitaxel/sorafenib | 1 |
| 1144 | capecitabine-lapatinib | 1 |
| 1145 | pemetrexed+erlotinib | 7 |
| 1146 | non-vestib | 3 |
| 1147 | parecoxib/valdecoxib | 8 |
| 1148 | cisplatin/firocoxib | 2 |
| 1149 | maa-alb | 2 |
| 1150 | d-fish-pb | 5 |
| 1151 | iv-pb | 5 |
| 1152 | no-acei/arb | 2 |
| 1153 | sisb | 10 |
| 1154 | lrsb | 9 |
| 1155 | ren2-eta/etb | 1 |
| 1156 | pvax1-ori-g-ltb | 2 |
| 1157 | probable/possible-ptb | 1 |
| 1158 | pss-c | 2 |
| 1159 | u.o.c | 1 |
| 1160 | vegf-a/c | 1 |
| 1161 | sb-p/c | 17 |
| 1162 | merck-20c | 9 |
| 1163 | antagonists+clonidine+1c | 1 |
| 1164 | hna-1b/-1c | 1 |
| 1165 | cpv-2c | 4 |
| 1166 | pet28b-tvcp3c | 1 |
| 1167 | 38.5c | 2 |
| 1168 | poly/bac | 14 |
| 1169 | obac | 4 |
| 1170 | post-nac | 5 |
| 1171 | placebo/washout/nac | 1 |
| 1172 | bellovac | 5 |
| 1173 | carbcountabc | 6 |
| 1174 | uobc | 5 |
| 1175 | jev-gcc | 4 |
| 1176 | lactose/mcc | 1 |
| 1177 | pd-apcc | 7 |
| 1178 | non-dc | 2 |
| 1179 | badc | 1 |
| 1180 | azt+ddc | 2 |
| 1181 | ddp-pdc | 1 |
| 1182 | tr-fec | 7 |
| 1183 | t-fec | 9 |
| 1184 | flortec | 9 |
| 1185 | fc+/fc | 1 |
| 1186 | arsenite-specific | 1 |
| 1187 | deontologic | 1 |
| 1188 | infra-systolic | 1 |
| 1189 | latina/hispanic | 1 |
| 1190 | osteopaenic | 1 |
| 1191 | anechogenic | 1 |
| 1192 | photoallergenic | 1 |
| 1193 | diatoric | 3 |
| 1194 | femoral/sciatic | 1 |
| 1195 | aplanatic | 1 |
| 1196 | pla+dtic | 1 |
| 1197 | placebo/dtic | 1 |
| 1198 | poly-phyletic | 1 |
| 1199 | paraparetic | 1 |
| 1200 | tetraparetic | 1 |
| 1201 | heretic | 1 |
| 1202 | dysplastic/neoplastic | 1 |
| 1203 | con-lc | 4 |
| 1204 | 4plc | 40 |
| 1205 | tzp-amc | 4 |
| 1206 | pip/taz-amc | 6 |
| 1207 | vinc | 5 |
| 1208 | neurobloc/myobloc | 1 |
| 1209 | evolocumab+soc | 4 |
| 1210 | sb-pc | 13 |
| 1211 | 1dpc | 1 |
| 1212 | non-ripc | 2 |
| 1213 | espc | 1 |
| 1214 | multi-rc | 8 |
| 1215 | tcp+ca+orc | 2 |
| 1216 | -sc | 1 |
| 1217 | pbo-sc | 10 |
| 1218 | rasc | 3 |
| 1219 | ge-dsc | 2 |
| 1220 | tetravisc | 1 |
| 1221 | azt/3tc | 8 |
| 1222 | lpv/r+tdf/ftc | 6 |
| 1223 | 3-ab+suc | 1 |
| 1224 | placebo-uvc | 2 |
| 1225 | pq1wc | 1 |
| 1226 | 310-320°c | 1 |
| 1227 | 35/30°c | 2 |
| 1228 | 62.2°c | 1 |
| 1229 | 0.31±0.12°c | 1 |
| 1230 | -32°c | 1 |
| 1231 | 37.7±0.4°c | 1 |
| 1232 | 35.4°c | 1 |
| 1233 | 0.35±0.14°c | 1 |
| 1234 | 255°c | 1 |
| 1235 | 29.6°c | 3 |
| 1236 | 40.06°c | 1 |
| 1237 | 5.27°c | 1 |
| 1238 | 3.37°c | 1 |
| 1239 | ≥37°c | 1 |
| 1240 | 32.9°c | 1 |
| 1241 | 37-39°c | 1 |
| 1242 | menacwy-d | 15 |
| 1243 | 8/d | 1 |
| 1244 | 50/25-mg/d | 1 |
| 1245 | 57.7+/-0.8l/d | 1 |
| 1246 | 9l/d | 1 |
| 1247 | imagevis3d | 1 |
| 1248 | diffuse-cad | 6 |
| 1249 | dndd | 1 |
| 1250 | nurse-qodd | 1 |
| 1251 | coach-prescribed | 1 |
| 1252 | filter-leukoreduced | 1 |
| 1253 | unspeeded-unspeeded | 1 |
| 1254 | bt-cottonseed | 1 |
| 1255 | bezafibrate-fed | 2 |
| 1256 | oats-fed | 1 |
| 1257 | clinic-managed | 3 |
| 1258 | ubiquitin-tagged | 1 |
| 1259 | not-coached | 2 |
| 1260 | olive-oil-enriched | 1 |
| 1261 | 1-branched | 3 |
| 1262 | 3-branched | 5 |
| 1263 | newly-launched | 1 |
| 1264 | non-age-matched | 1 |
| 1265 | nonemulsified | 1 |
| 1266 | antioxidant-fortified | 1 |
| 1267 | non-packed | 2 |
| 1268 | un-cross-linked | 1 |
| 1269 | under-cooked | 1 |
| 1270 | external/controlled | 1 |
| 1271 | placebo-primed | 1 |
| 1272 | adults.well-designed | 1 |
| 1273 | manufacturer-designed | 1 |
| 1274 | nonhaptics-trained | 1 |
| 1275 | down-conditioned | 1 |
| 1276 | tattoed | 1 |
| 1277 | dishcloth-gourd-shaped | 1 |
| 1278 | especially-developed | 1 |
| 1279 | unshared | 2 |
| 1280 | intramuscularly-administered | 1 |
| 1281 | flesh-colored | 1 |
| 1282 | self-centred | 1 |
| 1283 | injected-cured | 1 |
| 1284 | quantitative-measured | 1 |
| 1285 | non-ruptured | 1 |
| 1286 | sucrose-based | 1 |
| 1287 | dynamised | 1 |
| 1288 | under-immunised | 1 |
| 1289 | auto-polymerised | 1 |
| 1290 | sham-anaesthetised | 1 |
| 1291 | low-suppressed | 1 |
| 1292 | self-used | 1 |
| 1293 | loperamide-treated | 1 |
| 1294 | nonenzyme-treated | 1 |
| 1295 | usual-care-treated | 2 |
| 1296 | cm-treated | 2 |
| 1297 | wm-treated | 9 |
| 1298 | rifampin-treated | 2 |
| 1299 | rcht-treated | 1 |
| 1300 | not-treated | 3 |
| 1301 | breed-associated | 1 |
| 1302 | musculoskeletal-related | 1 |
| 1303 | non-dialysis-related | 1 |
| 1304 | sheet-like/lamellated | 1 |
| 1305 | nd-vaccinated | 2 |
| 1306 | circoflex-vaccinated | 2 |
| 1307 | nonhydrated | 3 |
| 1308 | non-titrated | 3 |
| 1309 | t-depleted | 1 |
| 1310 | spk-transplanted | 1 |
| 1311 | l-carnitine-supplemented | 1 |
| 1312 | non-documented | 1 |
| 1313 | snorted | 1 |
| 1314 | poorly-reported | 1 |
| 1315 | bevacizumab-pemetrexed | 7 |
| 1316 | doxorubicin-pemetrexed | 1 |
| 1317 | doxorubicin/pemetrexed | 1 |
| 1318 | alcohol-fixed | 1 |
| 1319 | non-mixed | 3 |
| 1320 | underemployed | 1 |
| 1321 | body-optimized | 6 |
| 1322 | pbs-immunized | 3 |
| 1323 | segd | 15 |
| 1324 | dm+chd | 1 |
| 1325 | ns-nsaid | 1 |
| 1326 | ethoglucid | 7 |
| 1327 | sulfaclomid | 2 |
| 1328 | sevoflurane-opioid | 1 |
| 1329 | sevoflurane/opioid | 3 |
| 1330 | lmw-heparinoid | 2 |
| 1331 | no-steroid | 9 |
| 1332 | tiaprid | 1 |
| 1333 | 6.34-fold | 1 |
| 1334 | 5.87-fold | 1 |
| 1335 | 17.1fold | 1 |
| 1336 | non-household | 3 |
| 1337 | pathological-and | 1 |
| 1338 | ligand-to-ligand | 1 |
| 1339 | halland | 1 |
| 1340 | n-acetyl-β-end | 1 |
| 1341 | re-offend | 3 |
| 1342 | rarc/plnd | 1 |
| 1343 | -0.51/second | 1 |
| 1344 | gill-over-the-ground | 1 |
| 1345 | sham-ultrasound | 7 |
| 1346 | o-blood | 1 |
| 1347 | st-pd | 4 |
| 1348 | vibration/pd | 4 |
| 1349 | no-bpd | 5 |
| 1350 | hvpd | 5 |
| 1351 | mfg-standard | 3 |
| 1352 | angioguard | 9 |
| 1353 | last-observations-carried-forward | 1 |
| 1354 | iiv3-sd | 5 |
| 1355 | slvsd | 4 |
| 1356 | bortezomib-td | 1 |
| 1357 | non-mtd | 1 |
| 1358 | ctl-std | 1 |
| 1359 | copper-iud | 1 |
| 1360 | adaptive-avd | 1 |
| 1361 | l-avd | 4 |
| 1362 | non-mvd | 2 |
| 1363 | non-rvd | 1 |
| 1364 | ns+e | 4 |
| 1365 | lac2e | 3 |
| 1366 | multi-gravidae | 1 |
| 1367 | statin+ezetimibe | 1 |
| 1368 | placebo/ezetimibe | 2 |
| 1369 | ctbe | 4 |
| 1370 | thermotube | 1 |
| 1371 | colace | 2 |
| 1372 | immunace | 3 |
| 1373 | -lbp/+brace | 2 |
| 1374 | head-brace | 1 |
| 1375 | no-brace | 12 |
| 1376 | soft-brace | 3 |
| 1377 | vace | 6 |
| 1378 | usual-practice | 2 |
| 1379 | moderate-resistance-high-endurance | 1 |
| 1380 | aerobic+resistance | 1 |
| 1381 | clomifene-resistance | 1 |
| 1382 | fluoroquinolone-resistance | 1 |
| 1383 | high-cadence | 1 |
| 1384 | corticodependence | 1 |
| 1385 | anti-science | 1 |
| 1386 | boswagade | 1 |
| 1387 | european-made | 1 |
| 1388 | lc-lcbde | 5 |
| 1389 | vinorelbine/ifosfamide | 3 |
| 1390 | cisplatin/paclitaxel/ifosfamide | 1 |
| 1391 | rituximab-cyclophosphamide | 1 |
| 1392 | fluorouracil/doxorubicin/cyclophosphamide | 3 |
| 1393 | 4-hydroperoxycyclophosphamide | 2 |
| 1394 | timolol/dorzolamide | 3 |
| 1395 | tnfα/cycloheximide | 1 |
| 1396 | melphalan/dexamethasone/thalidomide | 1 |
| 1397 | ∆triglyceride | 1 |
| 1398 | levosulpiride | 5 |
| 1399 | tresosulfan+/-etoposide | 1 |
| 1400 | topotecan-etoposide | 1 |
| 1401 | p-nitrophenyl-α-d-galactoside | 1 |
| 1402 | placebo-teriparatide | 10 |
| 1403 | midodrine-octreotide | 3 |
| 1404 | nosiheptide | 6 |
| 1405 | trichlormethiazide | 19 |
| 1406 | amlodipine/hydrochlorothiazide | 5 |
| 1407 | atenolol/hydrochlorothiazide | 2 |
| 1408 | nebivolol/hydrochlorothiazide | 1 |
| 1409 | hydrocholorothiazide | 1 |
| 1410 | l-dopa/benserazide | 1 |
| 1411 | glipizide | 210 |
| 1412 | co-amilozide | 12 |
| 1413 | a-code | 1 |
| 1414 | non-ee | 1 |
| 1415 | 80-age | 1 |
| 1416 | -hemorrhage | 1 |
| 1417 | alpha2,6-linkage | 1 |
| 1418 | arbitrage | 1 |
| 1419 | baby-massage | 3 |
| 1420 | vial-and-syringe | 6 |
| 1421 | cyp2j6-like | 2 |
| 1422 | herb-like | 1 |
| 1423 | pressurelike | 1 |
| 1424 | toe-strike | 1 |
| 1425 | 117.05±12.74le | 1 |
| 1426 | extreme/unable | 2 |
| 1427 | undertectable | 1 |
| 1428 | derivable | 1 |
| 1429 | maxilla/mandible | 1 |
| 1430 | doca-vehicle | 3 |
| 1431 | drug-vehicle | 1 |
| 1432 | placebo/vehicle | 5 |
| 1433 | gantaile | 3 |
| 1434 | cefacetrile | 1 |
| 1435 | cephamandole | 9 |
| 1436 | six-hole | 1 |
| 1437 | 1-butylimidazole | 1 |
| 1438 | cefazolin/metronidazole | 1 |
| 1439 | 2,1,3-benzoselenadiazole | 1 |
| 1440 | 5'-hydroxyomeprazole | 1 |
| 1441 | cotrimexazole | 2 |
| 1442 | trimethoprim-sulfameth-oxazole | 1 |
| 1443 | trimethoprime-sulfamethoxazole | 1 |
| 1444 | trimethoprimsulfamethoxazole | 11 |
| 1445 | letrezole | 2 |
| 1446 | ceftezole | 3 |
| 1447 | sabeluzole | 5 |
| 1448 | conventional-schedule | 1 |
| 1449 | placebo+lifestyle | 1 |
| 1450 | no-hme | 2 |
| 1451 | vancomycinceftazidime | 1 |
| 1452 | atropine-plus-pralidoxime | 1 |
| 1453 | upper-income/middle-income | 1 |
| 1454 | upper-income | 2 |
| 1455 | philadelphia-chromosome | 2 |
| 1456 | 2-furyldiazomethane | 1 |
| 1457 | biteplane | 1 |
| 1458 | 1,2-dioleoyl-3-trimethylammonium-propane | 1 |
| 1459 | dexmedetomidine-sevoflurane | 1 |
| 1460 | sevoflurane | 5 |
| 1461 | trans-3,4',5-trihydroxystilbene | 1 |
| 1462 | 2-furylcarbene | 1 |
| 1463 | 1,2-dihydroanthracene | 1 |
| 1464 | climiphene | 1 |
| 1465 | polytetrafluoroethelene | 1 |
| 1466 | 1-methylsilene | 1 |
| 1467 | dcu/gangrene | 1 |
| 1468 | mexilitene | 1 |
| 1469 | bap+β-carotene | 3 |
| 1470 | 13'-cis-β-carotene | 1 |
| 1471 | 9'-cis-β-carotene | 1 |
| 1472 | i-butene | 1 |
| 1473 | 4-nitrotoluene | 1 |
| 1474 | prosigne | 7 |
| 1475 | levobopivacaine | 1 |
| 1476 | dicaine | 6 |
| 1477 | daunorubicin/clofarabine | 1 |
| 1478 | bevacizumab-capecitabine | 1 |
| 1479 | trastuzumab-capecitabine | 8 |
| 1480 | lapatinib-capecitabine | 11 |
| 1481 | irinotecan/capecitabine | 1 |
| 1482 | tdf/emtricitabine | 4 |
| 1483 | efavirenz/tenofovir/emtricitabine | 8 |
| 1484 | paclitaxel/gemcitabine | 3 |
| 1485 | placebo/gemcitabine | 4 |
| 1486 | gemcitabine-ifosfamide-vinorelbine | 1 |
| 1487 | platinum/vinorelbine | 1 |
| 1488 | serogroup-c-meningococcal-conjugate-vaccine | 1 |
| 1489 | alanyl-leucine | 1 |
| 1490 | polyleucine | 1 |
| 1491 | dimethyloxalylglycine | 1 |
| 1492 | homoproparglyglycine | 2 |
| 1493 | meperedine | 4 |
| 1494 | n-cyclohexylcarboxamidine | 1 |
| 1495 | butorphanol-medetomidine | 1 |
| 1496 | lidocaine-ketamine-dexmedetomidine | 1 |
| 1497 | cocaine/dexmedetomidine | 1 |
| 1498 | 14c-thymidine | 1 |
| 1499 | bismuth-metronidazole-tetracycline-ranitidine | 1 |
| 1500 | 4-toluidine | 1 |
| 1501 | didanosine/stavudine | 3 |
| 1502 | rtv/sqv/stavudine | 1 |
| 1503 | abacavir-lamivudine | 28 |
| 1504 | abacavir/zidovudine/lamivudine | 3 |
| 1505 | tenofovir/lamivudine | 3 |
| 1506 | csd+caffeine | 2 |
| 1507 | ergotamine/caffeine | 1 |
| 1508 | novofine | 1 |
| 1509 | midazolam-morphine | 1 |
| 1510 | norepineprhine | 1 |
| 1511 | placebo/sertraline | 1 |
| 1512 | 'saline | 2 |
| 1513 | propofol/fentanyl/placebo-saline | 1 |
| 1514 | quinine-tetracycline | 1 |
| 1515 | placebo-doxycycline | 2 |
| 1516 | 5-nitro-8-hydroxyquinoline | 2 |
| 1517 | 1,10-phenan-throline | 1 |
| 1518 | thioproline | 6 |
| 1519 | trans-4-hydroxyproline | 1 |
| 1520 | amytriptyline | 3 |
| 1521 | dapsone-pyrimethamine | 1 |
| 1522 | dapsone/pyrimethamine | 6 |
| 1523 | 1-lysophosphatidylethanolamine | 1 |
| 1524 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 3 |
| 1525 | methscopolamine | 6 |
| 1526 | mosapramine | 2 |
| 1527 | romifidine-ketamine | 1 |
| 1528 | norepinephrine-dobutamine | 13 |
| 1529 | deferrioxamine | 6 |
| 1530 | catechin/theanine | 4 |
| 1531 | p-dihydroxyborylphenylalanine | 1 |
| 1532 | n-methyl-dehydroalanine | 1 |
| 1533 | paroxetine+quetiapine | 1 |
| 1534 | placebo/amlodipine | 3 |
| 1535 | saline-atropine | 1 |
| 1536 | tubocurarine | 1 |
| 1537 | prilocaine-phenylephrine | 1 |
| 1538 | aspirine | 5 |
| 1539 | infliximab/azathioprine | 2 |
| 1540 | cyclosporine/azathioprine | 1 |
| 1541 | aneurine | 1 |
| 1542 | visine | 3 |
| 1543 | cyclocreatine | 1 |
| 1544 | escitalopram-paroxetine | 1 |
| 1545 | n-acetyl-carnitine | 2 |
| 1546 | pseudooxynicotine | 1 |
| 1547 | mitomycin/vinblastine | 1 |
| 1548 | methotrexate/carboplatin/vinblastine | 1 |
| 1549 | prednimustine | 1 |
| 1550 | chloroquine-primaquine | 1 |
| 1551 | sulfasalazine+hydroxychloroquine | 2 |
| 1552 | euflavine | 8 |
| 1553 | carfentanil-xylazine | 1 |
| 1554 | naloxonazine | 1 |
| 1555 | trimethoprim/sulfamethopyrazine | 1 |
| 1556 | mequitazine | 3 |
| 1557 | shi-hung-one | 1 |
| 1558 | pronase/bicarbonate/simethicone | 1 |
| 1559 | acepromazine-methadone | 1 |
| 1560 | polyvinylpyrolidone | 1 |
| 1561 | placebo+risperidone | 3 |
| 1562 | lai-risperidone | 2 |
| 1563 | ketoprofen-oxymorphone | 3 |
| 1564 | folfiri-alone | 1 |
| 1565 | fluvastatin-alone | 1 |
| 1566 | education-alone | 1 |
| 1567 | map-alone | 3 |
| 1568 | alkalization-therapy-alone | 1 |
| 1569 | surgery-alone | 29 |
| 1570 | tamoxifen+prednisolone | 1 |
| 1571 | low-flavanone | 2 |
| 1572 | alpha-aminopropiophenone | 1 |
| 1573 | teprenone | 13 |
| 1574 | l-dopa/carbidopa/entacapone | 2 |
| 1575 | normal-testosterone | 1 |
| 1576 | thalidomide-dexamethasone | 9 |
| 1577 | vincristine-mitoxantrone-dexamethasone | 1 |
| 1578 | cyclophosphamide-vincristine-doxorubicin-dexamethasone | 6 |
| 1579 | thalidomide/dexamethasone | 2 |
| 1580 | mycophenolate/dexamethasone | 5 |
| 1581 | mitoxantrone-prednisone | 6 |
| 1582 | placebo-prednisone | 4 |
| 1583 | ciclosporin/azathioprine/prednisone | 1 |
| 1584 | placebo/prednisone | 1 |
| 1585 | azithromycin-atovaquone | 1 |
| 1586 | thymoquinone-4-palmitoylhydrazone | 1 |
| 1587 | sulphinpyrazone | 5 |
| 1588 | hypomenorrhoe | 1 |
| 1589 | jelled-type | 1 |
| 1590 | cullin-type | 1 |
| 1591 | d0-re | 2 |
| 1592 | referred-care | 1 |
| 1593 | usualcare | 2 |
| 1594 | piko/software | 2 |
| 1595 | egfp-cre | 1 |
| 1596 | land-basedthere | 1 |
| 1597 | controlthere | 1 |
| 1598 | experimental/before | 1 |
| 1599 | heartfailure | 1 |
| 1600 | sham-exposure | 2 |
| 1601 | sham-acupuncture | 35 |
| 1602 | skin/structure | 1 |
| 1603 | standard-suture | 1 |
| 1604 | yeast-se | 4 |
| 1605 | venlafaxine-extended-release | 1 |
| 1606 | premphase | 1 |
| 1607 | kynurenine-3-monooxygenase | 1 |
| 1608 | imiglucerase | 19 |
| 1609 | hotpack+exercise | 1 |
| 1610 | diet+exercise | 3 |
| 1611 | weight-management-plus-exercise | 2 |
| 1612 | rosuvastatin/exercise | 1 |
| 1613 | socialise | 1 |
| 1614 | fluoride-rinse | 1 |
| 1615 | randomised-response | 1 |
| 1616 | aurothioglucose | 1 |
| 1617 | post-last-dose | 1 |
| 1618 | pseudo-relapse | 1 |
| 1619 | placebo-methylphenidate | 1 |
| 1620 | tfv-diphosphate | 1 |
| 1621 | geranylgeranyl-pyrophosphate | 1 |
| 1622 | 4-chloro-3-hydroxyanthranilate | 1 |
| 1623 | daclizumab/tacrolimus/mycophenolate | 1 |
| 1624 | neostigmine/glycopyrrolate | 4 |
| 1625 | olanzapine+topiramate | 1 |
| 1626 | ethinylestradiol/norgestimate | 1 |
| 1627 | znpicolinate | 1 |
| 1628 | nonaminobisphosphonate | 1 |
| 1629 | methyljasmonate | 1 |
| 1630 | amodiaquine+artesunate | 4 |
| 1631 | lower-rate | 3 |
| 1632 | besafibrate | 3 |
| 1633 | hrt+bezafibrate | 3 |
| 1634 | fenofibrate/bezafibrate | 1 |
| 1635 | binifibrate | 3 |
| 1636 | higher-carbohydrate | 4 |
| 1637 | sildenafil-citrate | 1 |
| 1638 | downtitrate | 1 |
| 1639 | tablet/lyophilisate | 1 |
| 1640 | pyruvate-lactate | 3 |
| 1641 | very-low-dose-methotrexate | 1 |
| 1642 | lechatelierite | 1 |
| 1643 | dmte | 9 |
| 1644 | active-commute | 1 |
| 1645 | 40/minute | 1 |
| 1646 | cnidocyte | 1 |
| 1647 | nerve-myocyte | 1 |
| 1648 | pedialyte | 8 |
| 1649 | prostaglandinanalogue | 1 |
| 1650 | havrix-healive | 2 |
| 1651 | c-hypotensive | 1 |
| 1652 | leukotoxin-negative | 2 |
| 1653 | thermal/evaporative | 1 |
| 1654 | youthful/active | 2 |
| 1655 | -dna-positive | 1 |
| 1656 | tau-positive | 3 |
| 1657 | donor-seropositive | 1 |
| 1658 | pbo+exe | 5 |
| 1659 | alinamin-f | 1 |
| 1660 | beschitin-f | 2 |
| 1661 | r-af | 6 |
| 1662 | non-ecf | 2 |
| 1663 | efv+ftc/tdf | 7 |
| 1664 | atv/rtv+ftc/tdf | 4 |
| 1665 | efv/ftc/tdf | 27 |
| 1666 | lam/tdf | 2 |
| 1667 | t-cef | 2 |
| 1668 | redef | 8 |
| 1669 | preef | 7 |
| 1670 | non-wlff | 4 |
| 1671 | hm-off | 5 |
| 1672 | lay-off | 1 |
| 1673 | 9α,11β-pgf | 1 |
| 1674 | c-hf | 3 |
| 1675 | control/dhf | 1 |
| 1676 | 2-methf | 1 |
| 1677 | mtx+twhf | 4 |
| 1678 | non-twhf | 2 |
| 1679 | caif | 4 |
| 1680 | glf | 1 |
| 1681 | tac/mmf | 30 |
| 1682 | sham-nf | 1 |
| 1683 | conf | 5 |
| 1684 | hs/tnf | 1 |
| 1685 | 5/hpf | 3 |
| 1686 | non-rhg-csf | 2 |
| 1687 | mmf/myf | 1 |
| 1688 | diet+g | 1 |
| 1689 | 48.6±10.1g | 1 |
| 1690 | 57+/-8.2g | 1 |
| 1691 | a2064g | 1 |
| 1692 | 98.2±20.7g | 1 |
| 1693 | 145.4±22.9g | 1 |
| 1694 | obag | 4 |
| 1695 | psgag | 3 |
| 1696 | non-smbg | 2 |
| 1697 | cidr+hcg | 2 |
| 1698 | sbeg | 6 |
| 1699 | 4l-peg | 5 |
| 1700 | sg+gg | 2 |
| 1701 | =90mmhg | 1 |
| 1702 | 60±11mmhg | 1 |
| 1703 | 114±13mmhg | 1 |
| 1704 | =55mmhg | 1 |
| 1705 | 135.1±7.8mmhg | 1 |
| 1706 | 128mmhg | 1 |
| 1707 | 3μg.kg | 2 |
| 1708 | 0.5-mg/kg | 2 |
| 1709 | 700mg/kg | 1 |
| 1710 | 80-microg/kg | 1 |
| 1711 | 60u/kg | 1 |
| 1712 | 13.5±2.3kg | 1 |
| 1713 | 0.35kg | 1 |
| 1714 | 10/80-mg | 1 |
| 1715 | hal2mg+pim20mg | 1 |
| 1716 | 188.4mg | 1 |
| 1717 | 20/5mg | 4 |
| 1718 | 465mg | 1 |
| 1719 | 150.7mg | 1 |
| 1720 | tangmaikang | 3 |
| 1721 | hbsag-eng | 18 |
| 1722 | disrobing | 1 |
| 1723 | no-bracing | 1 |
| 1724 | nonbracing | 1 |
| 1725 | spoon-feeding | 5 |
| 1726 | sweat-feeding | 1 |
| 1727 | nonbreastfeeding | 1 |
| 1728 | inaccurate/lagging | 1 |
| 1729 | medline+handsearching | 1 |
| 1730 | yi-jing | 1 |
| 1731 | non-spanish-speaking | 1 |
| 1732 | creaking | 1 |
| 1733 | non-packing | 2 |
| 1734 | ribbling | 1 |
| 1735 | nonswaddling | 1 |
| 1736 | unfulfilling | 1 |
| 1737 | freeze-killing | 2 |
| 1738 | demeaning | 1 |
| 1739 | nonresurfacoing | 1 |
| 1740 | re-draping | 1 |
| 1741 | cutting/stepping | 1 |
| 1742 | no-burping | 1 |
| 1743 | 'uncaring | 1 |
| 1744 | swearing | 1 |
| 1745 | information-gathering | 1 |
| 1746 | non-suturing | 4 |
| 1747 | undressing | 1 |
| 1748 | immunosuppressing | 2 |
| 1749 | over-reciprocating | 1 |
| 1750 | nonaspirating | 1 |
| 1751 | co-habitating | 1 |
| 1752 | illness-detecting | 1 |
| 1753 | renting | 1 |
| 1754 | self-presenting | 1 |
| 1755 | non-stenting | 2 |
| 1756 | non-lasting | 1 |
| 1757 | daytime-wetting | 2 |
| 1758 | anticlotting | 2 |
| 1759 | steroid-continuing | 1 |
| 1760 | restudying | 5 |
| 1761 | 0.52log | 1 |
| 1762 | sg-ssg | 7 |
| 1763 | cy-flu-atg | 8 |
| 1764 | noplug | 6 |
| 1765 | 250µg | 1 |
| 1766 | b+h | 12 |
| 1767 | bb536-h | 5 |
| 1768 | shr-h | 3 |
| 1769 | 10.7/h | 1 |
| 1770 | 21:00h | 1 |
| 1771 | 13.70h | 1 |
| 1772 | =3h | 1 |
| 1773 | 4.4h | 1 |
| 1774 | 81.5h | 1 |
| 1775 | 5.0±1.7h | 1 |
| 1776 | 4.7±2.7h | 1 |
| 1777 | 128h | 1 |
| 1778 | halakhah | 1 |
| 1779 | hydroxyethyl-starch | 1 |
| 1780 | meibopatch | 2 |
| 1781 | laser-etch | 1 |
| 1782 | fec-dh | 6 |
| 1783 | mi-high | 2 |
| 1784 | nihh | 4 |
| 1785 | 92.9±21.4cmh | 1 |
| 1786 | 117.5±36.5cmh | 1 |
| 1787 | iui-coh | 2 |
| 1788 | daph | 1 |
| 1789 | duramorph | 4 |
| 1790 | water-brash | 1 |
| 1791 | aqdsh | 1 |
| 1792 | dragonfish | 1 |
| 1793 | crossed-path | 1 |
| 1794 | naturopath | 4 |
| 1795 | uvh | 6 |
| 1796 | aristololactam-i | 1 |
| 1797 | kjai | 5 |
| 1798 | risperidone-lai | 2 |
| 1799 | fp-bi | 5 |
| 1800 | dmbi | 12 |
| 1801 | maobi | 14 |
| 1802 | severe-tbi | 1 |
| 1803 | cf-wbi | 10 |
| 1804 | temporal+occi | 2 |
| 1805 | superior+occi | 2 |
| 1806 | cag+pci | 1 |
| 1807 | zdv+ddi | 5 |
| 1808 | jamshidi | 4 |
| 1809 | cfc-mdi | 7 |
| 1810 | cvt-mdi | 10 |
| 1811 | hetero-nuclei | 1 |
| 1812 | changmei | 7 |
| 1813 | a-gi | 4 |
| 1814 | low-protein/lgi | 1 |
| 1815 | riukiu-yomogi | 1 |
| 1816 | lch-ii | 5 |
| 1817 | li/li | 2 |
| 1818 | t-buli | 3 |
| 1819 | equuli | 1 |
| 1820 | norbni | 2 |
| 1821 | mmf/cni | 9 |
| 1822 | 2nrtis+pi | 1 |
| 1823 | bevacizumab-folfiri | 5 |
| 1824 | placebo+snri | 2 |
| 1825 | ols-si | 2 |
| 1826 | rtsi | 4 |
| 1827 | raktadushti | 1 |
| 1828 | comti | 8 |
| 1829 | pi/nnrti | 5 |
| 1830 | matti | 2 |
| 1831 | siui | 8 |
| 1832 | m-cavi | 6 |
| 1833 | lgj | 5 |
| 1834 | cold-break | 1 |
| 1835 | hotpack | 2 |
| 1836 | oraquick | 4 |
| 1837 | cryoshock | 1 |
| 1838 | non-block | 1 |
| 1839 | every-three-week | 1 |
| 1840 | 1·22/week | 1 |
| 1841 | 2×week | 1 |
| 1842 | pbo-tnk-tnk | 3 |
| 1843 | lentisk | 1 |
| 1844 | s-1/psk | 3 |
| 1845 | once-a-wk | 1 |
| 1846 | 2.46/wk | 1 |
| 1847 | folfox4/ptk/zk | 4 |
| 1848 | ii-l | 1 |
| 1849 | cemt-pi-l | 6 |
| 1850 | 1.21mg/l | 1 |
| 1851 | 36.7+/-16.3mgh/l | 1 |
| 1852 | 1.35mmol/l | 1 |
| 1853 | 1.57mmol/l | 1 |
| 1854 | 12.3±2.8µmol/l | 1 |
| 1855 | 10.7±2.8µmol/l | 1 |
| 1856 | 10.7±2.9µmol/l | 1 |
| 1857 | 269.8μmol/l | 1 |
| 1858 | methycobal | 6 |
| 1859 | immuno-pathological | 1 |
| 1860 | depressed/suicidal | 2 |
| 1861 | ibdq-social | 1 |
| 1862 | fasting/interprandial | 1 |
| 1863 | breast/endometrial | 1 |
| 1864 | 2-methyl-2-pentenal | 1 |
| 1865 | topical/intracameral | 2 |
| 1866 | caudo-ventro-lateral | 1 |
| 1867 | corral | 1 |
| 1868 | secondary/central | 1 |
| 1869 | non-epidural | 6 |
| 1870 | nidcap/experimental | 1 |
| 1871 | three-portal | 1 |
| 1872 | life-as-usual | 1 |
| 1873 | care-as-usual | 48 |
| 1874 | counseling-as-usual | 1 |
| 1875 | training-as-usual | 5 |
| 1876 | treatment-as-usual | 170 |
| 1877 | play-as-usual | 2 |
| 1878 | pylorus-removal | 1 |
| 1879 | adalimumab-withdrawal | 1 |
| 1880 | cni-withdrawal | 2 |
| 1881 | amx-cl | 6 |
| 1882 | ag/agcl/kcl | 1 |
| 1883 | =100mg/dl | 3 |
| 1884 | =160mg/dl | 1 |
| 1885 | aggregated-ldl | 1 |
| 1886 | diclofenac-gel | 4 |
| 1887 | act-hib+viscogel | 3 |
| 1888 | nonclopidogrel | 1 |
| 1889 | pertuzumab-docetaxel | 1 |
| 1890 | carboplatin-docetaxel | 6 |
| 1891 | cisplatin-paclitaxel | 4 |
| 1892 | gemcitabine/paclitaxel | 10 |
| 1893 | doxorubicin/cisplatin/paclitaxel | 1 |
| 1894 | mifl | 11 |
| 1895 | ymfl | 1 |
| 1896 | 5gl | 1 |
| 1897 | rituximab-chlorambucil | 4 |
| 1898 | dicyclanil | 4 |
| 1899 | propofol+alfentanil | 2 |
| 1900 | soy-oil | 3 |
| 1901 | saf-t-coil | 2 |
| 1902 | nootropil | 2 |
| 1903 | captoril | 5 |
| 1904 | hydrochlorothiazide/benazepril | 2 |
| 1905 | lg-sil | 3 |
| 1906 | pvi+ll | 6 |
| 1907 | intranasally.overall | 1 |
| 1908 | =200/ml | 1 |
| 1909 | 111±71pg/ml | 1 |
| 1910 | 191.4pg/ml | 1 |
| 1911 | 323.4±40.6pg/ml | 1 |
| 1912 | 16.6pg/ml | 1 |
| 1913 | 268.5±8.6pg/ml | 1 |
| 1914 | 14.4±1.8pg/ml | 1 |
| 1915 | 194.8pg/ml | 1 |
| 1916 | 508±149dayg/ml | 1 |
| 1917 | 10.2±2.9μg/ml | 1 |
| 1918 | less/ml | 1 |
| 1919 | 1544.4miu/ml | 1 |
| 1920 | 843ml | 1 |
| 1921 | 985±463ml | 1 |
| 1922 | 19±0.8ml | 1 |
| 1923 | encephabol | 3 |
| 1924 | tissucol | 5 |
| 1925 | fentanyl/droperidol | 2 |
| 1926 | thaumarchaeol | 1 |
| 1927 | ketofol | 56 |
| 1928 | hplchol | 4 |
| 1929 | no-menthol | 1 |
| 1930 | 17ß-estradiol | 1 |
| 1931 | drospirenone+ethinylestradiol | 3 |
| 1932 | 1,9-nonanediol | 1 |
| 1933 | 1,4-benzenedithiol | 1 |
| 1934 | nilestriol | 5 |
| 1935 | athenolol | 2 |
| 1936 | metorpolol | 1 |
| 1937 | co-codamol | 7 |
| 1938 | nefopam-paracetamol | 1 |
| 1939 | =1.70mmol | 1 |
| 1940 | =5.18mmol | 1 |
| 1941 | 1-octadecanol | 2 |
| 1942 | disophenol | 1 |
| 1943 | placebo-dronabinol | 1 |
| 1944 | back-school | 1 |
| 1945 | 10,000/microl | 2 |
| 1946 | 20,000/microl | 3 |
| 1947 | 15,000/microl | 2 |
| 1948 | ics/salmeterol | 3 |
| 1949 | budesonide+formoterol | 2 |
| 1950 | dihydrotachysterol | 3 |
| 1951 | time-control | 5 |
| 1952 | manual-control | 2 |
| 1953 | progression-control | 1 |
| 1954 | dhf/control | 1 |
| 1955 | placebo/control | 48 |
| 1956 | conceptrol | 4 |
| 1957 | stilbestrol | 2 |
| 1958 | paracematol | 1 |
| 1959 | erythritol/maltitol | 4 |
| 1960 | gh/pl | 3 |
| 1961 | non-btl | 2 |
| 1962 | nonsuccessful | 1 |
| 1963 | 42.1+/-16.9/mul | 1 |
| 1964 | tau/wl | 4 |
| 1965 | placebo-plus-bwl | 1 |
| 1966 | naphthylacyl | 2 |
| 1967 | 4-bromophenacyl | 1 |
| 1968 | sulphonylmethyl | 1 |
| 1969 | lavandulyl | 2 |
| 1970 | midazolam-fentanyl | 15 |
| 1971 | bupivacaine/fentanyl | 5 |
| 1972 | midazolam/fentanyl | 12 |
| 1973 | α-phenyl | 1 |
| 1974 | 2,3,4,4',5-pentachlorobiphenyl | 1 |
| 1975 | polyphenyl | 2 |
| 1976 | 2-chloro-4-pyridinyl | 1 |
| 1977 | 3'-acetyl | 1 |
| 1978 | a+m | 6 |
| 1979 | 70.5±22g/m | 1 |
| 1980 | 118.6g/m | 1 |
| 1981 | =30kg/m | 1 |
| 1982 | bmi≥35kg/m | 1 |
| 1983 | 32.6±4.7kg/m | 1 |
| 1984 | 27.8kg/m | 1 |
| 1985 | 375mg/m | 1 |
| 1986 | 26mg/m | 1 |
| 1987 | na2m | 1 |
| 1988 | 5.7ml/min/1.73m | 1 |
| 1989 | 1.72±0.18m | 1 |
| 1990 | no-am | 2 |
| 1991 | fccam | 7 |
| 1992 | b-beam | 7 |
| 1993 | placebo-sham | 5 |
| 1994 | control/sham | 6 |
| 1995 | dexmedetomidine-ketamine-midazolam | 1 |
| 1996 | estazolam | 35 |
| 1997 | pivampicillin/pivmecillinam | 6 |
| 1998 | modafinil+escitalopram | 1 |
| 1999 | ipt+escitalopram | 1 |
| 2000 | cefepime-tazobactam | 1 |
| 2001 | d-fish-bm | 5 |
| 2002 | cb+cbm | 2 |
| 2003 | dc+cm | 1 |
| 2004 | cbt+cm | 5 |
| 2005 | non-cm | 15 |
| 2006 | 517μa/cm | 1 |
| 2007 | 77.0cm | 1 |
| 2008 | 24±1cm | 1 |
| 2009 | 4+/-4cm | 1 |
| 2010 | 45.4cm | 1 |
| 2011 | 0.6cm | 1 |
| 2012 | 57.9cm | 1 |
| 2013 | non-icm | 12 |
| 2014 | azt+lcm | 3 |
| 2015 | mtx-cdp-adm | 2 |
| 2016 | t3cdm | 3 |
| 2017 | pm/em | 1 |
| 2018 | dl-diltiazem | 1 |
| 2019 | vac+dfm | 1 |
| 2020 | =10-mm | 3 |
| 2021 | no-mm | 3 |
| 2022 | 157.0±18.1/mm | 1 |
| 2023 | 32/mm | 1 |
| 2024 | 987/mm | 1 |
| 2025 | =100-cell/mm | 1 |
| 2026 | 5±2.3mm | 1 |
| 2027 | 1.37±6.4mm | 1 |
| 2028 | 2.7±0.5mm | 1 |
| 2029 | 16±5mm | 1 |
| 2030 | -3.6±6.8mm | 1 |
| 2031 | 274.2±23.9mm | 1 |
| 2032 | 100nm | 8 |
| 2033 | 24.2+/-4bpm | 1 |
| 2034 | 24+/-5bpm | 1 |
| 2035 | c/abpm | 7 |
| 2036 | buffer/cpm | 3 |
| 2037 | 14rpm | 1 |
| 2038 | sbp+rm | 2 |
| 2039 | erlotinib-arm | 1 |
| 2040 | sm+sm | 1 |
| 2041 | mentalism | 1 |
| 2042 | cometabolism | 2 |
| 2043 | creationism | 1 |
| 2044 | polytypism | 1 |
| 2045 | 90μmolphotonsm | 1 |
| 2046 | dermabondtm | 1 |
| 2047 | butm | 1 |
| 2048 | bunsimgi-eum | 2 |
| 2049 | denuded-endothelium | 1 |
| 2050 | sufentanil-vecuronium | 1 |
| 2051 | pueperium | 1 |
| 2052 | rostellum | 1 |
| 2053 | cis-dichlorodiamineplatinum | 1 |
| 2054 | ic50=1.6μm | 1 |
| 2055 | 747+130n | 1 |
| 2056 | 0.52+/-0.08n | 1 |
| 2057 | carboplatin-irinotecan | 1 |
| 2058 | non-irinotecan | 1 |
| 2059 | 5-fluorouracil/leucovorin/irinotecan | 1 |
| 2060 | vistascan | 1 |
| 2061 | foscan | 1 |
| 2062 | trimetaphan | 1 |
| 2063 | cyclorphan | 1 |
| 2064 | dingzhongxian | 3 |
| 2065 | pipobroman | 8 |
| 2066 | pertofran | 3 |
| 2067 | spirotetrahydrofuran | 1 |
| 2068 | xalatan | 19 |
| 2069 | lisinopril-telmisartan | 2 |
| 2070 | olmesertan | 1 |
| 2071 | spongostan | 17 |
| 2072 | neurostan | 5 |
| 2073 | tianquan | 2 |
| 2074 | molixan | 3 |
| 2075 | bcd+lcn | 4 |
| 2076 | sd-dn | 4 |
| 2077 | asdn | 2 |
| 2078 | naltriben | 1 |
| 2079 | flupentixol/melitracen | 2 |
| 2080 | not-sudden | 1 |
| 2081 | biperiden | 22 |
| 2082 | placebo/ibuprofen | 2 |
| 2083 | oxycodone/acetaminophen | 9 |
| 2084 | nonlinemen | 1 |
| 2085 | epipen | 26 |
| 2086 | xing-ren | 1 |
| 2087 | aten | 14 |
| 2088 | gfn | 8 |
| 2089 | il-2/ifn | 3 |
| 2090 | mp/ifn | 5 |
| 2091 | amisulprideagain | 1 |
| 2092 | fresubin | 5 |
| 2093 | amicacin | 2 |
| 2094 | placebo/moxifloxacin | 2 |
| 2095 | methotrexate-doxorubicin | 7 |
| 2096 | taxane/doxorubicin | 1 |
| 2097 | zorubicin | 4 |
| 2098 | tmp-smx-gentamicin | 4 |
| 2099 | saline/gentamicin | 2 |
| 2100 | clarithyromicin | 1 |
| 2101 | hsfd/streptozotocin | 1 |
| 2102 | pyrimathamine+clindamycin | 1 |
| 2103 | gentamicin/clindamycin | 4 |
| 2104 | tobramycin/clindamycin | 1 |
| 2105 | ampicillin-tobramycin | 1 |
| 2106 | ceftriaxone/tobramycin | 2 |
| 2107 | porfiromycin | 2 |
| 2108 | claritromycin | 1 |
| 2109 | 5fu-mitomycin | 1 |
| 2110 | deoxycoformycin | 5 |
| 2111 | 13'-cis-lutein | 1 |
| 2112 | 9'-cis-lutein | 1 |
| 2113 | baralgin | 2 |
| 2114 | desacyl-ghrelin | 6 |
| 2115 | antimellin | 1 |
| 2116 | sulbenicillin | 2 |
| 2117 | sulbactam/penicillin | 1 |
| 2118 | mtz+amoxicillin | 1 |
| 2119 | tcf/pangolin | 1 |
| 2120 | taurolin | 2 |
| 2121 | eplin | 1 |
| 2122 | -6/min | 1 |
| 2123 | fructose/min | 1 |
| 2124 | 80.0beats/min | 1 |
| 2125 | 20.0min | 1 |
| 2126 | 28.1min | 1 |
| 2127 | 7.4min | 1 |
| 2128 | 77.4min | 1 |
| 2129 | 7.25min | 2 |
| 2130 | 10.6min | 1 |
| 2131 | 153±46min | 1 |
| 2132 | 19.7min | 1 |
| 2133 | 206±67min | 1 |
| 2134 | glimepiride+metformin | 3 |
| 2135 | diet+metformin | 1 |
| 2136 | coeruloplasmin | 1 |
| 2137 | phytohaemagglutinin | 15 |
| 2138 | ademetionin | 2 |
| 2139 | elcatonin | 27 |
| 2140 | isoretinoin | 1 |
| 2141 | mephenytoin | 1 |
| 2142 | dosulepin | 7 |
| 2143 | -vildaglitpin | 1 |
| 2144 | on-warfarin | 1 |
| 2145 | heparin/warfarin | 3 |
| 2146 | 5-fu/heparin | 2 |
| 2147 | tetrahydroneopterin | 1 |
| 2148 | alphacypermethrin | 2 |
| 2149 | lysine-aspirin | 1 |
| 2150 | sofosbuvir-ribavirin | 4 |
| 2151 | salazopyrin | 7 |
| 2152 | uft/leucovorin/oxaliplatin | 1 |
| 2153 | oxliplatin | 1 |
| 2154 | etoposide-carboplatin | 2 |
| 2155 | vinorelbine/carboplatin | 1 |
| 2156 | bevacizumab/paclitaxel/carboplatin | 2 |
| 2157 | s-1+cisplatin | 6 |
| 2158 | paclitaxel+cisplatin | 2 |
| 2159 | placebo-cisplatin | 10 |
| 2160 | mitomycin/ifosfamide/cisplatin | 1 |
| 2161 | vindesine/cisplatin | 5 |
| 2162 | 5-fluorouracil/cisplatin | 2 |
| 2163 | vinorelbin/cisplatin | 2 |
| 2164 | oxyplatin | 1 |
| 2165 | placebo/statin | 2 |
| 2166 | caspase-3+calpastatin | 1 |
| 2167 | torcetrapib/atorvastatin | 4 |
| 2168 | ezetimibe/atorvastatin | 2 |
| 2169 | peg-ifnα-2a/rbv/fluvastatin | 1 |
| 2170 | adp-actin | 1 |
| 2171 | phyllocontin | 2 |
| 2172 | simvastotin | 1 |
| 2173 | synexin | 1 |
| 2174 | scombrotoxin | 1 |
| 2175 | hemcon | 8 |
| 2176 | sorbalgon | 4 |
| 2177 | t-incision | 1 |
| 2178 | post-incision | 7 |
| 2179 | non-division | 2 |
| 2180 | maltorsion | 1 |
| 2181 | agitation-aggression | 2 |
| 2182 | anger/depression | 1 |
| 2183 | bolus-infusion | 7 |
| 2184 | vaccination.conclusion | 1 |
| 2185 | obtrusion | 1 |
| 2186 | active-medication | 2 |
| 2187 | pre-stratification | 2 |
| 2188 | revivification | 1 |
| 2189 | endoduplication | 1 |
| 2190 | fracture/dislocation | 2 |
| 2191 | ß-oxidation | 1 |
| 2192 | glycation/glycoxidation | 1 |
| 2193 | nonirrigation | 1 |
| 2194 | mock-radiation | 1 |
| 2195 | sham-irradiation | 3 |
| 2196 | prevention/mediation | 1 |
| 2197 | hydrothermablation | 6 |
| 2198 | photoepilation | 2 |
| 2199 | knee-disarticulation | 1 |
| 2200 | fenestration/coagulation | 6 |
| 2201 | under-anticoagulation | 1 |
| 2202 | sham-stimulation | 5 |
| 2203 | placebo-stimulation | 1 |
| 2204 | non-inflammation | 1 |
| 2205 | atopy/inflammation | 1 |
| 2206 | hydride-generation | 1 |
| 2207 | nonaspiration | 1 |
| 2208 | normofiltration | 1 |
| 2209 | marsupialisation | 1 |
| 2210 | pseudo-randomisation | 1 |
| 2211 | under-resuscitation | 1 |
| 2212 | ultrafiltation | 1 |
| 2213 | oscillation+rotation | 2 |
| 2214 | adalimumab-continuation | 5 |
| 2215 | everolimus-continuation | 4 |
| 2216 | relapse/reactivation | 1 |
| 2217 | transinstitutionalization | 1 |
| 2218 | poly-victimization | 1 |
| 2219 | foreignization | 1 |
| 2220 | postacclimatization | 2 |
| 2221 | nondisinfection | 1 |
| 2222 | standard-detection | 4 |
| 2223 | inunction | 2 |
| 2224 | rapid-weight-reduction | 1 |
| 2225 | nonreduction | 1 |
| 2226 | non-leukoreduction | 1 |
| 2227 | indirect-induction | 1 |
| 2228 | non-suction | 3 |
| 2229 | renutrition | 1 |
| 2230 | full-intervention | 3 |
| 2231 | cecum/colon | 2 |
| 2232 | phenocoumaron | 1 |
| 2233 | imatinib+interferon | 1 |
| 2234 | densiron | 8 |
| 2235 | confocal/two-photon | 1 |
| 2236 | prentice-wilcoxon | 1 |
| 2237 | non-apn | 2 |
| 2238 | hlar-spn | 1 |
| 2239 | -tn | 3 |
| 2240 | error-strewn | 1 |
| 2241 | arvt+jobelyn | 2 |
| 2242 | cucl2·2h2o | 2 |
| 2243 | rhcl3·3h2o | 1 |
| 2244 | pla-cebo | 1 |
| 2245 | placebo | 87,219 |
| 2246 | olanzapine+placebo | 3 |
| 2247 | erp+placebo | 1 |
| 2248 | mtx+placebo | 1 |
| 2249 | ia-placebo | 3 |
| 2250 | dac-placebo | 3 |
| 2251 | matched-placebo | 3 |
| 2252 | saline-placebo | 1 |
| 2253 | methylphenidate-placebo | 1 |
| 2254 | thiopental-placebo | 1 |
| 2255 | docetaxel-placebo | 2 |
| 2256 | pill-placebo | 13 |
| 2257 | other-than-placebo | 1 |
| 2258 | p-placebo | 2 |
| 2259 | saber-placebo | 3 |
| 2260 | monacolins-washout-placebo | 1 |
| 2261 | 2nrti/etr/efv-placebo | 1 |
| 2262 | mtz-placebo | 2 |
| 2263 | letrozole/placebo | 2 |
| 2264 | galantamine/placebo | 1 |
| 2265 | rosiglitazone/placebo | 2 |
| 2266 | metformin/placebo | 9 |
| 2267 | enoxaparin/placebo | 3 |
| 2268 | tamsulosin/placebo | 4 |
| 2269 | simvastatin/placebo | 3 |
| 2270 | ifn-α/placebo | 1 |
| 2271 | pacebo | 2 |
| 2272 | weo | 7 |
| 2273 | salpingo | 1 |
| 2274 | si/ho | 3 |
| 2275 | alc-cho | 5 |
| 2276 | n-acetyl-asp-glu-val-asp-cho | 1 |
| 2277 | maleficio | 1 |
| 2278 | inratio | 1 |
| 2279 | atv+allo | 3 |
| 2280 | 3.4mo | 1 |
| 2281 | 4-morpholino | 1 |
| 2282 | czon+mino | 4 |
| 2283 | adapalene/bpo | 5 |
| 2284 | sho-seiru-to | 1 |
| 2285 | ldac+ato | 1 |
| 2286 | meoc+p | 8 |
| 2287 | ec-p | 10 |
| 2288 | -i.p | 1 |
| 2289 | erv14p | 1 |
| 2290 | no-ap | 9 |
| 2291 | lap+cap | 6 |
| 2292 | mei-cap | 5 |
| 2293 | vr-cap | 8 |
| 2294 | bev-cap | 4 |
| 2295 | r-dhap | 11 |
| 2296 | pp+map | 3 |
| 2297 | b-cpap | 5 |
| 2298 | placebo-cpap | 3 |
| 2299 | no-cpap | 2 |
| 2300 | vcpap | 4 |
| 2301 | ad-hpap | 2 |
| 2302 | blank-sap | 1 |
| 2303 | non-iabp | 4 |
| 2304 | apo-rbp | 1 |
| 2305 | ed-sbp | 6 |
| 2306 | ph-sbp | 6 |
| 2307 | non-cp | 6 |
| 2308 | lvad+ccp | 2 |
| 2309 | sbnocp | 4 |
| 2310 | crtcp | 1 |
| 2311 | lc+ep | 3 |
| 2312 | chloraprep | 6 |
| 2313 | salm/fp | 5 |
| 2314 | slogp | 1 |
| 2315 | arip | 5 |
| 2316 | filmstrip | 3 |
| 2317 | tupkp | 12 |
| 2318 | csa-aza-mp | 1 |
| 2319 | 1mamp | 2 |
| 2320 | thp+imp | 1 |
| 2321 | p-28rnp | 1 |
| 2322 | np-28rnp | 1 |
| 2323 | bacop | 2 |
| 2324 | mbt-iop | 3 |
| 2325 | tprop | 5 |
| 2326 | mvr-pp | 3 |
| 2327 | ideg+iasp | 4 |
| 2328 | γ-csp | 1 |
| 2329 | nbhsp | 1 |
| 2330 | sandblasted+ssp | 1 |
| 2331 | fsh-ctp | 1 |
| 2332 | ctx-m-9-group | 1 |
| 2333 | ofd-group | 3 |
| 2334 | pbo+li/dvp | 6 |
| 2335 | zdv/3tc/nvp | 4 |
| 2336 | zdv/nvp | 7 |
| 2337 | azt/sdnvp | 4 |
| 2338 | hxp | 5 |
| 2339 | sp-aq | 6 |
| 2340 | adq | 3 |
| 2341 | sp+as+pq | 2 |
| 2342 | cq-pq | 8 |
| 2343 | azq | 4 |
| 2344 | chop-r | 17 |
| 2345 | g12r | 1 |
| 2346 | q148r | 1 |
| 2347 | headgear | 95 |
| 2348 | 1.15/year | 1 |
| 2349 | 0.24/patient/year | 1 |
| 2350 | iglar | 117 |
| 2351 | mini-parapatellar | 3 |
| 2352 | linear/micronodular | 2 |
| 2353 | near-planar | 1 |
| 2354 | nacr | 10 |
| 2355 | non-pathcr | 1 |
| 2356 | m-er | 5 |
| 2357 | no-cancer | 1 |
| 2358 | non-producer | 1 |
| 2359 | event-recorder | 2 |
| 2360 | phosphate-buffer | 1 |
| 2361 | caragher | 1 |
| 2362 | silylether | 1 |
| 2363 | gem/other | 2 |
| 2364 | crt-pacemaker | 3 |
| 2365 | acei/β-blocker | 1 |
| 2366 | fortune-teller | 1 |
| 2367 | chitosan-hexamer | 1 |
| 2368 | pelvitrainer | 2 |
| 2369 | sugar-water | 2 |
| 2370 | cprmeter | 7 |
| 2371 | cr-after | 1 |
| 2372 | mission/shelter | 1 |
| 2373 | peritrochanter | 1 |
| 2374 | endoserter | 5 |
| 2375 | electrocauter | 1 |
| 2376 | lma.however | 1 |
| 2377 | red-clover | 1 |
| 2378 | ctr+hr | 1 |
| 2379 | 16-hr | 4 |
| 2380 | α4β2nachr | 1 |
| 2381 | ta-ir | 10 |
| 2382 | oxc-ir | 9 |
| 2383 | tipranavir-ritonavir | 10 |
| 2384 | atazanavir-ritonavir | 8 |
| 2385 | lopinavir-ritonavir | 18 |
| 2386 | etravirine-darunavir-ritonavir | 2 |
| 2387 | saquinavir/ritonavir | 6 |
| 2388 | lopinavirritonavir | 2 |
| 2389 | lopinavir–ritonavir | 1 |
| 2390 | etr/darunavir | 1 |
| 2391 | didanosine/lamivudine/tenofovir | 1 |
| 2392 | desciclovir | 7 |
| 2393 | non-emr | 1 |
| 2394 | mva-f6-sfmr | 1 |
| 2395 | plc-pmr | 2 |
| 2396 | tio+for | 5 |
| 2397 | doctor-counselor | 1 |
| 2398 | aggressor | 7 |
| 2399 | pacemaker-defibrillator | 1 |
| 2400 | ivacaftor-to-ivacaftor | 2 |
| 2401 | po+pr | 1 |
| 2402 | placebo/pr | 3 |
| 2403 | simeprevir/pr | 5 |
| 2404 | vgpr/pr | 1 |
| 2405 | tvr/pr | 3 |
| 2406 | std-cpr | 15 |
| 2407 | s-cpr | 15 |
| 2408 | sigirr | 1 |
| 2409 | tanezumab+dsr | 3 |
| 2410 | placebo+dsr | 2 |
| 2411 | mini-octr | 3 |
| 2412 | citr | 1 |
| 2413 | no-str | 2 |
| 2414 | easyfour | 4 |
| 2415 | metformin-xr | 2 |
| 2416 | smdxr | 2 |
| 2417 | gtp-gamma-s | 2 |
| 2418 | sodb-s | 1 |
| 2419 | rct-s | 6 |
| 2420 | 6.56m/s | 1 |
| 2421 | 10.34°/s | 1 |
| 2422 | 1.74°/s | 1 |
| 2423 | 242±141s | 1 |
| 2424 | g12s | 1 |
| 2425 | 8.2±0.3s | 1 |
| 2426 | 4079±333s | 1 |
| 2427 | 0.9+/-0.5s | 1 |
| 2428 | 51.2±18.9s | 1 |
| 2429 | ics+labas | 2 |
| 2430 | sheikhas | 1 |
| 2431 | unmatched-bias | 1 |
| 2432 | fibrothecomas | 1 |
| 2433 | aceis/aras | 1 |
| 2434 | hydrocolpometras | 1 |
| 2435 | arbs+ccbs | 1 |
| 2436 | leto-gbs | 1 |
| 2437 | egbs | 8 |
| 2438 | cribs | 9 |
| 2439 | gh/cs | 7 |
| 2440 | non-st-elevation-acs | 1 |
| 2441 | dsbcs | 4 |
| 2442 | sham-tdcs | 12 |
| 2443 | post-tdcs | 4 |
| 2444 | lmwh+gcs | 1 |
| 2445 | mont+ics | 2 |
| 2446 | heterospecifics | 1 |
| 2447 | serotonergics | 2 |
| 2448 | macro-ethics | 1 |
| 2449 | beta-blockers/diuretics | 2 |
| 2450 | pro/prebiotics | 3 |
| 2451 | meta-characteristics | 1 |
| 2452 | dipyrone/spasmolytics | 5 |
| 2453 | auto-hmscs | 1 |
| 2454 | sl-uvcs | 4 |
| 2455 | tcas/oads | 3 |
| 2456 | non-bds | 1 |
| 2457 | aicds | 1 |
| 2458 | band-aids | 1 |
| 2459 | peridinioids | 1 |
| 2460 | placebo/steroids | 1 |
| 2461 | ovoids | 1 |
| 2462 | boy/girlfriends | 1 |
| 2463 | ex-boyfriends | 1 |
| 2464 | non-kyds | 2 |
| 2465 | sham-devices | 1 |
| 2466 | states/provinces | 1 |
| 2467 | sevo-des | 1 |
| 2468 | bms/des | 4 |
| 2469 | imidamides | 1 |
| 2470 | nonnucleosides | 3 |
| 2471 | power-modes | 1 |
| 2472 | paranodes | 1 |
| 2473 | pp-ees | 11 |
| 2474 | no-fes | 5 |
| 2475 | α1,3-linkages | 1 |
| 2476 | bellyaches | 1 |
| 2477 | sabethes | 1 |
| 2478 | post-studies | 1 |
| 2479 | poly-chemotherapies | 1 |
| 2480 | small-series | 1 |
| 2481 | comorbities | 1 |
| 2482 | non-celebrities | 1 |
| 2483 | sordariales | 1 |
| 2484 | ice-popsicles | 2 |
| 2485 | 1,4-bisnucleophiles | 1 |
| 2486 | pinnules | 1 |
| 2487 | allergenes | 1 |
| 2488 | tetracyanobuta-1,3-dienes | 1 |
| 2489 | -alkylamino-1,2,3,4-tetrahydropyridines | 1 |
| 2490 | nondihydropyridines | 2 |
| 2491 | xanthen-9h-ones | 1 |
| 2492 | minicones | 1 |
| 2493 | polymethoxychalcones | 2 |
| 2494 | music-headphones | 1 |
| 2495 | epotilones | 1 |
| 2496 | lc-ioes | 5 |
| 2497 | pb-pes | 5 |
| 2498 | radio-isotopes | 1 |
| 2499 | photophores | 1 |
| 2500 | postprocedures | 1 |
| 2501 | pes/ses | 5 |
| 2502 | oxa-carbapenemases | 1 |
| 2503 | pseudophosphatases | 1 |
| 2504 | non-losses | 1 |
| 2505 | noncandidates | 3 |
| 2506 | no-diabetes | 3 |
| 2507 | self-perspectives | 2 |
| 2508 | cocr-zes | 7 |
| 2509 | ecdfs | 1 |
| 2510 | dyestuffs | 1 |
| 2511 | cddgs | 2 |
| 2512 | toxins/drugs | 1 |
| 2513 | ee+hs | 1 |
| 2514 | ckd/hs | 1 |
| 2515 | 8.1months | 1 |
| 2516 | 13.6months | 1 |
| 2517 | 12.7months | 1 |
| 2518 | 10.9months | 1 |
| 2519 | alk-tkis | 1 |
| 2520 | pl-mis | 2 |
| 2521 | itnis | 1 |
| 2522 | maoris | 1 |
| 2523 | postpyloris | 1 |
| 2524 | arthodesis | 1 |
| 2525 | hyper-kinesis | 1 |
| 2526 | dysperistalsis | 1 |
| 2527 | pre-cirrhosis | 1 |
| 2528 | kyposcoliosis | 1 |
| 2529 | desmosterolosis | 1 |
| 2530 | nodulosis | 1 |
| 2531 | anergy/apoptosis | 1 |
| 2532 | bacteremia/urosepsis | 1 |
| 2533 | pseudoepiphysis | 1 |
| 2534 | hyperthyroiditis | 1 |
| 2535 | non-meningitis | 4 |
| 2536 | prostate-vesiculo-epididymitis | 2 |
| 2537 | cerebritis | 1 |
| 2538 | stomatovis | 4 |
| 2539 | hypothalamo-pituitary-adrenal-axis | 2 |
| 2540 | bite-blocks | 2 |
| 2541 | 52weeks | 2 |
| 2542 | nonradicals | 1 |
| 2543 | vocals | 3 |
| 2544 | h-meals | 3 |
| 2545 | l-meals | 1 |
| 2546 | micromaterials | 1 |
| 2547 | change-trials | 1 |
| 2548 | end-goals | 2 |
| 2549 | small-goals | 1 |
| 2550 | s-scls | 4 |
| 2551 | acels | 5 |
| 2552 | keels | 2 |
| 2553 | r-cells | 1 |
| 2554 | 1,2-enediols | 1 |
| 2555 | polyoxytetramethylenediols | 1 |
| 2556 | aspirin+phytosterols | 1 |
| 2557 | progression-controls | 1 |
| 2558 | diazemuls | 5 |
| 2559 | placebo+ms | 2 |
| 2560 | nbca-ms | 10 |
| 2561 | -0.04±0.38ms | 1 |
| 2562 | xeromammograms | 2 |
| 2563 | non-carbapenems | 2 |
| 2564 | sub-systems | 2 |
| 2565 | kpms | 1 |
| 2566 | eg-arms | 1 |
| 2567 | free-forms | 1 |
| 2568 | passive-rtms | 8 |
| 2569 | sham-rtms | 8 |
| 2570 | mi+ns | 1 |
| 2571 | phosphoantigens | 1 |
| 2572 | antipathogens | 1 |
| 2573 | free-regimens | 1 |
| 2574 | placebo-tens | 14 |
| 2575 | λ-signs | 2 |
| 2576 | αb-crystallins | 3 |
| 2577 | microinvasions | 1 |
| 2578 | co-indications | 1 |
| 2579 | triplications | 1 |
| 2580 | conglomerations | 1 |
| 2581 | f1-generations | 1 |
| 2582 | reexplorations | 1 |
| 2583 | venesections | 1 |
| 2584 | non-interventions | 1 |
| 2585 | semipoisons | 1 |
| 2586 | cst+os | 3 |
| 2587 | triclofos | 6 |
| 2588 | psos | 1 |
| 2589 | post-ps | 1 |
| 2590 | tt-ps | 1 |
| 2591 | prolaps | 2 |
| 2592 | oaps | 7 |
| 2593 | prednisolone/mps | 1 |
| 2594 | rp-8-br-camps | 1 |
| 2595 | menps | 21 |
| 2596 | intragroups | 1 |
| 2597 | noninducers | 1 |
| 2598 | nonylphenylethers | 1 |
| 2599 | diuretics/beta-blockers | 7 |
| 2600 | angiotensin-receptor-blockers | 4 |
| 2601 | severe-cyclers | 1 |
| 2602 | decamers | 1 |
| 2603 | hetero-dimers | 1 |
| 2604 | nondisclosers | 1 |
| 2605 | non-endorsers | 2 |
| 2606 | inconsistent/nonusers | 1 |
| 2607 | 3,000/microliters | 2 |
| 2608 | nonstarters | 1 |
| 2609 | zinc-ors | 5 |
| 2610 | ho-ors | 6 |
| 2611 | suture-anchors | 2 |
| 2612 | non-initiators | 4 |
| 2613 | bionators | 2 |
| 2614 | 8.7±3.9hours | 1 |
| 2615 | vurs | 1 |
| 2616 | nonsuccess | 4 |
| 2617 | lkess | 2 |
| 2618 | itopride.nevertheless | 1 |
| 2619 | platinum-responsiveness | 1 |
| 2620 | sloppiness | 1 |
| 2621 | nonusefulness | 1 |
| 2622 | anxiety/nervousness | 1 |
| 2623 | rawness | 1 |
| 2624 | technetium-stress | 3 |
| 2625 | low-weight-loss | 1 |
| 2626 | monoproducts | 1 |
| 2627 | no-ets | 2 |
| 2628 | cdiets | 3 |
| 2629 | gillnets | 2 |
| 2630 | scfts | 1 |
| 2631 | salpingits | 1 |
| 2632 | bronchiolits | 1 |
| 2633 | β₄-subunits | 1 |
| 2634 | mo-salts | 1 |
| 2635 | t-nts | 1 |
| 2636 | plastificants | 1 |
| 2637 | antiplatelets/anticoagulants | 1 |
| 2638 | biagents | 1 |
| 2639 | antiabortifacients | 1 |
| 2640 | valence-judgments | 1 |
| 2641 | cpg-treatments | 2 |
| 2642 | clotrimazole-ointments | 1 |
| 2643 | smartconsents | 1 |
| 2644 | pre-delinquents | 2 |
| 2645 | m-substituents | 1 |
| 2646 | f-tests | 2 |
| 2647 | dermatovenerologists | 1 |
| 2648 | placebo-walnuts | 1 |
| 2649 | aecus | 9 |
| 2650 | hsf3-gus | 1 |
| 2651 | hsf4-gus | 1 |
| 2652 | ldl-radius | 1 |
| 2653 | moodswings-plus | 3 |
| 2654 | alemtuzumab/tacrolimus | 1 |
| 2655 | methotrexate/tacrolimus | 7 |
| 2656 | mtx/tacrolimus | 1 |
| 2657 | octreotide-everolimus | 1 |
| 2658 | cyclosporine/sirolimus | 4 |
| 2659 | tacrolimus/methotrexate/sirolimus | 1 |
| 2660 | tacrolimus/sirolimus | 13 |
| 2661 | dalotuzumab/ridaforolimus | 1 |
| 2662 | cardiopalmus | 1 |
| 2663 | nonspontaneous | 3 |
| 2664 | inguinal-subcutaneous | 1 |
| 2665 | octanol-aqueous | 1 |
| 2666 | axospinous | 1 |
| 2667 | dre/trus | 1 |
| 2668 | exitus | 1 |
| 2669 | tu.xs | 1 |
| 2670 | even-days | 1 |
| 2671 | 20±7.5days | 1 |
| 2672 | o+g+t | 9 |
| 2673 | 1,0,1/t | 1 |
| 2674 | dm/t | 7 |
| 2675 | rtv/sqv/d4t | 5 |
| 2676 | tp/at | 8 |
| 2677 | pharm-cat | 4 |
| 2678 | nogo-repeat | 1 |
| 2679 | group-threat | 2 |
| 2680 | low-cho/high-monounsaturated-fat | 1 |
| 2681 | hydrogenated-vegetable-fat | 1 |
| 2682 | vivostat | 11 |
| 2683 | venlafaxine+cbt | 1 |
| 2684 | placebo/cbt | 1 |
| 2685 | ldr-icbt | 3 |
| 2686 | placebo+obt | 1 |
| 2687 | adhd-ct | 4 |
| 2688 | mi-act | 6 |
| 2689 | celtect | 2 |
| 2690 | losartan/hct | 4 |
| 2691 | tau+mct | 1 |
| 2692 | chemotherapy/autologoussct | 1 |
| 2693 | placebo+adt | 3 |
| 2694 | epi-adt | 2 |
| 2695 | fcdt | 24 |
| 2696 | c-pdt | 5 |
| 2697 | ls+et | 2 |
| 2698 | tincet | 1 |
| 2699 | ddiet | 6 |
| 2700 | cluster-set | 1 |
| 2701 | psychological-mindset | 1 |
| 2702 | diabetes/igt | 3 |
| 2703 | live-caught | 1 |
| 2704 | kardonit | 1 |
| 2705 | haemtocrit | 4 |
| 2706 | deoxycorticosterone/salt | 4 |
| 2707 | et+mt | 9 |
| 2708 | sham-emt | 6 |
| 2709 | sham-imt | 3 |
| 2710 | placebo-imt | 4 |
| 2711 | trimagant | 1 |
| 2712 | vapo-coolant | 2 |
| 2713 | micro-implant | 5 |
| 2714 | insuplant | 6 |
| 2715 | placebo-fulvestrant | 2 |
| 2716 | beractant | 41 |
| 2717 | non-cohabitant | 1 |
| 2718 | non-concomitant | 1 |
| 2719 | loracarbef-resistant | 1 |
| 2720 | unintelligent | 1 |
| 2721 | flagellin-deficient | 1 |
| 2722 | 1.9/patient | 1 |
| 2723 | readmissions/patient | 1 |
| 2724 | hydroxyapatite-cement | 1 |
| 2725 | stentplacement | 4 |
| 2726 | grandiosity/excitement | 1 |
| 2727 | target-achievement | 1 |
| 2728 | staffing/equipment | 1 |
| 2729 | placebo-treatment | 10 |
| 2730 | ffns-treatment | 1 |
| 2731 | disajustment | 1 |
| 2732 | uncoated-stent | 1 |
| 2733 | non-consistent | 2 |
| 2734 | hpv-persistent | 1 |
| 2735 | ≤3-point | 1 |
| 2736 | acrypoint | 1 |
| 2737 | 3804+/-494jsprint | 1 |
| 2738 | cc-pt | 3 |
| 2739 | escitalopram+ipt | 2 |
| 2740 | mipt | 4 |
| 2741 | trusopt | 10 |
| 2742 | fb-rt | 7 |
| 2743 | glargine/detemir-aspart | 1 |
| 2744 | glargine/aspart | 2 |
| 2745 | wp-crt | 9 |
| 2746 | ef-rt.crt | 1 |
| 2747 | 5fu-ccrt | 6 |
| 2748 | hfrt/afrt | 1 |
| 2749 | ngrt | 6 |
| 2750 | s-imrt | 4 |
| 2751 | sham-nrt | 1 |
| 2752 | ucort | 2 |
| 2753 | pstae-yoghurt | 1 |
| 2754 | bilevel-st | 7 |
| 2755 | tac/mmf/st | 1 |
| 2756 | wilcoxon-rank-sum-test | 1 |
| 2757 | non-vest | 1 |
| 2758 | atheist | 1 |
| 2759 | stomatologist | 1 |
| 2760 | tearmist | 1 |
| 2761 | b2-antagonist | 1 |
| 2762 | bak-tafluprost | 2 |
| 2763 | non-pst | 3 |
| 2764 | enalapril-first | 4 |
| 2765 | bisoprolol-first | 5 |
| 2766 | defibrillation-first | 2 |
| 2767 | matt | 15 |
| 2768 | trα-knock-out | 1 |
| 2769 | lo-output | 1 |
| 2770 | pdt/ivb/ivt | 1 |
| 2771 | 200-u | 6 |
| 2772 | keishinieppiittokaryojutsubu | 2 |
| 2773 | cisplatin/leucovorin/5-fu | 1 |
| 2774 | t5-fu | 5 |
| 2775 | eglu | 1 |
| 2776 | bencao-gangmu | 1 |
| 2777 | dtmu | 1 |
| 2778 | tssu | 1 |
| 2779 | ldv/sof+rbv | 2 |
| 2780 | peg-ifnα2b/rbv | 2 |
| 2781 | zalcitabine/zdv | 1 |
| 2782 | pac+cb+bev | 7 |
| 2783 | xeliri-bev | 7 |
| 2784 | folfox/bev | 4 |
| 2785 | xelox/bev | 4 |
| 2786 | paccbev | 6 |
| 2787 | tdf/ftc/efv | 1 |
| 2788 | zdv/3tc/nfv | 2 |
| 2789 | i+iv | 1 |
| 2790 | dcg-iv | 1 |
| 2791 | dzp-iv | 5 |
| 2792 | tcz-iv | 10 |
| 2793 | cc5-mrsa-i/ii/iv | 1 |
| 2794 | hcp-laiv | 5 |
| 2795 | proactiv | 4 |
| 2796 | fu+lv | 9 |
| 2797 | irinotecan+fu/lv | 1 |
| 2798 | irinotecan+5fu/lv | 1 |
| 2799 | uv/mv | 1 |
| 2800 | dtp-ipv | 4 |
| 2801 | li-nppv | 10 |
| 2802 | dvd-irv | 1 |
| 2803 | 27.8±9.4msv | 1 |
| 2804 | 7.4±2.6msv | 1 |
| 2805 | npsv | 7 |
| 2806 | abc/3tc+atv | 7 |
| 2807 | darunavir-rtv | 1 |
| 2808 | tid40w | 2 |
| 2809 | sham-aw | 1 |
| 2810 | free-jaw | 2 |
| 2811 | grandmother-in-law | 1 |
| 2812 | craniocaudal-view | 1 |
| 2813 | -elbow | 1 |
| 2814 | auc-low | 3 |
| 2815 | integrated-low | 2 |
| 2816 | ii-low | 1 |
| 2817 | asdas-low | 4 |
| 2818 | not-follow | 1 |
| 2819 | σ-re-x | 1 |
| 2820 | depain-x | 8 |
| 2821 | 556.x | 1 |
| 2822 | x/x | 1 |
| 2823 | hemopneumothorax | 2 |
| 2824 | dryvax | 4 |
| 2825 | prp/bdx | 3 |
| 2826 | nobex | 4 |
| 2827 | a_rimidex | 1 |
| 2828 | mesnex | 2 |
| 2829 | non-apex | 2 |
| 2830 | earex | 1 |
| 2831 | bfhx | 6 |
| 2832 | hypafix-elefix | 2 |
| 2833 | pre-mix | 14 |
| 2834 | zn-ppix | 2 |
| 2835 | dermamatrix | 3 |
| 2836 | primatrix | 3 |
| 2837 | havrix-havrix | 1 |
| 2838 | at→cmx | 2 |
| 2839 | rif-mmx | 8 |
| 2840 | tm-smx | 1 |
| 2841 | hypo-pharynx | 1 |
| 2842 | mobicox | 2 |
| 2843 | bevacizumab-xelox | 7 |
| 2844 | norx | 4 |
| 2845 | dtmu/trx | 1 |
| 2846 | placebo+mtx | 12 |
| 2847 | placebo-mtx | 6 |
| 2848 | infliximab/mtx | 2 |
| 2849 | pbo/mtx | 5 |
| 2850 | 5fu/mtx | 4 |
| 2851 | cbdca/ptx | 4 |
| 2852 | enoxaparin-idrabiotaparinux | 2 |
| 2853 | d1246y | 2 |
| 2854 | ln=y | 1 |
| 2855 | 3.1g/day | 1 |
| 2856 | 6g/kg/day | 2 |
| 2857 | 300mg/kg/day | 4 |
| 2858 | 100ml/kg/day | 2 |
| 2859 | 3h/day | 1 |
| 2860 | 4mgday | 1 |
| 2861 | jaukay | 1 |
| 2862 | 12gray | 1 |
| 2863 | angioconray | 3 |
| 2864 | disability/dependency | 2 |
| 2865 | ivcy | 4 |
| 2866 | *i-ib-mal-d-geeek-nanobody | 1 |
| 2867 | 15-gy | 3 |
| 2868 | 6.0gy | 1 |
| 2869 | 30gy | 8 |
| 2870 | 3.8gy | 1 |
| 2871 | xenophagy | 1 |
| 2872 | micromitophagy | 1 |
| 2873 | otorragy | 1 |
| 2874 | na-hy | 8 |
| 2875 | angiorrhaphy | 1 |
| 2876 | xeromammography | 2 |
| 2877 | galactography | 5 |
| 2878 | never/rarely | 3 |
| 2879 | non-intensively | 2 |
| 2880 | transtympanically | 1 |
| 2881 | post-synaptically | 1 |
| 2882 | cortico-subcortically | 2 |
| 2883 | infratentorially | 1 |
| 2884 | paraxially | 1 |
| 2885 | extraturbinally | 1 |
| 2886 | supraliminally | 1 |
| 2887 | peritumorally | 1 |
| 2888 | supraperiostally | 1 |
| 2889 | pre-conceptually | 1 |
| 2890 | hfsa-only | 1 |
| 2891 | repaglinide-only | 2 |
| 2892 | dinoprostone-only | 5 |
| 2893 | methylphenidate-only | 4 |
| 2894 | icsi-only | 2 |
| 2895 | oral-only | 4 |
| 2896 | detoxification-only | 3 |
| 2897 | polymer-only | 2 |
| 2898 | cpr-only | 3 |
| 2899 | abstracts-only | 3 |
| 2900 | tau-only | 5 |
| 2901 | mild/early | 6 |
| 2902 | non-concomitantly | 2 |
| 2903 | neo-adjuvantly | 1 |
| 2904 | dermofasciectomy | 3 |
| 2905 | adenoitonsillectomy | 1 |
| 2906 | phaco-trabeculectomy | 5 |
| 2907 | trabeculectomy-alt-trabeculectomy | 2 |
| 2908 | microtrabeculectomy | 4 |
| 2909 | pancreatico-splenectomy | 4 |
| 2910 | retinectomy | 1 |
| 2911 | eversion-endarterectomy | 1 |
| 2912 | parametrectomy | 1 |
| 2913 | bi/trisegmentectomy | 1 |
| 2914 | tubotomy | 4 |
| 2915 | nonceliotomy | 1 |
| 2916 | laporotomy | 1 |
| 2917 | colocolostomy | 1 |
| 2918 | pancreatojejunostomy | 6 |
| 2919 | ptany | 1 |
| 2920 | control-therapy | 2 |
| 2921 | antiplatelet-therapy | 1 |
| 2922 | ato+atra+chemotherapy | 1 |
| 2923 | immuno-chemotherapy | 11 |
| 2924 | aspirin-monotherapy | 3 |
| 2925 | triple-immunotherapy | 2 |
| 2926 | nonfluoroscopy | 2 |
| 2927 | non-atopy | 1 |
| 2928 | principal/secondary | 1 |
| 2929 | right-noncoronary | 1 |
| 2930 | low-fat/sedentary | 1 |
| 2931 | cold/dry | 1 |
| 2932 | opcab-surgery | 1 |
| 2933 | biopsy/surgery | 2 |
| 2934 | embosurgery | 1 |
| 2935 | negative-angry | 1 |
| 2936 | olfactory+gustatory | 1 |
| 2937 | aav2-cox8-mcherry | 2 |
| 2938 | play-audiometry | 1 |
| 2939 | irrelevant/noisy | 1 |
| 2940 | co-toxicity | 1 |
| 2941 | transsexuality | 1 |
| 2942 | indeterminate-probability | 1 |
| 2943 | buildability | 1 |
| 2944 | acceptability/tolerability | 4 |
| 2945 | aggression/hostility | 1 |
| 2946 | malignity | 4 |
| 2947 | locularity | 2 |
| 2948 | angularity | 1 |
| 2949 | self-complementarity | 1 |
| 2950 | low-cavity | 1 |
| 2951 | 6-activity | 2 |
| 2952 | non-activity | 1 |
| 2953 | midpuberty | 1 |
| 2954 | mosaicplasty | 18 |
| 2955 | nfjxy | 1 |
| 2956 | mono-methoxy | 1 |
| 2957 | ooxy | 6 |
| 2958 | adlacz | 6 |
| 2959 | 4.6+/-1.1ms/hz | 1 |
| 2960 | lopinavir/ritonavir+efavirenz | 1 |
| 2961 | stavudine/lamivudine/efavirenz | 1 |
| 2962 | abacavir/lamivudine/efavirenz | 1 |
| 2963 | ghr+phosphate-sandoz | 2 |
| 2964 | clnp-bpo2.5/tz | 3 |
| 2965 | aml+hctz | 5 |
| 2966 | valsartan-hctz | 2 |
| 2967 | aml/hctz | 3 |
| 2968 | d₄₂ | 1 |
| 2969 | na₂seo₃ | 5 |
| 2970 | 140℃ | 2 |
| 2971 | ltd₄ | 1 |
| 2972 | kbh₄ | 1 |
| 2973 | pbp2xhis₆ | 1 |
| 2974 | berocca™ | 4 |
| 2975 | engerix-b™ | 6 |
| 2976 | hiberix™ | 7 |
| 2977 | 1.996.500€ | 1 |
| 2978 | survanta® | 2 |
| 2979 | sagb® | 2 |
| 2980 | hextend® | 7 |
| 2981 | cannualaide® | 2 |
| 2982 | restylane® | 5 |
| 2983 | hurricaine® | 3 |
| 2984 | yvoire® | 2 |
| 2985 | concise® | 1 |
| 2986 | beschitin-f® | 3 |
| 2987 | cervex-brush® | 2 |
| 2988 | mmrii® | 1 |
| 2989 | pepsi® | 1 |
| 2990 | opticol® | 2 |
| 2991 | structum® | 4 |
| 2992 | prolastin® | 2 |
| 2993 | forteo® | 2 |
| 2994 | locator® | 6 |
| 2995 | pds® | 1 |
| 2996 | erypo®/eprex® | 11 |
| 2997 | cinnovex® | 1 |
| 2998 | 17.9‰ | 1 |
| 2999 | 24.0° | 2 |
| 3000 | 270° | 6 |
| 3001 | -4.8±3.1° | 1 |
| 3002 | 49.1° | 1 |
| 3003 | 1.41° | 1 |
| 3004 | 31.3° | 2 |
| 3005 | 163.3° | 1 |
| 3006 | 29.3° | 1 |
| 3007 | 76°±3° | 1 |
| 3008 | 19.4°±11.4° | 1 |
| 3009 | 90.5° | 1 |
| 3010 | 12.5° | 3 |
| 3011 | 84.5° | 1 |
| 3012 | 181.6° | 1 |
| 3013 | 9.3±2.6° | 1 |
| 3014 | 54.6° | 2 |
| 3015 | 64.6° | 1 |
| 3016 | 7.0°±4.6° | 1 |
| 3017 | 14.9±1.7° | 1 |
| 3018 | 10.5±2.8° | 1 |
| 3019 | 128° | 6 |
| 3020 | 49° | 2 |
| 3021 | δtnf-α | 1 |
| 3022 | nap+ifn-α | 1 |
| 3023 | bcg-ifn-α | 1 |
| 3024 | cd79α | 1 |
| 3025 | α-substituted-α-hydroxy-β | 1 |
| 3026 | r-γ | 1 |